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ABSTRACT
This thesis examined the incidence and factors affecting the rate o f  posterior capsular 
opacification (PCO), the most com mon complication o f  cataract surgery, in diabetic 
and uveitic patients and in patients with multifocal intraocular lenses (IO L s). These 
patients are particularly sensitive to PCO developm ent because o f  the risks 
associated with Nd:Y AG  capsulotom y in the former two groups and the potential 
effect on visual function in the latter group. PCO rate was estimated both 
retrospectively, using N d:Y A G  capsulotomy as a surrogate m easure o f  clinically 
significant PCO, as well as prospeetively using clinical and im aging methods.
Diabetic patients were found to have a lower incidence and risk o f  Nd:YAG 
capsulotomy than non-diabetic patients within 4 years after surgery. Y oung age, 
postoperative inflammation, pars plana vitrectomy and, in comparison to 3-piece 
silicone lOL, polym ethylmethacrylate (PM M A ) and plate-haptic silicone IOLs were 
associated with increased risk o f  N d.Y A G  capsulotomy. In subgroup analysis, male 
gender was found to be a risk factor in the non-diabetic group and the duration and 
type o f  diabetes and diabetic retinopathy grade were not risk factors. In a prospective 
randomised trial, hydrophobic acrylic IOLs, while associated with a higher flare 
value within the early postoperative period, had a significantly lower rate o f  PCX) 
development than plate-haptic silicone IOLs after 6 months and 1 year in diabetic 
patients. Optical coherence tom ography revealed the development o f  a characteristic 
mid-peripheral apposition between the optic and the posterior capsule with 
hydrophobic acrylic IOLs both early and late after surgery, and the lack thereof with 
plate-haptic silicone IOLs, which is consistent with and explains the difference in 
PCO rate between the two IOLs.
In uveitic patients, the incidence o f  Nd:Y AG  capsulotomy was higher within the first 
two years after surgery than in non-uveitic patients, although the presence o f  uveitis 
was not an independent risk factor for an increased rate o f  N d:Y AG  capsulotomy. 
The use o f  preoperative systemic steroids reduced the risk o f  N d .Y A G  capsulotom y 
and, in comparison to PM M A  IOLs, silicone IOLs reduced the risk o f  Nd:YAG 
capsulotomy while hydrophilic acrylic IOLs and young age increased it.
In patients with multifocal IOLs, within 4 years o f  follow-up the incidence o f  PC'O 
and Nd:YAG capsulotomy were similar to those reported with monofocal implants
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and young age was a risk factor for the development o f PCO. Patients with 
multifocal IOLs present for Nd:YAG capsulotomy with earlier loss of high and low- 
contrast acuity, which could increase the rate o f Nd:YAG capsulotomy in these 
patients.
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1 INTRODUCTION AND REVIEW OF THE 
LITERATURE
1.1 INTRODUCTION
1.1.1 Cataract surgery and posterior capsular opacification: 
perspective and aims of the thesis
Cataract, the leading cause o f blindness all over the world, poses a significant 
challenge to the medical profession and health authorities. The increase in the 
population age and the modem enhancement o f surgical techniques have led to lower 
threshold for surgical intervention and hence an increase in the cataract workload. 
Approximately 156,500 cataract operations were carried out under the National 
Health Service in England and Wales in 1995/6 (Minassian et al, 2000). This is now 
estimated to have risen to 270,000 in 2002/3, making it one o f the most commonly 
performed elective procedures in the UK (Royal College o f Ophthalmologists, 2004). 
Moreover, the number of cataract extraction procedures performed all over the world 
is predicted to increase under the auspices o f Vision 2020 Global Initiative from the 
current annual rate of 8 millions to about 35 millions by 2020 (Taylor, 1999).
In diabtic and uveitic patients, cataract is more prevalent. In a review o f two case- 
control studies, Harding et al, 1993 (Harding et al, 1993), found that diabetes was a 
highly significant risk factor for cataract development with a relative risk o f 5.04. In 
the Wisconsin Epidemiological Study o f Diabetic Retinopathy (WESDR) (Klein et 
al, 1984), cataract was the most common cause of decreased vision in older-onset 
and the second commonest cause after proliferative retinopathy in younger-onset 
diabetics. The relative scarcity o f uveitis patients led to the lack o f epidemiological 
data on the prevalence o f cataract in them. Howevre, the incidence has been 
estimated to be between 10%, in HLA-B27 negative patients (Power et al, 1998), and 
77.8%, in Fuchs’ heterochromic cyclitis patients (Velilla et al, 2001).
Posterior capsular opacification (PCO) remains the most common complication of 
modem extracapsular cataract extraction and intraocular lens (IOL) implantation. It 
impairs the visual function (Magno et a l, 1997;Hayashi et al, 2003) and obstructs the
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fundus view and, therefore, can interfere with early recognition and timely treatment 
o f posterior segment diseases such as diabetic retinopathy in diabetic patients and 
macular oedema in diabetic and uveitic patients. In patients with multifocal IOLs, 
PCO can compromise visual function, in particular contrast sensitivity that is already 
compromised by the multifocal design o f the implant optic.
Nd:YAG laser capsulotomy, the procedure of choice in treating patients with PCO, is 
a simple outpatient procedure that takes few minutes to perform and leads to 
significant improvement o f visual function in the majority o f patients (Magno et al, 
1997;Hayashi et al, 2003). The procedure, however, is not without complications that 
include damage to the IOL, rise o f intraocular pressure, anterior uveitis and 
potentially sight-threatening complications such as cystoid macular oedema and 
retinal breaks or detachment (Keates et al, 1984;Javitt et al, 1992;Johnson et al, 
1984;Jahn et al, 2003;Ranta et al, 2004). Moreover, Nd:YAG capsulotomy incurs 
considerable costs and exhausts the resources o f healthcare systems. In the United 
States, Nd:YAG capsulotomy is the second most commonly reimbursed procedure 
after cataract extraction and has been estimated to cost the Medicare program $250 
million a year (Steinberg et al, 1993). The prohibitive cost of laser machines limits 
the availability o f Nd:YAG capsulotomy to patients in the developing counties.
PCO has been estimated to occur in up to a third o f the patients in 5 years 
(Schaumberg et al, 1998). While several studies have investigated PCO development 
in non-diabetic and non-uveitis patients and after monofocal IOL implantation, 
information about the incidence and factors affecting PCO rate in diabetic and 
uveitic patients and after multifocal IOL implantation are either conflicting or 
lacking.
Recent PCO studies often relied on the quantitative measurement o f the density or 
extent of PCO using several imaging techniques for reporting PCO development and 
its incidence. While invaluable for research purposes, these imaging techniques and 
the reported PCO rates very often merely reflected early postoperative LEC activities 
and do not necessarily reflect what might be a clinically significant PCO i.e. one that 
reduces visual function or visibility o f the posterior segment and thus requires 
treatment. Lens epithelial cell growth onto the posterior capsule can be variable in 
the short-term (Findl et al, 2004) and even show regression on the long-tem (Hollick 
et al, 1998;Meacock et al, 2001 ;Findl et al, 2004).
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On the other hand, Nd:YAG capsulotomy, which has been used before as a surrogate 
measure of clinically significant PCO (Knorz et al, 1991; Apple et al, 2001;Baratz et 
al, 2001;Ando et al, 2003), is a perfectly acceptable surrgate measure o f PCO if our 
goal is to reduce the additional clinical and financial burdens the procedure imposes 
on patients as well as on the already exhausted health care resources, in addition to 
improving the overall outcome o f cataract surgery. Although, it has been contended 
that the indications for Nd:YAG capsulotomy can be subject to variations in patients’ 
tolerance o f PCO-induced symptoms and to clinician’s threshold for intervention, 
these indications are generally uniform within the same unit and universally fall into 
either o f two main categories: (1) to improve the visual function or eliminate other 
PCO-induced symptoms e.g. glare or double vision, or (2) to improve the fundus 
visualisation.
In this thesis, the main aims were:
1. To estimate the incidence o f PCO, using Nd:YAG capsulotomy as a surrogate 
measure o f clinically significant PCO, in diabetic and uveitic patients and 
after multifocal intraocular lens implantation.
2. To examine the factors influencing Nd:YAG capsulotomy rates in the three 
patient groups with emphasis on the effect o f different IOLs in diabetic and 
uveitic patients and functional changes in patients with multifocal IOLs.
Estimating the incidence and identifying the factors influencing the development of 
PCO and the need for Nd:YAG capsulotomy will help in peri-perative counselling of 
patients as well as in developing strategies to reduce or even prevent the 
development o f PCO and the need for Nd:YAG capsulotomy in the above patient 
groups. That should help to reduce the demands on the healthcare system resources 
and improve the overall outcome o f cataract surgery.
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1.1.2 Embryology, anatomy and histology of the lens and its 
capsule
Crystalline lens development (Saha et al, l989;Henry & Grainger, l990;Kuszak et 
al, 2000) begins at the first month o f gestation from the surface ectoderm overlying 
the optic vesicle. The ectodermal cells thicken to form the lens placode, which 
subsequently invaginates and eventually separates forming the lens vesicle. The 
basement membrane o f the epithelial cells, lying now on the exterior o f the lens 
vesicle, forms the lens capsule. The cuboidal epithelium lining the posterior half o f 
the vesicle then begins to elongate and extend anteriorly, forming the primary lens 
fibres and obliterating the cavity o f the lens vesicle. The anterior cuboidal cells, 
known later as the lens epithelial cells (LECs), also proliferate at the equator, 
forming the secondary lens fibres.
The lens (Saxby, 1999) is located behind the iris and pupil, held in place by means of 
zonular fibres that attach it the ciliary body processes, with its anterior surface in 
contact with the aqueous humour and its posterior surface in contact with the 
vitreous. It has an asymmetric oblate spheroid shape and its equatorial axis lies 
perpendicular to the sagittal plane and its polar axis lies parallel to the sagittal plane. 
The anterior lens surface is 3.5mm behind the cornea. The dimensions o f the lens 
increase steadily throughout life, with the highest rate occurring during the early 
years. The equatorial diameter is about 5mm at birth and steadily increases to reach 9 
to 10mm at the age o f 20 years. The central thickness is about 3.5 to 4mm at birth 
and can reach up to 4.75 to 5 mm.
The lens capsule (Saha et al, 1989;Henry & Grainger, 1990;Saxby, 1999;Kuszak et 
al, 2000) is a PAS-positive structure that is produced by the LECs. The anterior 
capsule is 14-21 pm while the posterior is 4 pm. The capsule increases in thickness 
until approximately 35 years o f age when the equator and the posterior pole thin 
slightly while the anterior capsule remains stable (Kuszak, 1997;Kuszak et al, 2000). 
Immunohistochemical studies showed that the anterior capsule contains collagen 
types IV, V & VI, while the posterior capsule laminin and collagen type IV (Saika et 
al, 1998).
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Two distinct types o f LECs were described (Vargas et a l, 2001;Kuszak et al, 2000). 
The first type is A-cells. These cells are located in the anterior central zone 
(corresponding to the zone o f the anterior lens capsule) and have minimal mitotic 
activity. When disturbed, the primary type o f response o f A-cells is to proliferate in 
situ and form fibrous tissue by undergoing fibrous metaplasia (Font & Brownstein, 
1974;Fagerholm, 1982). The anterior subcapsular plaques that form in a variety of 
disorders (e.g., inflammation, trauma or with certain types o f posterior chamber or 
phakic IOLs) are typical examples o f A-cell response. The second type is E-cells. 
These cells are the germinal cells located at the equator o f the lens and normally 
contribute to the formation o f the nucleus, epi-nucleus and cortex o f the crystalline 
lens. They normally show mitotic activities, and continuously produce new lens 
fibres, accounting for a constant growth in size and weight o f the lens throughout 
life. They are also rich in enzymes and have extensive protein metabolism. In 
pathological states, the E-cells tend to migrate posteriorly along the posterior 
capsule, forming large, balloon-like bladder cells (Wedl cells). E-cells are the 
primary source o f classic secondary cataract, especially LEC pearls (Kappelhof et al, 
1986;Fagerholm, 1982). They are also responsible for the formation o f Soemmering's 
ring, an amalgam lesion composed o f retained or regenerated cortex and LECs and is 
considered the basic prototype o f classic PCO (Kappelhof et al, 1985).
The lens fibres (Kuszak, 1997;Saxby, 1999;Kuszak et al, 2000) form three distinct 
layers: the elongating fibres, the cortical fibres and the nuclear fibres. The elongating 
fibres consist o f newly forming lens fibres that mature by losing their intracellular 
organelles, namely the nuclei, the Golgi apparatus and endoplasmic reticulum. The 
cortex is comprised o f all mature secondary fibres. The nucleus consists also of 
mature secondary fibres but is divided according to developmental and growth 
criteria into: a) the embryonic nucleus consisting solely of primary lens fibres, b) the 
foetal nucleus consisting o f the embryonic nucleus and all the added secondary fibres 
until parturition, d) the infantile nucleus consisting of the foetal nucleus and all the 
secondary fibres that are formed within the first 4 years o f life, e) the juvenile 
nucleus consisting of the secondary fibres formed until sexual maturation and f) the 
adult nucleus, consisting o f the juvenile nucleus and all the fibres added onto it until 
middle age.
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1.1.3 Cataract extraction techniques
Couching is the first surgical procedure known to treat cataract surgically and is only 
o f historic interest. Intracapsular cataract extraction is now obsolete. The most 
common techniques used nowadays for cataract extraction in adults are extracapsular 
cataract extraction (ECCE) and phacoemulsification, both are described below. The 
universal tendency is towards expanding the use o f phacoemulsification as the 
primary technique of cataract extraction for the advantages that are discussed later 
(1.1.3.2.2). In the United States, phacoemulsification is now used in more than 90% 
of cataract surgeries (Masket et al, 2001;Leaming, 2002) and in the UK’s 1997/8 
National Cataract Survey (Desai et al, 1999), phacoemulsification was performed on 
77% o f cases in the National Health Service (NHS), with proportions between 10% 
and 99%.
1.1.3.1 Extracapsular cataract extraction (Figure 1 -1)
The technique o f ECCE is shown in Figure l - l . It involves a corneal or corneoscleral 
incision o f about 10-mm chord (between 2 and 10 o’clock at the superior limbus). 
This is followed by the injection o f a viscoelastic substance in the anterior chamber 
and the performance o f a can-opener capsulotomy. The nucleus is then 
hydrodissected, to separate it from the cortex, and delivered through the wound using 
a vectis to apply gentle pressure at the superior limbal area, and a hook to assist that 
by counter-pressing at the inferior limbal area. The cortical lens matter is then 
removed using either a manual or an automated irrigation-aspiration system. Filling 
the anterior chamber with a viscoelastic substance precedes the implantation o f an 
IOL and closure of the wound with 10/0 nylon sutures after washing out o f the 
excess viscoelastic substance, which concludes the procedure.
Several modifications have been made to the above technique. The most important of 
these was the ‘endocapsular’ or ‘intercapsular cataract extraction’. In this technique, 
an incomplete capsulotomy is made by creating a semicircular flap o f the anterior 
capsule. The nucleus and cortical matter are then removed as before, the IOL placed 
inside the capsular bag and the capsulotomy completed. The rest o f the procedure is 
as above. The advantages were protection of comeal endothelial cells in addition to 
those advantages of in-the-bag placement o f the IOL i.e. reduced incidence of IOL 
decentration and posterior synechiae (Naylor et al, 1989).
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Figure 1-1. A schem atic  d iag ram  of the steps of ex tra cap su la r  c a ta ra c t 
extraction. P artia l-th ick n ess  corneal section (a & b) o f abo u t 10-mm ch o rd ; can- 
opener capsulo tom y (c) o r con tinuous cu rv ilin ea r capsu lorhex is (d) p erfo rm ed  
th rough  a sm all incision; hvdrod issection  and  n u clear m aneuvering  to sep ara te  
it from  the cortex  (e); en la rg em en t of the corneal section (f); n u c lear delivery  by 
pressing  on the su p erio r edge of the w ound by a vectis and  coun te r-p ress in g  a t 
the opposite lim bal a rea  by a hook (g); irrig a tio n -a sp ira tio n  o f the cortical 
m a tte r (h); insertion  of the IO L  in the sulcus o r cap su la r bag (i); closure of the 
w ound w ith 10/0 nylon (j) (L aw rence , 2000) (with perm ission from  S aunders
C om pany).
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1.1.3.2 Phacoemulsification cataract extraction (Figure 1-2)
The introduction o f the concept of phacoemulsification by Charles Kelman during 
the 60’s decade (Kelman, 1967), marked a significant evolutionary stage o f cataract 
surgery.
/ .  1.3.2.1 Surgical technique
The procedure o f phacoemulsification is normally carried out under local 
anaesthesia, using anaesthetic eye drops or subtenon, retrobulbar or peribulbar 
injections. General anaesthesia is infrequently used in patients who refuse local 
anaesthesia and in those unable to cooperate such as children and mentally disabled 
adults.
The technique o f phacoemulsification (Figure 1-2) includes a corneal or scleral 
tunnel incision, a continuous curvilinear capsulorhexis, ultrasound-assisted 
emulsification of the lens nucleus, irrigation-aspiration removal o f the cortical lens 
matter and insertion of an IOL in the capsular bag after filling it with a viscoelastic 
substance. The development o f foldable intraocular lenses, , accompanied the 
increasing use o f phacoemulsification and enabled the use of smaller incisions of 2.8 
to 3.2mm.
1.1.3.2.2 A (/vantages o f  phacoem  unification
The technique of phacoemulsificaition has several advantages over ECCE. The 
smaller corneal incision used in phacoemulsification minimises postoperative 
surgically-induced astigmatism (el Maghraby et al, 1993;Zheng et al, 1997;Naus et 
al, 1995;Neumann et al, 1989). The tight seal of the small incision around the hand­
piece allows better maintenance o f the anterior chamber and intraocular pressure 
during the procedure and reduces the likelihood of vitreous prolapse in case of 
posterior capsular tear and suprachoroidal haemorrhage in predisposed patients. 
Also, phacoemulsification o f the nucleus induces minimal trauma to the iris and 
results in less damage to the blood-aqueous barrier than after ECCE and hence less 
postoperative inflammation (Oshika et al, 1992). The latter contributes to reducing 
the incidence of postoperative cystoid macular oedema (Ursell et al, 1999;Mentes et 
al, 2003). These attributes have resulted in speedy postoperative functional recovery 
of the patients (Watson & Sunderraj, 1992;Naus et al, 1995). Also, when required,
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posterior segment surgery such as vitrectomy or scleral buckling can be safely 
performed because o f the small and more secure wound.
L l.3 .2 .3  Disadvantages o f  phacoemulsification
Reliance on technology, the need for a longer period o f training than with ECCE in 
addition to the excessive cost o f the equipment and their maintenance are obvious 
disadvantages of phacoemulsification, with costs being the main limiting factor for 
its widespread use in the developing countries.
On balance, however, it is believed that the peri-operative complication rate during 
the learning period o f phacoemulsification is comparable to that of ECCE (Seward et 
al, 1993;Thomas et al, 1997) and that overall the advantages outweigh the 
disadvantages.
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Figure 1-2. A schem atic d iag ram  of the steps of phacoem ulsification. D esigning 
the incision: u n ip lan a r , b ip la n a r o r tr ip la n a r  (a), continuous cu rv ilin ea r 
capsulorhexis by sh earing  (b) o r trac tio n  using forceps (c), hydrod issection  (d), 
initial grooving of the nucleus (e), d iv id ing  the nucleus into halves (f), d ividing 
the nucleus into q u a d ra n ts  an d  rem oval of each q u a d ra n t in sequence (g), 
chopping  (an a lte rn a te  w ay of d iv id ing  the nucleus) (h), irr ig a tio n -a sp ira tio n  of 
the cortical lens m a tte r  (i), in sertion  of a foldable IO L im plan ts (A zar & 
R um elt, 2000) (w ith perm ission  from  S aunders C om pany).
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1.1.4 Intraocular lenses used after cataract extraction: 
physical properties and clinical features
Harold Ridley in 1949 (Ridley, 1952;Ridley, 1954) was the first to use IOLs. He 
conceived the idea after he observed that pilots who sustained Plexglas intraocular 
foreign bodies from aeroplane canopies, did not manifest significant intraocular 
inflammatory reaction.
Table 1-1 shows the general features of the three materials used for manufacturing 
IOL optics, namely polymethylmethacrylate, silicone and acrylate (or acrylic). IOLs 
(Seward, 1997;Dick et al, 2001;Daynes et al, 2002;Tehrani et al, 2004) vary widely 
in the physical properties o f their material e.g. refractive indices, water contents and 
the water-contact angle. The latter is measured by the sessile drop method and 
characterises the material surface tension and negatively correlates with its 
hydrophilicity (Cunanan et al, 1998;Dick et al, 2001;Tehrani et al, 2004). Increased 
hydrophilicity was shown to enhance the implant uveal biocompatibility, leading to 
decreased surface cellular reaction and less damage to the blood-aqueous barrier 
(Amon & Menapace, 1992;Amon & Menapace, 1994;Mester et al, 1998;McCulley, 
2003). Increased IOL hydrophilicity, however, was also shown to increase LECs 
proliferation and PCO development i.e. reduced capsular biocompatibility (Hollick et 
al, 1999b;Mullner-Eidenbock et al, 2001;Abela-Formanek et al, 2002c; Abela- 
Formanek et al, 2002b). IOLs also vary in their overall diameter, the optic size and 
shape, the haptic shape, angulation and material. Functionally, IOLs are classified 
depending on whether their design allows for a single focus (monofocal) or multiple 
foci (multifocal) formation on the retina.
1.1.4.1 Polymethylmethacrylate (PMMA) IOLs
PMMA IOLs are still considered the reference to which other IOLs are compared. 
The main features of PMMA IOLs are detailed in Table l - l .  These lenses are rigid, 
inert, light and relatively inexpensive. They has <1% water content. Because of their 
rigidity, they are introduced through large incisions (usually >5mm), which often 
require suturing.
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Table 1-1. General physical properties of the currently available generic types of IOLs (Seward, 1997;Cunanan e ta l , 1998;Doan
et al, 2002;Tehrani et al, 2004)
PMMA Silicone Hydrophobic Acrylic Hydrophilic Acrylic (hydrogel)
Material Polymethyl-methacrylate Elastomer of polydimethylsiloxane Copolymers o f acrylate and methacrylate Copolymer o f methacrylate
Rigidity Rigid Foldable Foldable Foldable
Contact angle 68.1-75.5 106-119 87.6-72.7 59.2-69.1
Water contents <1 % <1 % <2% 18%-30%
Refractive index 1.49 1.41-1.47 1.44-1.55 1.47
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PCO was found to occur at a higher rate with PMMA IOLs than with silicone and 
acrylic IOLs (Ursell et al, 1998;Hayashi et al, 1998c;Hollick et al, 1999c;Apple, 
2000). Heaprin-coating o f the PMMA IOL surface has led to reduced cellular 
reaction on their anterior surfaces (Amon et al, 1996) and less postoperative 
inflammatory reaction (Borgioli et al, 1992;Shah & Spalton, 1995a). Recently, 
‘snowflake opacification’ of PMMA IOLs has been described by Apple et al (Apple 
et al, 2002). It was suggested to be due to direct destruction or molecular breakdown 
of the PMMA polymer by ultraviolet radiation and found to cause visual disturbance 
ranging from glare to severe blurring o f vision.
1.1.4.1,1 Monofocal and diffractive multifocal PMMA IOLs (Figure 1-3)
Monofocal PMMA IOLs are the most commonly used type o f PMMA implants. 
Diffractive multifocal PMMA IOLs (Davison, 2001) function by using the 
phenomenon of ‘constructive and destructive interference’. As a result most of these 
implants are in effect bifocal. The lens has a spherical anterior surface and a grooved 
posterior surface (Figure 1-3) that splits the light and creates ripples o f wave fronts 
‘interference patterns or fringes’. These wave fronts cross each other and create 
either ‘constructive interference’ if  in-phase or ‘destructive interference’ if out-of- 
phase. Combining the spherical power of the anterior surface with the constructive or 
destructive interference patterns results in the formation of either a near or distance 
focus, respectively. Because the diffractive patterns are created throughout the optic 
of the implant, it is less dependent on the pupillary size than refractive IOLs 
(Discussed in 1.1.4.2.4). However, almost 18% of the incident light is lost because of 
interference. This is believed to explain the more profound reduction in contrast 
sensitivity that patients with these implants were shown to suffer from in comparison 
to patients with refractive implants (Pieh et al, 1998).
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Figure 1-3. Design of Diffractive IOL
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1.1.4.2 Silicone IOLs
The physical properties o f the silicone IOLs are detailed in Table 1-1. These lenses 
were approved by the Food and Drug Administration (FDA) in 1990. The lenses are 
made o f polymers of silicone and oxygen. The most common silicone IOLs are 
elastomers of polydiethylsiloxane backbone.
Silicone IOLs are inert, non-adherent to tissue and stable at a range of temperatures. 
They are also hydrophobic and difficult to handle when wet as they become slippery. 
The newer generation o f silicone IOLs have higher refractive indices (1.46-1.47), 
and thus have thinner optics over a range o f dioptric power, which enables 
implantation through a small wound size. One important feature o f these lenses is 
their rapid unfolding action that can be hazardous especially in a patient with 
posterior capsular tear or zonular dialysis. After implantation, the rate o f giant cell 
deposition was shown to be lower than with PMMA (Ravalico et al, 1997) and 
comparable to that with hydrophobic acrylic IOLs (Samuelson et al, 2000). The 
lenses also exhibit a lower threshold for Nd:YAG laser damage (Newland et al, 
1999;Trinavarat et al, 2001) and were shown to adhere to silicone oil in patients who 
undergo vitrectomy and silicone oil tamponade (Apple et al, 1996;Dick et al, 
1997;Apple et al, 1997). Senn, in an experimental study, showed that this could 
potentially affect its optical qualities (Senn et al, 1997). Recently case reports have 
been published of greyish to brownish opacification o f some of these lenses 
including SI30NB (Parkin & Pitts-Crick, 2000), SI40NB (Hilgert et al, 2004;Tanaka 
et al, 2004b) and SA40N Array (Elgohary et al, 2005). The origin of this 
opacification is not clearly understood but was proposed to be the result of 
impurities, water incorporation into the IOL material or interaction with instruments 
or medications.
1.1.4.2.1 One-piece plate-haptic silicone IOLs (Figure 1-4)
These implants have a broad haptic and can be inserted through a small incision 
using an injector (Coombes et al, 2001). Hwang et al (Hwang et al, 1998) showed 
greater amount of decentration with 3-piece silicone IOLs than with plate-haptic 
silicone IOLs. Increasing the size o f the positioning holes was suggested to have 
increased the stability of these implants in the capsular bag (Mamalis et al,
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1996a;Kent et al, 1997;Whiteside et al, 1998) and several other studies have shown 
its favourable long-term outcome (Cumming, 1993;Maar et al, 2002).
The lenses, however, were shown to be associated with increased opacification and 
contraction of the anterior capsule (Werner et al, 2000b;Apple, 2000), which is 
attributed to the larger area o f contact between the haptic and the anterior capsule 
and the hydrophobic nature o f its material. The plate-haptic IOL design is also 
believed to be susceptible to forces of capsular contraction. There are reports o f early 
decentration (Subramaniam & Tuft, 2001;Mackool, 1996), late subluxation and even 
posterior dislocation of the lens, either spontaneously (Agustin & Miller, 2000) or 
after Nd:YAG capsulotomy (Tuft & Talks, 1998;Petersen et al, 2000). Faucher and 
Rootman (Faucher & Rootman, 2001) reported anterior dislocation o f the lens into 
the anterior chamber 4 months after an uneventful surgery.
1.1.4.2.2 Toric one-piece plate-haptic silicone IOLs
These lenses have a spherocylindrical anterior surface that is designed to correct 
corneal astigmatism of 1.5 to 3.5 dioptres. This is achieved by aligning the axis 
markings o f the implant to the steep corneal meridian.
Although the lenses were found to effectively and stably correct the astigmatism in 
the majority o f patients (Ruhswurm et al, 2000;Leyland et al, 2001), they are 
susceptible to the same postoperative positional changes as their spherical 
counterparts, namely decentration or dislocation, which can have a more dramatic 
effect on the visual function. Leyland et al (Leyland et al, 2001) reported 9% of the 
lenses undergoing rotation o f more than 30 degrees both in the early and late 
postoperative periods.
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Figure 1-4. Plate-haptic IOL (C11UB, Bausch & Lomb)
(From: Foldable Lens Range: European Edition, Bausch & Lomb product
manual)
Figure 1-5. STAAR toric one-piece silicone IOL. The mark on the optic shows
the axis of additional power. 
(http://www.stlukeseye.com/news/items/toric_lens.jpg)
38
Chapter 1: Introduction and Review o f the Literature
1.1.4.2.3 Three-piece silicone IOLs
These are the most commonly used type of silicone IOLs. All the lenses have 
rounded edges except that o f CeeOn-Edge 911 (Pharmacia Atlanta, GA, USA) and 
Clariflex (AMO, Irvine, CA, USA), which have sharp posterior edges.
The first generation o f these lenses had a PCO rate similar to that associated with 
PMMA IOLs and higher than that with hydrophobic acrylic IOLs. That has improved 
remarkably with the second generation o f implants. Daynes et al, 2002, found that 
SI40, a second generation 3-piece silicone IOL, had a PCO rate similar to 
hydrophobic acrylic IOLs (Daynes et al, 2002). Several studies also found that 
square-edged silicone IOLs had a preventative effect on LEC migration and PCO 
development similar to that o f hydrophobic acrylic IOLs (Nishi et al, 2000;Schmack 
& Gerstmeyer, 2000). Mullner-Eidenbock et al (Mullner-Eidenbock et al, 2001) 
found that CeeOn Edge IOL had a low incidence of LEC growth and reduced non­
specific foreign-body reactions in comparison to hydrophilic and hydrophobic acrylic 
IOLs.
1.1.4.2.4 Multifocal silicone IOL (Refractive type) (Figure 1-6)
The silicone multifocal design was developed in order to help patients overcome the 
accommodative loss associated with pseudophakia while enabling folding and 
implantating the IOL through a small incision. SA40N AMO Array (AMO) IOL 
(Figure 1-6) will be discussed in detail as it is the one studied in this thesis and is the 
most commonly used refractive multifocal implant.
1.1.4.2.4.1 Desizn and optics (Figures 1-6 to 1-8)
The Array IOL (Featherstone et al, 1999;Davison, 2001) is a 3-piece silicone IOL 
that has an overall diameter o f 13mm, an optic diameter o f 6mm and two PMMA 
haptics that make an angle o f 10° with the optic. The optic has a biconvex surface, a 
spherical refractive posterior surface and an anterior surface that has 5 concentric 
refractive zones that give it a wavy-shape (Figure 1-6). The central zone o f the optic 
is distance-dominant, as are the third and fifth zones. The second and fourth zones 
are near-dominant, each with 3.5 dioptres add (Figure 1-7). In each o f the distance- 
dominant zones, the distance power is placed centrally and power gradually increases 
toward the periphery o f the zone (zonal-progressive) to provide intermediate vision
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(Figure 1-8). The concentric zones are meant to make the IOL less sensitive to 
variation in pupil size and to provide stable vision under a variety o f luminance 
conditions. At a pupillary size o f  4mm, approxim ately 50% o f available light is 
allocated to the distance focus, 37% to the near focus and 13% to the intermediate 
focus.
Figure 1-6. SA40N AMO Array©: the five zonal progressive multifocal IOL in
situ
Figure 1-7. Diagrammatic representation of the different zones of AMO array 
multifocal IOL (Courtesy of Advanced Medical Optics, Inc.).
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Figure 1-8. Ray diagram of the refractive multifocal IOL (Courtesy of 
Advanced Medical Optics, Inc.).
1.1.4.2.4.2 Functional outcome
Multifocal intraocular lenses have proved to provide reasonably useful near and 
intermediate vision without spectacles and without adversely affecting distance 
vision (Brydon et al, 2000;Javitt et al, 2000;Steinert, 2000;Vaquero-Ruano et al, 
1998;Leyland et al, 2002). These implants, however, are known to reduce contrast 
sensitivity, especially under low contrast (Steinert et al, 1999;Schmitz et al, 2000) 
and mesopic conditions (W illiamson et al, 1994). They also cause dysphotopic 
phenom ena such as glare and haloes with bright light (Steinert et al, 1999).
Increasing age, variation o f  pupil size and the degree o f  corneal astigmatism were 
found to affect the degree o f  contrast sensitivity loss as well as patients’ satisfaction 
with these lenses. Schmitz et al, 2000 (Schmitz et al, 2000), found that, with and 
without glare disability, patients over 70 years have reduced contrast sensitivity. In a 
study by Hayashi et al (Hayashi et al, 2001), a pupil size o f  less than 4.5mm was 
found to reduce near vision ability. Using an experimental optical model consisting 
o f  a helium-neon laser, a triangular optical bench with a precision collimator, a 
micropositionable immersion stage to support the IOL and a digital image-processing 
system, Ravalico et al (Ravalico et al, 1999) found that correcting astigmatism o f 
more than 1 dioptre reduces light intensity by about 20%. Also, Hayashi et al 
(Hayashi et al, 2000) found that up to 1.5 dioptres, astigmatism reduced distance and
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intermediate vision but that all degrees of astigmatism up to 2.5 dioptres favoured 
near vision. On the other hand, Schmitz et al (Schmitz et al, 2000) found that there 
was no clinically significant difference between monofocal and multifocal IOL 
groups with and without > 1 dioptre of astigmatism.
1.1.4.3 Hydrophobic acrylic IOLs
Hydrophobic acrylic IOLs are relatively new lenses, with FDA approval obtained 
only in December 1994. Three-piece with PMMA haptics or one-piece design are 
available and in common use. These lenses are made of copolymers of acrylate and 
methacrylate. They have a contact angle o f 73° and are thinner, because o f their 
higher refractive index, and lighter than silicone IOLs (Table 1-1). They have lower 
elasticity and increased stiffness and thus require larger incisions to be introduced 
into the eye. The implant feels like PMMA at low temperature and it needs to be 
warmed to facilitate its folding. These features, however, make its unfolding in the 
capsular bag slower and more controlled but also make it fragile and more liable to 
scratches and dents.
Hydrophobic acrylic IOLs are less likely to cause problems of adherence when 
silicone oil tamponade is used than silicone IOLs (Apple et al, 1997). The square- 
edged design of some o f these implants creates a capsular bend preventing migration 
of LECs onto the posterior capsule and PCO formation (Nishi et al, 1998c;Nishi & 
Nishi, 1999;Nishi et al, 2000). The square edge, however, causes internal reflection 
of the incident light leading to positive dysphotopic complaints such as glare, streaks 
or flashes o f lights; or negative dysphotopic symptoms such as dark shadows 
(Farbowitz et al, 2000;Davison, 2000). New implant designs with a frosted edge 
(SA60, Alcon) or rounded anterior edge (Sensar, Allergan) have been developed to 
minimise these symptoms. These lenses are also more resistant to damage by 
Nd:YAG laser than PMMA and silicone IOLs (Newland et al, 1999;Trinavarat et al, 
2001).
Several reports have shown the development of ‘glistenings’ within hydrophobic 
acrylic (Alcon) IOLs (Gunenc et al, 2001;Christiansen et al, 2001 ;Tognetto et al, 
2002). These were proved to be water vacuoles and the phenomenon was related to a 
change in the equilibrium o f water content caused by temperature changes (Miyata & 
Yaguchi, 2004;Shiba et al, 2003;Tognetto et al, 2002). Recent reports have shown no
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effect (Gunenc et al, 2001) or only a mild effect (Christiansen et al, 2001) on visual 
acuity in cases with severe ‘glistenings’.
1.1.4.4 Hydrophilic acrylic (hydrogel) IOLs
Hydrophilic acrylic (hydrogel) IOLs are composed of a mixture of a 
hydroxyethylmethacrylate (poly-HEMA) backbone and a hydrophilic acrylic 
monomer. The water content varies between 18-30%. Because of their water content, 
they must be kept hydrated until implantation. The lenses are soft and resist scratches 
and surface damage from folding because of their high water content and flexible 
surfaces. They fold and unfold faster than hydrophobic acrylic but still are more 
controllable than silicone IOLs. They are also resistant to damage by Nd:YAG laser 
and have minimal adherence to silicone oil.
Several studies reported an excellent uveal biocompatibility profile for these 
implants i.e. less flare in the early postoperative period and a low incidence of non- 
specific foreign body reaction, i.e. less deposition of small and giant cells on its 
surface, than with silicone and hydrophobic acrylic IOLs (Schauersberger et al, 
1999;Hollick et al, 1999b;Mullner-Eidenbock et al, 2001;Abela-Formanek et al, 
2002c). However, the lens was found to be associated with a high rate of LEC 
proliferation and high PCO and Nd:YAG capsulotomy rates i.e. it has a low capsular 
biocompatibility (Hollick et al, 1999b;Abela-Formanek et al, 2002c; Abela-Formanek 
et al, 2002d;McCulley, 2003).
MemoryLens (Ciba Vision) is a pre-rolled 3-piece implant hydrophilic acrylic 
implant. It slowly unfolds within the eye in a controlled fashion. This lens was 
reported to be associated with a late-onset of toxic anterior segment syndrome (Jehan 
et al, 2000), which was attributed by the manufacturer to residual polishing 
compounds in the lens.
Hydroview (Bausch & Lomb) is a three-piece IOL that lens has been reported to 
develop late opacification due to calcium phosphate deposition within the optic 
(Werner et al, 2000a), a phenomenon which is still under investigation. These proved 
to be visually significant and required IOL explantation in many patients (Fernando 
& Crayford, 2000;Mamalis et al, 2004). The origin of this phenomenon was blamed 
on the silicone packaging of the IOL (Dorey et al, 2003).
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1.1.5 Anterior segment changes after cataract extraction
1.1.5.1 Breakdown of the blood-aqueous barrier
Surgical trauma, the presence of an IOL, which attracts a foreign body reaction, and 
the release of inflammatory mediators synthesized by LECs are the main factors 
responsible for the breakdown o f the blood-aqueous barrier (BAB) after cataract 
extraction (Miyake et al, 1996;Nishi et al, 1995b;Nishi et al, 1996c). This is 
mediated by prostaglandin E2 and various other cytokines, such as interleukin-1 and 
interleukin-6 that can be produced by LECs. Clinically this gives rise to flare 
(protein) and cells in the anterior chamber, which can be quantified by laser flare-cell 
photometry (Shah & Spalton, 1994).
Several factors seem to affect the degree of breakdown o f the BAB and hence the 
anterior chamber flare value or cell count. Increased BAB breakdown was found to 
be associated with larger corneal incisions such as those used for ECCE as compared 
to small incisions used in phacoemulsification (Oshika et al, 1992;Pande et al, 
1996b;Chee et al, 1999), sclero-comeal as compared to pure corneal incisions (Dick 
et al, 2000), sulcus as compared to in-the-bag placement o f the IOL (Alio et al,
1997), tom capsulorhexis as compared to intact ones (Pande et al, 1996a) and 
hydrophobic as compared to hydrophilic IOLs (Miyake et al, 1996;Schauersberger et 
al, 1999).
1.1.5.2 Cellular reaction on IOL surface
Immunohistochemical staining has been used to study the cellular deposits on the 
surface o f IOLs (Saika et al, 1998). Specular microscopy, using high magnification 
and intense illumination on the slit lamp, enables us to clinically identify these 
cellular elements in vivo (Wenzel M et al, 1988;Shah et al, 1993;Shah & Spalton, 
1995b). These include blood-derived monocytes, which give rise to histiocytes and 
its different forms including macrophages, spindle-shaped or fibroblast-like cells, 
epitheloid and giant cells (Wolter & Kunkel, 1983a;Wolter, 1985;Wolter & 
Kleberger, 1985), capsule-derived LECs (Wolter, 1993;Ibaraki et al, 1995;Saika et 
al, 1998;Hollick et al, 1999b) and iris-derived melanocytes (Tanner et al, 1998).
These cellular deposits can produce a clear membrane on the IOL composed of a 
film of extracelluar matrix (Wolter & Kunkel, 1983c;Wolter et al, 1985;Saika et al,
44
Chapter 1: Introduction and Review of the Literature
1998). Experimental and postmortem studies have shown this membrane to be 
produced in the early postoperative period (within few hours to few days) (Wolter & 
Kunkel, 1983b;Wolter & Kleberger, 1985). They also showed that it contained 
proteins such as fibronectin (Kanagawa et al, 1990;Saika et al, 1992;Saika et al, 
1995), collagen types I, III and IV (Saika et al, 1995;Saika et al, 1997), vitronectin 
and laminin (Linnola et al, 1999b;Linnola et al, 2000a;Linnola et al, 2000b).
The IOL material has an effect on the number o f cells attached to the IOL surface. 
Fewer epitheloid and giant cells were found attached to hydrophilic IOLs: HSM- 
PMMA in comparison to PMMA IOLs (Larsson et al, 1989;Amon et al, 
1996;Fagerholm et al, 1989;Shah & Spalton, 1995a), and hydrophilic acrylic 
(Hydroview) in comparison to hydrophobic acrylic (AcrySof) and silicone IOLs 
(CeeOn 920) (Mullner-Eidenbock et al, 2001).
1.1.6 Changes in the capsular bag
The changes in the capsular bag after IOL implantation are the most important 
changes as they lead to more lasting and clinically significant effects.
1.1.6.1 .1 Anterior capsular opacification and contraction (Figure 1-9)
Anterior capsular opacification (ACO) is probably the earliest and most common 
pathological development in the capsular bag. It may occur as soon as one month and 
variably in almost all the patients. A clinically more important change is anterior 
capsular contraction (ACC) or phimosis, which is usually associated with and often 
consequential upon ACO. Davison (Davison, 1993) suggested that ACC occurs as a 
result of an imbalance between centrifugal and centripetal forces of the contracting 
fibrous tissue on the capsular bag. ACC was shown to occur maximally within the 
first 3 months after surgery (Hayashi et al, 1997;Zambarakji et al, 1997) and, on 
average, amounts to about 22% o f the original CCC size (Sugimoto et al, 1998). 
Both ACO and ACC have common pathological features and have similar 
predisposing factors.
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Figure 1-9. Opacification of the anterior capsule (top left). Severe contraction of 
the anterior capsule (top, right). Closure of the capsular opening as a result of 
severe phimosis (bottom, left). PMMA IOL subluxation within a fibrotic
capsular bag (bottom, left).
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1.1.6.1.1.1 Pathology o f  A CO and ACC
The pathological changes leading to the development of ACO occur mainly 
underneath the capsule. Macky et al (Macky et al, 2001) indicated that a more 
accurate term is ‘anterior subcapsular opacification’ but the term is maintained as it 
is well established in the literature and in clinical practice. These pathological 
changes include LEC proliferation and trans-differentiation, and extracellular matrix 
formation (Ishibashi et al, 1993). Human anterior capsule fibrosis samples were 
found to have dense fibrous tissue and numerous activated fibroblasts with 
contractile capacity, because o f the presence of a-smooth muscle actin in the cell 
cytoplasm (Tanaka et al, 2004a). Collagen, fibronectin, osteoporin and 
glycosaminoglycans such as chondroitin, keratan, and dermatan sulphate, are among 
the extracellular matrix substances that were found in histological specimens 
(Ishibashi et al, 1993;Azuma et al, 1998). Azuma et al (Azuma et al, 1998) 
suggested that the substances found in ACO resemble those found in wound healing.
1.1.6.1.1.2 Factors associated with ACO and ACC and clinical features
Three major factors have been postulated to affect the degree of ACO and 
consequently the development of ACC: the initial size of the capsulorhexis, the IOL 
material and design and pre-existing diseases. It is proposed that the larger the 
remaining anterior capsular leaflet, the more anterior subcapsular epithelial cells 
there are and, therefore, the greater the potential for capsular opacification and 
contraction (Davison, 1993;Arshinoff, 1994;Packard, 1998). Miyake et al (Miyake et 
al, 1996) found a negative correlation between the hydrophilicity of an IOL and the 
severity of postoperative inflammation and the speed of ACO, with hydrophobic 
silicone of 99° water contact angle having greater postoperative inflammation and 
anterior capsular opacification. On the other hand, Wemer et al (Werner et al, 2001) 
found that 3-piece, hydrophobic acrylic optic, PMMA-haptic IOLs (AcrySof) had a 
lower ACO score than small- and large-hole, single-piece, plate-haptic silicone IOLs. 
This was also confirmed in several other histopathological studies (Apple, 
2000;Wemer et al, 2000b;Wemer et al, 2001;Wemer et al, 2000b) that showed plate- 
haptic silicone IOLs to be associated with a higher rate of ACO than PMMA and 
acrylic IOLs.
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The amount of ACC was shown to be significantly greater with silicone than with 
PMMA IOLs (Zambarakji et al, 1997;Cochener et al, 1999;Hayashi et al, 1997) and 
acrylic IOLs (Ursell et al, 1997). The haptic material (polypropylene versus 
polymethylmethacrylate in two otherwise similar silicone IOLs) did not affect the 
amount o f ACC (Gallagher & Pavilack, 1999). Dahlhauser et al (Dahlhauser et al,
1998) reported that 14% of patients who had plate-haptic silicone IOLs developed 
clinically significant ACC and needed Nd:YAG anterior capsulotomy. Other factors 
found to be associated with increased ACC are increased anterior chamber flare, 
older age (Sugimoto et al, 1998;Kato et al, 2002), smaller capsulorhexis (Sugimoto 
et al, 1998), diabetes mellitus and the presence of diabetic retinopathy (Hayashi et al, 
1998b;Kato et al, 2001). The risk of anterior capsular contraction was found to be 
greater in eyes with zonular weakness such as those with pseudoexfoliation 
syndrome (Davison, 1993;Gallagher & Pavilack, 1999;Moreno-Montanes et al,
2002). Also, patients with retinitis pigmentosa (Nishi & Nishi, 1993;Jackson et al, 
2001 ;Lee et al, 2004), uveitis (Davison, 1993), and myotonic dystrophy (Newman, 
1998;Hansen et al, 1993) were found to have a greater tendency to develop ACC.
1.1.6.1.1.3 Treatment
Polishing the anterior capsule to remove the subcapsular lens epithelium is a useful 
technique to reduce the incidence of ACO (Davison, 1993;Nishi, 1987), using large 
CCC (>5.5mm diameter) and implantation of large PMMA IOLs or intracapsular 
PMMA rings should be considered in high risk patients (Spang et al, 1999;Hayashi 
et al, 1998a).
As soon as ACC is noted in high-risk patients or those who have already had ACC- 
related problems in the other eye, relaxing radial anterior capsular incisions can be 
performed using Nd:YAG laser (Davison, 1993;Scorolli et al, 1996;Chawla & 
Shaikh, 1999). These incisions will help to reduce traction on the equator of the 
capsular bag and hence pre-empt the development of complications such as lens 
decentration, subluxation and dislocation. Surgical anterior capsulotomy may be 
required in patients with severe degrees of ACC that can not be treated with laser 
(Yeh et al, 2002).
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1.1.6.1.2 Posterior capsular opacification (PCO)
1.1.6.1.2.1 Pathology o f  PCO
Schmidbauer et al (Schmidbauer et al, 2001b) and Aslam et al, 2003 (Aslam et al, 
2003b), pointed out that the term ‘posterior capsular opacification’ is a misnomer as 
the changes are sub-capsular. However, similar to ‘anterior capsular opacification’, 
the term is maintained because it is commonly accepted and widely used.
1.1.6.1.2.1.1 Methods of studying PCO development
Several methods have been used to study PCO (Wormstone, 2002). These include 
cell culture, in vivo animal studies, capsular bag models, in vivo clinical studies and 
analysis of post-mortem material. Cell culture studies have provided information on 
certain aspects o f LECs such as factors affecting their growth. Capsular bag cultures 
and in vivo animal studies have been used to establish the effect of surgical 
techniques and IOLs design and material on the development of PCO. Different 
posterior capsule imaging and image analysis systems have enabled in vivo 
monitoring o f PCO development and progression. Post-mortem examination, using 
electron microscopy, immunohistochemistry and ELISA techniques has provided 
information about the different molecules that exist in the capsular bag and the 
possible effect they have on PCO development and progression.
1.1.6.1.2.1.2 Anatomical considerations
As discussed before (in 1.1.2), there are two anatomical classes of LECs: A-cells and 
E-cells. While A and E-cells are capable of contributing to all forms of capsular 
opacification, A-cells are primarily responsible for the development o f anterior 
capsular opacification and the fibrotic changes of PCO and E-cells for the cellular 
element of PCO and inter-lenticular opacification in patients with piggyback IOLs 
(Schmidbauer et al, 2001b).
E-cell proliferation and migration onto the posterior capsule lead to the formation of 
large, balloon-like bladder cells (Wedl cells) of Elshnig’s pearls. Metaplastic 
transformation (transdifferentiation) o f LECs into spindle-shaped or myofibroblast­
like cells and residual lens fibres lead to fibrotic changes, including greyish
( I\
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discolouration and wrinkling of the posterior capsule, and Sommering’s ring 
formation at the equator.
1.1.6.1.2.1.3 Pathogenesis of PCO
McDonell et al (McDonnell et al, 1983;McDonnell et al, 1984;McDonnell et al, 
1985;Green & McDonnell, 1985) have shown that LECs in both rabbits and humans 
initially undergo hyperplasia and transdifferentiation into myofibroblast-like cells 
within 4 days of surgery. The proliferation of LECs has been shown to be under 
control of paracrine and autocrine pathways (Wormstone et al, 2002). Paracrine 
control is related to increased aqueous protein content, including serum growth 
factors, induced by the breakdown of the BAB and the inflammatory response to 
surgery (Wallentin et al, 1998;Pande et al, 1996b). These were shown to increase 
LEC proliferation and collagen formation (Nishi et al, 1996a). The autocrine 
mechanism is conceivable in patients who develop PCO several years after surgery 
when the aqueous protein levels would have subsided to preoperative levels. This is 
evidenced by the ability o f LECs to survive under minimal cultural conditions and to 
produce de novo proteins (Wormstone et al, 1997;Wormstone et al, 2001).
Both the autocrine and paracrine mechanisms were found to be influenced by several 
cytokines. Nishi O et al (Nishi et al, 1996a) found that cytokines such as interleukin 
(IL) 1 and basic fibroblast growth factor (b-FGF) increased LECs mitosis and 
collagen synthesis. Wallentin et al (Wallentin et al, 1998) found that LEC 
proliferation positively correlated with protein concentration and with leukocyte 
count but negatively with TGF-p concentration. The latter finding was consistent 
with the findings by Kurosaka et al (Kurosaka & Nagamoto, 1994;Kurosaka et al, 
1995).
Myofibroblastic transdifferentiation of LECs leads clinically to the formation of 
wrinkles and contraction of the capsule. Kurosaka et al (Kurosaka et al, 1996) 
showed the presence o f alpha smooth muscle actin in LECs after experimental 
cataract extraction. They also showed that adding TGF-p2 to a culture of LECs on a 
collagen gel increased the shrinkage o f the collagen gel as well as the expression of 
alpha smooth muscle actin from these cells in a dose dependent manner (Kurosaka et 
al, 2000).
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LEC migration onto the posterior capsule was shown to be facilitated by the presence 
o f collagen type IV, laminin and fibronectin (Olivero & Furcht, 1993). Also, 
metalloproteinases (gelatinases), which are proteolytic enzymes that were found to 
be stimulated by sham cataract surgery (Tamiya et al, 2000), were suggested to play 
an important role in the regulation of LEC migration onto the posterior capsule 
(Kawashima et al, 2000;Wong et al, 2004).
Extracellular matrix (ECM) formation by LECs is the result o f capsular bag wound- 
healing response after extracapsular cataract surgery. The cells become surrounded 
by multiple layers of ECM consisting predominantly of dermatan, chondroitin and 
heparan sulphates, and collagen types I, III, IV, V, VI (Ishibashi et al, 1994;Azuma 
et al, 1998;Nishi et al, 1995c), XII and XIV (Saika et al, 2001). Other substances 
found are laminin (Zhang et al, 2001) and osteopontin (Saika et al, 2003).
1.1.6.1.2.2 Clinical types o f  PCO (Figure 1-10)
Clinically there are two main morphological types o f PCO: fibrotic and cellular. The 
fibrotic type is the result o f collagen deposition and myofibroblastic 
transdifferentiation of LECs. This type leads to greyish-white discolouration and 
often wrinkling o f the posterior capsule. The cellular type is associated with the 
formation of lens epithelial cell clumps (Elshnig’s pearls) as a result of growth factor 
and cytokine stimulation of LEC proliferation. In the majority of cases, the two 
forms normally coexist, although a predominant feature can often be identified.
In a series of patients who had a square-edged hydrophobic acrylic IOLs (AcrySof), 
Wolken and Oetting (Wolken & Oetting, 2001) described a linear form o f PCO that 
developed along the posterior capsular striae. These striae, which are often seen both 
during surgery and in the early postoperative period with these implants as well as 
with other 3-piece IOLs, were believed to have provided tunnels for the LECs to 
migrate through and onto the posterior capsule.
Following Nd:YAG capsulotomy, LEC pearls were found to form around the margin 
of the capsular opening (Kato et al, 1997a;Kurosaka et al, 2002). The cumulative 
probability of that occurrence was estimated to be 70% in 2 years, but according to 
Kurosaka et al (Kurosaka et al, 2002) only 20% of these pearls were progressive and 
required a second capsulotomy procedure.
51
Chapter 1: Introduction and Review o f  the Literature
s
Figure 1-10. Clinical types of PCO: Fibrotic type showing posterior capsule 
wrinkles (a) and grayish haze (b); and cellular type showing LEC pearls (c).
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Posterior capsular and anterior hyaloid opacification or closure of the capsular 
opening after Nd:YAG capsulotomy was reported before in patients younger than 50 
years (McPherson & Govan, 1995) and was found to be significantly more frequent 
in diabetic patients (Kumagai et al, 1999) and with hydrogel IOLs (Georgopoulos et 
al, 2003).
1.1.6.1.2.3 Methods o f  assessment o f  PCO
1.1.6.1.2.3.1 Subjective methods: visual function tests
Centripetal migration of the LECs, fibrosis and wrinkling of the posterior capsule 
leads to scattering of the light entering the eye (forward scatter) and hence 
compromises visual function. The two main visual functions that are commonly 
tested and that were shown to be compromised by PCO are visual acuity and contrast 
sensitivity (Hayashi et al, 2003;Tan et al, 1998;Aslam & Patton, 2004;Meacock et al,
2003). In addition, glare disability (Hayashi et al, 2003;Tan et al, 1998;Aslam & 
Patton, 2004) and forward light scatter (Meacock et al, 2003) have been linked to 
PCO development.
Using Scheimpflug videophotography and measurements o f visual acuity and 
contrast sensitivity with and without glare, Hayashi et al, 2003 (Hayashi et al, 2003), 
found that the degree of PCO correlated with both these visual functions, although 
most strongly with visual acuity. Tan et al (Tan et al, 1999) reported that high spatial 
frequency contrast sensitivity loss (3 cycles/degree) provided a more sensitive 
measure than other spatial frequencies in the early stages of PCO fromation. 
Sunderraj et al (Sunderraj et al, 1992) found that glare disability is more prominent 
in some patients who still had good visual acuity.
Meacock et al (Meacock et al, 2003) estimated that the percentage of PCO required 
for a decline in visual acuity to occur was 78% but was 38% to 46% for a decline in 
contrast sensitivity and less than 1% for a decline in forward light-scatter. The 
authors thus concluded that the latter is the most sensitive test to assess the influence 
of PCO on visual function.
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1.1.6.1.2.3.2 Objective methods
1.1.6.1.2.3.2.1 Slit lamp grading
Many authors have used different systems that rely on slit lamp grading of PCO. 
Kruger et al (Kruger et al, 2000) used a system that graded capsular opacification 
within the central 3mm into: 0=absent, l=very mild, 2=moderate, and 3=dense white. 
Sellman and Lindstrom (Sellman & Lindstrom, 1988) graded fibrosis and Elshnig’s 
pearls on a similar four-point scale, which was used by other studies (Oner et al, 
2000;Winther-Nielson et al, 1998). They used diagrams to illustrate the various 
grades o f both fibrosis and cell pearls: 1= no or slight PCO without reduced red 
reflex and no pearls to the IOL edge; 2 = mild PCO reducing the red reflex, Elshnig’s 
pearls to the IOL edge; 3 = moderate fibrosis or Elshnig pearls inside IOL edge but 
with a clear visual axis; 4 = severe fibrosis or Elshnig’s pearls covering the visual 
axis and severely reducing red reflex. Legler et al (Legler et al, 1993) used ease of 
visibility of posterior segment structures, including the optic nerve head, retinal 
blood vessels and retinal nerve fibre layer, with the indirect ophthalmoscope. Prajna 
et al (Prajna et al, 2000) combined this method with the slit lamp grading system. 
According to Prajna’s system, in grades II and III the capsular opacity is visible 
through an undilated pupil and grade II is characterised by clearly seen optic nerve 
head but hazy retinal nerve fibre layer and blood vessels, whereas in grade III, even 
the optic nerve head is not visible.
These methods are easy to apply clinically and their reproducibility is expected to be 
high for an experienced observer but they are still subject to inherent interobserver 
variability. Also, although they can be considered to be semi-quantitative, they lack 
precise quantification.
1.1.6.1.2.3.2.2 Imaging systems
1.1.6.1.2.3.2.2.1 Scheimpflug system
Scheimpflug system was introduced by Lasa et al in 1995 (Lasa et al, 1995) then 
further developed by Hayashi in 1998 (Hayashi et al, 1998d;Hayashi et al, 1998e) to 
enable quantification of the density o f the PCO. The system is called Anterior Eye 
Segment Analysis (EAS-1000; Nidek, Japan) and has been used in several studies
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(Klos et al, 1999;Zaczek & Zetterstrom, 1999;Hayashi et al, 2001;Hayashi et al, 
2002;Tsuchiya eJ al, 2003;Hayashi e/ al, 2003;Hayashi & Hayashi, 2004;Hayashi e/ 
al, 2004). The central 3-mm position of the posterior capsule is quantified by means 
of area densitometry that measures the scattering light intensity. Slit images of the 
implanted IOL are taken at 0, 45, 90 and 135 meridians after full pupillary dilatation. 
The highest quality image o f each meridian is selected and then transferred to a 
computer. The axial densitometry is used to calculate the scattered light density of 
the central 3-mm area o f the posterior capsule. The density value of one section is 
determined by subtracting the scatter light density value of the IOL from that of the 
posterior capsule. The averaged density of the 4 meridians then determines the PCO 
density value. Hayashi et al (Hayashi et al, 1998e) found intraobserver and 
interobserver correlation coefficient of 0.95 and 0.976, respectively, that indicated 
high reproducibility. However, in a recent study by Tantaka et al (Tanaka et al, 
2004c), IOL material was found to significantly influence the scattered light density 
measurements of Scheimpflug system, and thus the density o f PCO quantified by this 
system cannot be directly compared with different optic materials.
1.1.6.1.2.3.2.2.2 Digital photography
Digital photography or digital image acquisition of the posterior capsule (Aslam et 
al, 2002) includes a group of computer-based systems, each adopts a specific 
principle to quantify PCO.
Brightness-based analysis system relies on the image pixel grey value (light intensity 
of the pixel) to classify it into either PCO area or not according to a given light 
intensity threshold. The percentage o f classified pixels is then calculated by a 
computer to give the percentage o f PCO. Wang et al (Wang & Woung, 2000) used 
digital images with the EAS anterior segment analysis system and graded brightness 
within the central and peripheral zones o f the optic area from 0 to 255. A predefined 
threshold of transparency is 167 and the percentage level of transparency is estimated 
by mean of a computer program. Because the system requires that each pixel be 
defined individually as opaque or clear, problems o f image analysis and 
interpretation arise due to the inherently variable background illumination intensity. 
This can be due to variations in patient fixation, head posture, pupillary size, fundus
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pigmentation and IOL centration or refractive index (Pande et al, 1997;Barman et al, 
2000).
Density map system is another imaging system that was developed by Friedman et al 
(Friedman et al, 1999). In that method, a polarised light is incorporated in the 
illumination and viewing systems of the camera to suppress much of the comeal 
reflex. The image illumination is evened out by an image analysis technique that 
produces an illumination-compensated image. The grading o f PCO assesses both 
average area density (grey level o f opacification), which is converted to a scale (0 to 
4), and percentage coverage o f PCO. Validation studies showed that the image 
analysis system identifies the percentage coverage and the density o f PCO similar to 
subjective assessment by an ophthalmologist. The system, however, seems to lack 
ability to identify progression o f PCO. Because the system uses the average density, 
when more area is covered with less dense PCO the overall average decreases. 
Therefore, it was suggested that using the standard deviation (rather than the mean) 
of the density for the specified area, regionalising areas of different opacities and 
assessing texture of the capsule would improve the assessment scheme.
Evaluation o f the Posterior Capsule Opacification (EPCO) system was developed by 
Heidelberg and uses retro-illumination colour photographs taken with a Zeiss photo 
slit lamp to score PCO. This system was first described by Tetz et in 1997 (Tetz et al, 
1997). The area o f opacification o f the posterior capsule is encircled and graded 0-4 
according to perceived density. The overall opacity is then calculated by multiplying 
the density of the opacification by the fraction of the area behind the IOL optic that is 
involved. The system is cheap and is claimed to be one of the best systems for 
evaluating PCO. Inter-observer and intra-observer variability were assessed by 
estimating the standard deviation o f the PCO grade and was found to be low. The 
system, however, was not assessed for its ability to identify progression and is 
limited by not being fully objective as it relies on the observer to define the PCO 
level d in different areas.
Texture segmentation system has been described by Pande et al (Pande et al, 1997) 
and recently by Barman et al (Barman et al, 2000). It has been used in several studies 
by the research group at St Thomas Hospital, London since 1997. It depends on 
specialised photographic equipment that produces a high-resolution, evenly 
illuminated image of the posterior capsule. The image analysis software is based on
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TRACEE, an image analysis computer program that is enhanced with dedicated 
modules written for the purpose of PCO analysis. The system analyses the area 
behind the optic o f the IOL and not obscured by the anterior capsule ‘the mask’. All 
images undergo processing steps including removal of Purkinje images, contrast- 
enhancement, filtering to enhance the texture of areas of opacity that look like clear 
capsule and texture segmentation to classify the mask area into areas of opacity and 
transparency. This binary classification is dependent on the texture (structural 
details), with increased texture indicating opacity. The final result is calculated in 
percentage area of opacification based on the number of opaque pixels in the mask 
area compared with the total number of pixels within the mask. A colour-coded form 
of the software has been developed with the intention of simplifying interpretation.
The system has been validated by comparing the computer-derived percentages of 
PCO to clinical assessment of PCO percentage on the slit lamp by experienced 
clinicians and intra-observer variability was found to be less than 10% (Barman et al, 
2000).
1.1.6.1.2.4 Treatment o f  PCO
1.1.6.1.2.4.1 Nd:YAG capsulotomy
Nd:YAG laser capsulotomy was introduced as a method of treating PCO in the 1980s 
by Aron-Rosa (Aron-Rosa et al, 1980) and Fankhauser(Fankhauser et al, 1981) and 
proved to be both effective and safe.
1.1.6.1.2.4.1.1 Principles of Nd:YAG laser
Nd:YAG laser (Murrill et al, 1995;Thall, 1999) is a CO2 infrared laser of l,064nm 
wavelength that works on the principle o f photodisruption. When amplified, focused 
and applied to tissues, Nd:YAG laser light strips the electrons away from their nuclei 
and produces plasma. The reuniting o f the electrons and nuclei creates an acoustic 
shock wave that damages the tissues.
Commonly used Nd:YAG lasers are either Q-switched or mode-locked or both. In Q- 
switching, a shutter in front of one o f the mirrors prevents any significant laser 
emission until a large population inversion of electrons has been achieved. The 
shutter is then opened and the energy exits in a very short pulse (~10-20ns). In mode-
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locking, an interferometer inside the cavity o f the laser tube synchronises the modes 
of the emitted light in a train o f 7 to 10 shorter pulses than that of a Q-switched pulse 
(~30ps). Q-switched lasers are more commonly used since they are less expensive.
1.1.6.1.2.4.1.2 Technique of Nd:YAG capsulotomy
Since Nd:YAG laser is an invisible infrared light, an ancillary helium-neon (He-Ne) 
aiming system is used. A slight discrepancy of the foci of both lasers results from 
chromatic aberration, with the shorter wavelength of the He-Ne focusing in front of 
the infrared light of the Nd:YAG (Thall, 1999). Also, although photodisruption 
occurs at the focus of the laser, impurities o f the laser or lens material may produce 
damage to the lens implant before the focusing point (Thall, 1999). Slightly 
defocusing the laser behind the point of intended delivery helps avoid damaging the 
implants. Also, using a contact lens to converge the light at a steeper angle makes the 
impact at an area remote from the focus point less likely (Downing & Alberhasky, 
1990).
Capsular opening made with the laser should be at least 1.5mm. Hu et al (Hu et al,
2001) found that the size of the opening tended to increase in size up to 1 month and 
then stabilises. Decentration o f the capsular opening by up to 1mm was not found to 
affect visual function as long as the opening was clear (Aslam & Dhillon, 2002).
1.1.6.1.2.4.1.3 Complications of Nd:YAG capsulotomy
Nd:YAG capsulotomy can lead to several complications, some of which can be sight 
threatening.
1.1.6.1.2.4.1.3.1 Rise oflOP
The incidence of this complication varies between 25% and 90%. An increase of IOP 
up to 30mmHg was found to occur in 5.7% (Keates et al, 1984) to 28.6% in the early 
reports of the procedure (Terry et al, 1983;Stark et al, 1985). The maximal increase 
in IOP occurs within 3-4 hours after capsulotomy (Richter et al, 1985). Keates et al 
(Keates et al, 1984) found that the increase in IOP returned to its pre-treatment level 
in 89% of patients after 1 week. A persistent elevation of IOP was reported to occur 
in about 1% of patients (Stark et al, 1985). The authors also found the ratio of the 
IOP in the treated eye to that in the other eye to be significantly higher than in the 
group with intact capsule. A late-onset elevation of IOP after a mean follow-up of
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2.7 years was found in 5.9% o f patients (Fourman & Apisson, 1991). Recently Hu et 
al (Hu et al, 2000) and Ge et al (Ge et al, 2000) reported conflicting evidence on the 
effect o f Nd:YAG capsulotomy on the IOP. Hu’s study showed no significant rise in 
IOP up to 3 months after Nd:YAG capsulotomy. Ge’s study, on the other hand, 
showed a long-term rise o f IOP in patients who developed an increase o f IOP within 
an hour o f the procedure and in patients with glaucoma.
The mechanisms of this complication include obstruction of the trabecular meshwork 
by inflammatory cells, capsular (Stark et al, 1985;Lynch et al, 1986) and dialyzable 
proteins of a small molecular weight from the disrupted anterior vitreous face 
(Schubert et al, 1985). Shock-wave damage to the trabecular endothelial cells (Lynch 
et al, 1986), and release of inflammatory mediators (Stjemschantz et al, 1986) have 
also been suggested to be involved in producing IOP rise following Nd:YAG 
capsulotomy.
Risk factors for IOP rise following Nd:YAG capsulotomy include larger size of the 
capsular opening (Channell & Beckman, 1984) aphakia (Richter et al, 1985;Javitt et 
al, 1992), glaucoma (Ge et al, 2000) and myopia (Schubert, 1987). Similarly, 
although some authors found that increased total laser energy was associated with 
increased IOP (Channell & Beckman, 1984;Richter et al, 1985), Slomovic et al 
(Slomovic & Parrish, 1985) was unable to find a significant correlation between 
them.
Apraclonidine 1% or Timolol 0.5% drops and oral acetazolamide are among the most 
commonly used medications to prevent and control IOP spikes following Nd:YAG 
capsulotomy. To date, there is no evidence for a long-lasting visual damage as a 
result of IOP rise following Nd. YAG capsulotomy.
1.1.6.1.2.4.1.3.2 Retinal breaks and detachment
In patients who underwent ECCE, the incidence of retinal detachment following 
Nd:YAG capsulotomy has been estimated to be between 0.4% (Keates et al, 1984) 
and 3.6% (Rickman-Barger et al, 1989). Mre recently, Jahn et al (Jahn et al, 2003) 
found the incidence of retinal detachment to be 0.5% within 24 months after 
phacoemulsification and subsequent Nd:YAG capsulotomy.
Javitt et al (Javitt et al, 1992) found almost fourfold increase in the incidence of 
retinal tears or detachment following Nd:YAG capsulotomy. Also, Nd:YAG
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capsulotomy was identified as an independent risk factor for the development of 
retinal detachment in a case-control study (Tielsch et al, 1996). Powell et al (Powell 
& Olson, 1995), however, found no significant difference in the incidence of retinal 
detachement between patients who underwent phacoemulsification alone and those 
who underwent Nd:YAG capsulotomy following phacoemulsification.
The risk factors o f developing retinal detachment after Nd:YAG capsulotomy 
include high myopia, lattice degeneration with associated holes, greater laser energy 
and larger capsulotomy size (Koch et al, 1989;MacEwen & Baines, 1989). Dardeme 
et al (Dardenne et al, 1989) and Steinert et al (Steinert et al, 1991), however, were 
uanable to establish a relationship between the laser parameters and the incidence of 
retinal detachment.
1.1.6.1.2.4.1.3.3 Cystoid macular oedema (CMO)
The incidence of CMO following Nd:YAG capsulotomy ranges between 0.68 to 
1.23% (Shah et al, 1986;Steinert et al, 1991). The exact mechanism leading to the 
development of CMO is not known. However, it is postulated to be a non-specific 
response to any intraocular surgical procedures. The disruption of the anterior 
hyaloid face, movement of the vitreous and possibly vitreoretinal traction are 
believed to contribute to its development. It was also postulated to be the result of an 
inflammatory response to the release of capsular fragments that involves the release 
o f prostaglandins and leukotrienes (Murrill et al, 1995).
The majority of cases of CMO following Nd:YAG capsulotomy are asymptomatic 
and in only a small percentage is there a drop in vision. Fluorescein angiography can 
demonstrate the leakage from the peri-foveal capillaries. The low incidence and 
difficulty in quantifying CMO rendered the assessment of the effectiveness of its 
treatment difficult. A common therapeutic regimen includes applying either non­
steroidal antiinflammatory or steroidal eye drops 4 times a day for 4 weeks (Murrill 
et al, 1995). The use of the non-invasive technique of optical coherence tomography 
to measure the changes in macular thickness after cataract surgery (Sourdille & 
Santiago, 1999;Grewing & Becker, 2000) offers an effective and safe means to 
further investigate this complication and its treatment following Nd:YAG 
capsulotomy.
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1.1.6.1.2.4.1.3.4 IOL damage
The most common occurrence during Nd:YAG capsulotomy is ‘striking’ or ‘pitting’ 
of the IOL by the laser, with rates between 4% to 40% (Stark et al, 1985;Weiblinger, 
1986). Silicone IOLs were found to have a lower threshold of damage by the laser in 
comparison to acrylic and PMMA IOLs (Trinavarat et al, 2001). The threshold for 
damage o f these implants was estimated to be 0.37mJ, 0.52 to 0.66mJ and 0.68mJ, 
respectively. Mainster et al (Mainster et al, 1983) indicated that the threshold of 
damage to an implant decreases with repeated striking by the laser.
The Nd:YAG laser optical breakdown was shown to occur up to 2mm anterior to its 
focal plane (Clayman & Jaffe, 1988). Fallor et al (Fallor & Hoft, 1985) showed that 
an IOL with a theoretical separation of 0.25mm or more between the lens and the 
posterior capsule sustains no damage. Also using a contact lens to focus the laser 
beam just behind the posterior capsule minimises the damage to the IOL (Downing 
& Alberhasky, 1990).
Newland et al (Newland et al, 1999) showed that silicone implants, in addition to 
having the lowest threshold for laser-induced damage, exhibit collateral damage in 
the form of a greater linear extension of damage (Figure 1-11) than PMMA and 
acrylic implants.They also showed that PMMA and silicone polymers could eject 
particulate matters adjacent to the entry site. One study showed cytotoxicity to 
cultured choroidal and retinal pigment epithelial cells by compounds released from 
experimentally damaged PMMA IOLs at energy levels of lOmJ or higher but not at 
2-5mJ (Terry et al, 1985). There is, however, no clinical evidence of any toxic effect 
to the corneal endothelium or other intraocular tissues from striking the IOLs.
Generally, IOL ‘strikes’ or ‘pits’, unless excessive, are of no clinical significance 
(Keates et al, 1984), Rarely, however, they may cause glare, blurring or even 
distortion of vision (Gardner et al, 1985;Nirankari & Richards, 1985;Mamalis et al, 
1990) that might at times require removal of the IOL (Mamalis et al, 1990).
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Figure 1-11. An exam ple of the collateral dam age in a silicone IO L  (SI30NB; 
Advanced Medical Optic, Inc., AMO). I t shows m arks  of laser strikes (pitting) 
and  rad ia l extensions of the m arks  p resum ably  cuts (arrow s) w ithin the optic.
1.1.6.1.2.4.1.3.5 IOL displacement
Findl et al (Findl et al, 1999), using dual beam partial coherence interferometry, 
showed that a small but measurable backward movement of the IOL occurs after 
Nd:YAG capsulotomy. The backward movement was more pronounced in patients 
with plate-haptic IOLs than with one-piece PMMA or 3-piece foldable IOLs and its 
magnitude was related to the size of the capsular opening.
Several case reports have been published of spontaneously dislocated IOLs following 
Nd:YAG capsulotomy that included hydrogel (Levy et al, 1990), PMMA (Framme et 
al, 1998) and plate-haptic silicone IOLs (Tuft & Talks, 1998;Dick et al, 
1998;Akerele et al, 1999;Petersen et al, 2000). In one of the patients, this led to 
pupillary block glaucoma (Shankar & Halliwell, 2003).
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1.1.6.1.2.4.1.3.6 Other rare complications
Anterior uveitis (0.4%-1.4%) (Keates et al, 1984;Chambless, 1985), persistent vitritis 
after 6 months (0.6%) (Keates et al, 1984), spread of low-grade infective 
endophthalmitis (Carlson & Koch, l988;Neuteboom & Vries-Knoppert, 
l988;Hollander et al, 2004), iris haemorrhage (Gardner et al, 1985), secondary 
closure of capsular aperture (Oshika et al, 2001) and corneal oedema (Wasserman et 
al, 1985) were rarely reported following Nd:YAG capsulotomy.
1.1.6.1.2.4.2 Surgical discision
Surgical discision (Murrill et al, 1995) either at the time of surgery or later on was 
the treatment of choice of PCO before the development of Nd:YAG laser 
capsulotomy. The procedure was associated with numerous serious complications 
such as corneal endothelial damage, IOL dislocation, vitreous loss, endophthalmitis 
and retinal detachment (Weiblinger, 1986;Flohr et al, 1985).
1.1.6.1.2.5 Prevention o f  PCO
1.1.6.1.2.5.1 Surgical technique
In a review by Apple et al (Apple et al, 1992), two major principles have been 
proposed to apply to the prevention of PCO. These included minimising the number 
of residual LECs, especially the equatorial cells, and creating a secondary barrier to 
block migration of LECs from the equatorial region toward the visual axis. They 
identified six factors, three of them are surgery-related and three are IOL-related, that 
play crucial roles in preventing or delaying the development of this complication 
(Ram et al, 1999;Apple et al, 2000;Peng et al, 2000;Apple et al, 2001). The surgery- 
related factors are hydrodissection-enhanced cortical removal, a smaller continuous 
capsulorhexis than the optic and in the bag placement of the IOL. The IOL-related 
factors are the biocompatibility o f the IOL material to reduce stimulation of cellular 
proliferation, square-optic geometry of the IOL and maximal optic-capsule contact.
63
Chapter 1: Introduction and Review o f the Literature
A PMMA square-edged capsular bag tension ring was used by Hara (Hara et al,
1995), Hashizoe (Hashizoe et al, 1998), and Nishi (Nishi et al, 1998b;Nishi et al, 
1998a), who showed a significant reduction in PCO development. Nishi et al 
(Nishi et al, 1998a) concluded that a discontinuous bend in the capsule 
significantly inhibits LEC migration. The subsequent development of the square- 
edged IOLs and the establishment o f their beneficial effect have made this 
technique redundant, however.
Posterior continuous curvilinear capsulorhexis (PCCC) and the optic capture 
technique with or without vitrectomy is another method that was primarily used in 
children and was reported by many authors to successfully prevent posterior capsular 
opacification (Gimbel, 1996;Vasavada et al, 2001;Raina et al, 2002). The procedure, 
however, did not prevent the growth of LECs on the anterior hyaloid face and 
Vasavada et al (Vasavada et al, 2004) reported up to almost 40% of anterior hyaloid 
opacification. Secondary surgical procedure was required after a mean follow-up of
2.3 years in 13.6% to clear the visual axis.
Tassignon et al (Tassignon et al, 2002) recently described the ‘bag-in-the-lens’ 
technique (Figure 1-12 & 1-13), where two identical continuous curvilinear 
capsulorhexes are created in both the anterior and posterior capsules and the capsular 
leaflets are inserted between the flanges of an IOL especially designed for that 
technique ‘twin-capsulorhexis IOL’. The authors reported no PCO or rather any 
similar retro-lenticular opacification in adults (Tassignon et al, 2002);(Tassignon, 
2004b) and children (Tassignon, 2004a). They advocated the technique as the most 
effective surgical technique to prevent the development of PCO in high-risk patients 
such as children, uveitic patients and following vitrectomy. The procedure, however, 
is technically demanding but the authors report no increased risk of vitreous loss or 
increased incidence of cystoid macular oedema.
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Figure 1-12. A schematic d iag ram  of the twin-capsulorhexis and  the IOL with 
the two perpend icu larly  orientated  haptics (1 & 3). The side view shows the 
characteristic  groove (2) tha t em braces the two capsu la r  leaflets (Courtesy of 
Prof. Tassignon (Tassignon et al, 2002))
Figure 1-13. A schematic d iag ram  illustrating a com parison between the 
conventional in-the-bag IOL with the LECs covering the posterior capsule and 
the bag-in-the lens with the two flanges of the haptics em bracing  the capsular 
leaflets tha t in turn  captures the LE C s in between them. (Courtesy of Prof. 
Tassignon (Tassignon et al, 2002))
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1.1.6.1.2.5.2 Surface modification of IOLs
Coating the IOL surfaces is generally meant to change their surface tension, which 
determines their relative hydrophilicity. The latter affects the attraction of the cells 
and their growth onto the IOL surfaces and is inversely related to their surface 
tension and to their contact angles (section 1.1.4).
Heparin-coating of PMMA IOLs renders their surfaces hydrophilic, with a contact 
angle of 33° to 56.5° (Cunanan et al, 1998;Dick et al, 2001;Tehrani et al, 2004). 
Although the lens was shown to have higher uveal biocompatibility i.e. less anterior 
chamber inflammation (Fagerholm et al, 1989;Percival & Pai, 1993) and cellular 
deposits (Shah & Spalton, 1995a), Umezawa et al showed that it increased the 
incidence of PCO (Umezawa & Shimizu, 1993).
Surface-passivation of PMMA IOLs changes their surface energy and hence renders 
them more hydrophobic with a contact angle of 90° (Umezawa & Shimizu, 1993). 
Kochounia et al (Kochounian et al, 1991) found that surface-passivated PMMA IOLs 
activated complement to the same degree of regular PMMA and no significant effect 
was found on lowering the incidence of PCO (Umezawa & Shimizu, 1993).
1.1.6.1.2.5.3 Inhibiting lens epithelial cell proliferation
The main classes of medications that have been used to inhibit LEC proliferation are: 
a) Antiproliferative drugs such as 5-fluorouracil (Ruiz et al, 1990;Ismail et al, 1996), 
daunorubicin (Tetz et al, 1996), colchicines (Legler et al, 1993) and mitomicin 
C(Ismail et al, 1996;Chung et al, 2000); b) Immunotoxins such as 4197X-ricin A 
immunoconjugate (Tarsio et al, 1997), lens epithelial cell adhesion molecule 
blocking agent (Nishi et al, 1997) and immunotoxin MDX-RA (Clark et al, 1998) 
and c) Antiinflammatory drugs such as indomethacin (Nishi et al, 1996b;Tetz et al,
1996) and diclofenac sodium (Nishi et al, 1995a;Cortina et al, 1997) and cyclosporin 
A (Cortina et al, 1997). These medications are applied either intraoperatively, 
through a long-acting delivery system or postoperatively. None of these medications, 
however, have been proved clinically useful yet.
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1.1.6.1.2.5.4 Other methods
Experimental use of heparin-mixed anterior chamber irrigating solution during 
cataract extraction (Zaturinsky et al, 1990) and implantation of an anterior chamber 
heparin drug-delivery system (Xie et al, 2003) were found to be useful in reducing 
the postoperative inflammatory reaction and the incidence of PCO. Also, in a case- 
controlled trial, heparin eye drops have been shown to reduce the incidence of PCO 
after 4 years (Mastropasqua et al, 1997). The long-term effectiveness of these 
methods has not been yet established.
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1.2 REVIEW OF THE LITERATURE
1.2.1 Incidence of PCO
PCO is the most common postoperative complication after modem cataract 
extraction surgery. Published estimates that are based on the need for Nd:YAG 
capsulotomy have shown a gradually increasing incidence of PCO after surgery. 
Within the first postoperative year, the incidence was found to be up to 12% 
(Sudhakar et al, 1989;Schaumberg et al, 1998;Baratz et al, 2001;Ando et al, 2003) 
and that increases to about 50% in 5 years (Moisseiev et al, 1989;Apple et al, 
1992;Baratz et al, 2001;Ando et al, 2003). Sundelin (Sundelin & Sjostrand, 1999) 
found that, 5 years after surgery, there was a ‘hidden’ untreated group of 
approximately 9% of patients that had clinically significant PCO and would benefit 
from Nd:YAG capsulotomy.
Table 1-2 and 1-3 details the incidence rate o f PCO, as indicated by the need for 
Nd:YAG capsulotomy, reported in the most recent studies with a follow-up of at 
least 1 year after ECCE and phacoemulsification. Incidence o f NdrYAG capsulotomy 
has mainly been used in retrospective (Mamalis et al, 1996b;Ninn-Pedersen & Bauer, 
1997;Dana et al, 1997;Baratz et al, 2001;Beltrame et al, 2002;Ando et al, 
2003;Abhilakh Missier et al, 2003) and post-mortem studies (Apple et al, 
2001;Schmidbauer et al, 2001a). The method is criticised for its subjectivity as it 
relies on patients’ complaints and surgeons’ threshold for intervention. However, the 
method derives validity from the fact that it reflects ‘clinically significant’ PCO i.e. 
PCO that affects visual function or obscures the fundus view.
Several factors related either to the patient or the surgical technique have been 
suggested to affect the incidence and rate of PCO.
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1.2.2 Factors affecting the incidence of PCO
1.2.2.1 Surgery related factors
/. 2.2.1.1 Surgical technique
Although, a meta-analysis by Powe et al (Powe et al, 1994) was unable to show a 
significant difference between ECCE and phacoemulsification techniques in the 
incidence o f PCO, a decline in PCO and Nd:YAG capsulotomy rates has recently 
been documented in a large post-mortem study of Nd:YAG capsulotomy rate (Apple 
et al, 2001). Reports of the 5-year incidence following ECCE indicated that PCO 
occured in up to 50% (Moisseiev et al, 1989;Apple et al, 1992), while after 
phacoemulsification the incidence was only up to 33% (Baratz et al, 2001;Ando et 
al, 2003). In a study by Ram et al (Ram et al, 2001) ECCE was found to have a 
higher rate o f visually significant PCO than phacoemulsification (42.5% vs. 19.2%). 
The lower incidence with phacoemulsification is believed to be related to the 
improvement in the surgical techniques, the use of smaller incisions, better cortical 
clean-up and the use o f modem foldable intraocular lenses with better design 
profiles. Also, the reduced postoperative inflammatory reaction shown to occur after 
phacoemulsification (Oshika et al, 1992;Ursell et al, 1999;Mentes et al, 2003) seem 
to have a role in lowering the incidence of PCO.
The type and size of capsulorhexis affects the incidence of PCO. The performance of 
continuous curvilinear capsulorhexis was found to be associated with less PCO than 
‘envelope’ capsulectomy (Birinci et al, 1999). Hollick et al, 1999 (Hollick et al, 
1999a), and Aykan et al, 2003 (Aykan et al, 2003), reported an increase in the 
percentage of area of opacified posterior capsule after phacoemulsification and 
implantation of PMMA IOLs in patients with larger capsulorhexis (6-7mm in 
comparison to 4.5-5mm). Also, Wejde et al (Wejde et al, 2004) found that a small 
central CCC that totally covers the optic edge was associated with significantly less 
PCO than that that lies partially or completely off-the-optic.
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1.2.2.1.2 Intraocular lens
1.2.2.1.2.1 IOL and its position
Implantation of an IOL following cataract surgery was shown to decrease the 
incidence o f PCO and Nd:YAG capsulotomy in comparison to aphakia (Nishi, 
1986;Badr et al, 1995). Also, bag-fixated IOLs were found to decrease the incidence 
of PCO (Laurell et al, 1998) and Nd:YAG capsulotomy (Ram et al, 1999;Ram et al, 
2001).
1.2.2.1.2.2 Design o f  the IOL
Angulation of the haptic and the overall size of an implant or its optic can have an 
effect on the rate of PCO. Patients implanted with PMMA IOLs with angled 
haptics were found to have a lower capsular discission rate than uniplanar PMMA 
IOLs (7.9% vs. 15%) (Downing, 1986). In a later study by Shmidbauer et al 
(Schmidbauer et al, 2002) this was not found to be the case, however. Mamalis et 
al (Mamalis et al, 1995) found less PCO requiring Nd:YAG capsulotomies in a 
PMMA IOL group with an overall lens diameter less than 13.5 mm, than in a 
PMMA IOL group with an overall diameter of 13.5mm or larger. Nishi and Nishi 
(Nishi & Nishi, 2003) found that acrylic IOLs with larger optics (7 mm) had a 
higher rate of PCO development than those with smaller optics (5.5 mm).
Similarly, the configuration of the posterior surface of the IOL has been found to 
affect the rate o f PCO as well as the type of opacification that develops. Intraocular 
lenses with a convex posterior surface were found to have a lower capsulotomy 
rate (up to 17.6%) than those with a plane posterior surface (up to 29.3%) (Sterling 
& Wood, 1986). Following a continuous capsulorhexis and phacoemulsification, 
Yamada et al (Yamada et al, 1995) found that Nd:YAG capsulotomy rates were 
5.9% and 32.5% after plano-convex and biconvex IOL implantation, respectively.
A laser-created ridge on the posterior surface of the implant was found in earlier 
studies to lower the PCO rate (Maltzman et al, 1989). Bom et al (Bom & Ryan,
1990) found that implants of biconvex or plano-convex design that had broader 
posterior surface contact with the posterior capsule had a lower cumulative
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capsulotomy rates than implants with a convex-plano optic or those with laser 
ridges (5.9% versus 40%).
Plate-haptic silicone IOLs was shown to have less PCO requiring Nd:YAG 
capsulotomy in comparison to 3-piece silicone IOLs (Cumming, 1993). Mamalis et 
al (Mamalis et al, 1996b) found the same results but the difference between the 
capsulotomy rates in their study was not statistically significant (30.2% and 
39.1%). In a recent study by Abhilakh Missier (Abhilakh Missier et al, 2003), 
plate-haptic silicone IOL had more PCO and Nd:YAG capsulotomy rate than 
hydrophobic acrylic IOLs.
A square-edge profile o f an IOL has been shown to reduce or even prevent 
migration of LECs onto the posterior capsule and hence the development of PCO 
through either a contact inhibition mechanism (Nishi et al, 1998c) or a mechanical 
barrier effect (Boyce et al, 2002). Nishi et al has shown that to be the case in 
experimental and clinical settings (Nishi et al, 1998a;Nishi et al, 1998c;Nishi & 
Nishi, 1999;Nishi et al, 2000). Peng et al (Peng et al, 2000), in a study of 150 
autopsy eyes with 3 types of IOLs: PMMA, silicone and hydrophobic acrylic, 
noticed that there was an abrupt termination of cells at the peripheral edge of the 
truncated or square-edged optic. In a study by Kruger et al (Kruger et al, 2000), 
after 2 years of follow-up, silicone implants with square edges had less PCO and 
Nd:YAG capsulotomy rates than those with rounded edges.
The optic edge profile was shown to be more relevant in preventing PCO 
development than the optic material. Nishi et al (Nishi et al, 2000;Nishi & Nishi, 
2002) found the speed of capsular bend-formation at the optic edge was 
comparable and that there was no difference in PCO between two square-edged 3 
piece IOLs made of silicone and hydrophobic acrylic material. Nishi also found 
that hydrophobic acrylic implants with rounded edge lost their PCO preventative 
effect (Nishi et al, 2001).
1.2.2.1.2.3 IOL material
Several studies have shown that PMMA IOLs have a higher Nd:YAG capsulotomy 
rate than silicone and acrylic implants. Hollick et al (Hollick et al, 1999c) reported
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26%, 14% and 0% Nd:YAG capsulotomy after 3 years for PMMA, silicone and 
hydrophobic acrylic IOLs, respectively.
Nagata et al and Oshika et al found that the adhesion force of a type I collagen 
sheet and of the posterior capsule to intraocular lenses made of acrylate was greater 
than with PMMA (Nagata et al, 1998;Oshika et al, 1998b) or silicone IOLs 
(Oshika et al, 1998b). Linnola et al (Linnola et al, 1999a) suggested that acrylate is 
a bioactive material that adheres to the biological tissues better than silicone and 
PMMA. They suggested that this is due to better adhesion of fibronectin to acrylate 
than to silicone and PMMA IOLs. This was postulated to explain the stronger 
adhesion between the posterior capsule and acrylic IOLs than PMMA and silicone 
IOLs and hence the preventative effect on LEC migration and PCO development 
(Linnola et al, 1999b;Linnola et al, 2000a;Linnola et al, 2000b). They also 
proposed that a single layer o f lens epithelial cell binds both to the IOL and to the 
posterior capsule, which produces a sandwich-like structure, including the IOL, the 
cell monolayer, and the posterior capsule; and that this sealed sandwich-like 
structure prevents further epithelial ingrowth and PCO development (The sandwich 
theory) (Linnola, 1997;Linnola et al, 1999b;Linnola et al, 2000b;Linnola et al, 
2000a).
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Table 1-2. Published incidence of Nd:YAG capsulotomy after ECCE and 
implantation of IOLs with different materials and designs and a follow-up of at 
least one year (modified and updated with permission from Linnola) (Linnola
R., 2001).
Study & Year IOL model Haptic m aterial No. Follow-up (m onths) Nd:YAG %
PMMA
(Winther-Nielson et al, 1998) Pharmacia 725b PMMA 60 36 43
(Winther-Nielson et al, 1998) Pharmacia 700b PMMA 62 36 43.5
(Khan & Percival, 1999) Cilco JF1LRU PMMA 40 144 50
(Hollick et al, 1999c) Alcon MC60BM PMMA 23 36 26
Hydrophilic acrylic (HSM -PM M A)
(Winther-Nielson e ta l, 1998) Pharmacia HSM-725b PMMA 70 36 44
(Winther-Nielson e ta l, 1998) Pharmacia HSM-700b PMMA 58 36 67
(Khan & Percival, 1999) logel PC 12 Single-piece 35 144 20
Silicone
(Hollick e ta l, 1999c) 
Hydrophobic Acrylic
lolab L14IU PMMA 22 36 14
(O shikae/a /, 1996) Alcon AcrySof MA60BM PMMA 64 24 11.1
(Hollick et al, 1999c) Alcon AcrySof MA60BM PMMA 19 36 0
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Table 1-3. Published incidence of Nd:YAG capsulotomy after 
phacoemulsification and implantation of IOLs with different materials and 
designs and a follow-up of at least one year (modified and updated with 
permission from Linnola) (Linnola R., 2001).
Study&  Year IOL model H aptic m aterial No. Follow-up (months) Nd:YAG %
PMMA
(Hayashi e ta l , 1998c) Alcon MZ60BD PMMA 69 24 30.4
(Olson & Crandall, 1998) * PMMA 59 36 33
(Erie e ta l , 1998) Pharmacia 720/Storz 650 CUV PMMA 198 41 26.5
(Erie et al, 1998) Pharmacia 805/Storz 359 PMMA 171 41 23.5
(Oner et al, 2000) 
Silicone
Opsia-Agena 550 PMMA 77 17.8+1.7 26.3
(Cumming, 1993) * Plate-haptic 503 30 2.3
(Mamalis et al, 1996b) Staar AA-4203 Plate-haptic 139 21 30.2
(Mamalis et al, 1996b) AMO S118NB/S130NB Polypropylene 349 23.3 39.1
(Hayashi et al, 1998c) AMO S130NB Polypropelene 70 24 5.7
(Linnola & Holst, 1998) Pharmacia CeeOn 920 PMMA 45 12 1 1
(Olson & Crandall, 1998) AMO SI30NB Polypropelene 60 36 24
(Abhilakh Missier et al, 2003) 
Hydrophilic acrylic
Staar AA4-203 Plate-haptic 107 36 23.1
(Brown et al, 1998) Staar Collamer Plate-haptic 125 65 4.7
(Stordahl & Drolsum, 2003) 
Hydrophobic Acrylic
loltech Stabibag Hydroge 370 23.7(3.1) 7.6
(Hayashi et al, 1998c) Alcon AcrySof MA60BM PMMA 73 24 2.7
(Oner et al, 2000) Alcon AcrySof MA30BA PMMA 80 17.8+1.7 14.34
(Abhilakh Missier et al, 2003) Alcon AcrySof 
MA30BA/60BM
PMMA 107 9 (2-23)/ 5.5(5-6) 0.34/0.64
(Stordahl & Drolsum, 2003)
Alcon AcrySof MA30BA
PMMA 335 23.3(3.3) 2.7
ECCE=Extracapsular cataract extraction; AMO= Advanced Medical Optics. * = data not available.
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1.2.2.2 Patient-related factors
1.2.2.2.1 Ocular factors
1.2.2.2.1.1 Uveitis
Several studies have reported the incidence or prevalence of PCO in uveitis patients 
after ECCE or phacoemulsification cataract extraction. After extracapsular cataract 
extraction, Krishna et al (Krishna et al, 1998) reported a prevalence o f 58% after a 
mean follow-up period of 81.4 months. In a case-controlled retrospective study of 
patients who underwent either ECCE or phacoemulsification, Dana et al (Dana et al,
1997) reported 45% of PCO rate after a mean follow-up of 4.3 years. In that study, 
the rate was compared to a contemporary group of non-uveitic patients who had a 
mean follow-up of 3.9 years and a PCO rate o f 40%. Although the difference was 
statistically significant, the difference became no longer significant after adjusting 
for the younger age o f the uveitis patients.
After phacoemulsification in uveitis patients, Estafanous et al (Estafanous et al,
2001) reported PCO in 62% of patients after a mean follow-up of 20 months. Also, 
Suresh et al (Suresh & Jones, 2001), reported 42% of PCO and 21 % of Nd:YAG 
capsulotomy among their patients after a mean follow-up of 2 years.
Berker et al (Berker et al, 2004) indicated that PCO was the most frequent 
complication, occurring in 37.5% of 40 eyes of patients with uveitis and B e lie fs  
disease after phacoemulsification and IOL implantation. In a recent study by Rahman 
et al (Rahman & Jones, 2004), the long-term incidence of PCO in uveitis patients 
(after a mean follow-up of 7.5 years) was 96%.
1.2.2.2.1.2 Myopia
After phacoemulsification, patients with myopia and increased axial length were 
found to have an increased incidence of PCO. In a series of 109 highly myopic eyes 
(axial length over 26 mm) with a mean postoperative follow-up of 27 months, Lyle et 
al (Lyle & Jin, 1996), found an incidence of 50% of PCO, 95% of whom needed 
Nd:YAG capsulotomy. In another retrospective study of 32 eyes of 27 highly myopic 
patients (axial length=31mm to more than 35 mm) who had cataract surgery and
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negative power_posterior chamber IOL implantation (-1.0 to -8.0 dioptres), PCO 
occurred in 44% after a follow-up of 6 to 36 months (Kohnen & Brauweiler, 1996).
1.2.2.2.1.3 Retinitis pi2mentosa
Auffarath et al (Auffarth et al, 1996) found that, after phacoemulsification, patients 
with retinitis pigmentosa had an incidence of PCO of about 70.7% after 1 to 4 years. 
That was found to be significantly higher than an age and follow-up matched control 
group. Ando et al found that retinitis pigmentosa was an independent risk factor for 
the development of PCO (Ando et al, 2003).
1.2.2.2.1.4 Pseudoexfoliation
In a retrospective study of 197 patients, 99 of whom had pseudoexfoliation 
syndrome, Kuchle et al (Kuchle et al, 1997) reported an incidence of 45% of PCO in 
comparison to 9% in the control group.
1.2.2.2.1.5 Glaucoma and phaco-trabeculectomv
The relationship between glaucoma and the incidence of PCO appears to be related 
mainly to the surgical technique performed or to coexistent diseases. Phaco- 
trabeculectomy was found to have a decreased incidence of early PCO than 
combined ECCE and trabeculectomy (Anand et al, 1997). Shin et al (Shin et al, 
2002) found that the incidence of PCO did not particularly increase after phaco- 
trabeculectomy when compared to phacoemulsification. They found, however, that 
the use of mitomycin C and the presence of diabetes mellitus significantly decreased 
the rate of PCO. An increased rate of PCO, on the other hand, was reported in eyes 
having a combined procedure and a limbal-based conjunctival flap when compared 
to those with a combined procedure and a fornix-based flap (Tezel et al, 1997). Ober 
et al (Ober et al, 2000) found no difference between silicone and acrylic IOLs in the 
incidence of PCO after phaco-trabeculectomy.
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1.2.2.2.2 Systemic factors
1.2.2.2.2.1 Age
Both experimental and clinical studies have shown the effect of age on the 
development of PCO. Wormstone and coauthors (Wormstone et al, 1997) found that 
lens epithelial cell growth rate was age-dependent. They found that LEC count was 
significantly higher in the capsular bags of children in comparison to adults with 
senile cataract. Majima (Majima, 1995) showed a higher growth potential of LECs in 
patients with congenital cataract compared to those with senile cataract. Also, Jamal 
(Jamal & Solomon, 1993) found that an increased risk of developing epithelial pearls 
onto the posterior capsular associated with younger age and Stager (Stager, Jr. et al,
2002) reported an incidence o f PCO up to 100 % in children under 4 years after 2.75 
years of follow-up.
1.2.2.2.2.2 Sex
In an epidemiological study, Ninn-Pedersen et al (Ninn-Pedersen & Bauer, 1997) 
showed that after about 4 to 5 years, the percentage of patients not having had a 
Nd:YAG capsulotomy was reduced to around 50% for women and 60% for men. 
Also, Ando, et al (Ando et al, 2003) found that female sex was an independent risk 
factor for increased rate of Nd:YAG capsulotomy.
1.2.2.2.2.3 Diabetes mellitus
Conflicting reports exist regarding the effect of diabetes mellitus on PCO. A lower 
PCO rate in diabetic patients was reported by Knorz et al (Knorz et al, 1991) in a 
retrospective study of 939 eyes with an average follow-up of 26.3 months following 
ECCE and in a prospective study by Zaczek and Zetterstrom (Zaczek & Zetterstrom, 
1999) following phacoemulsification and implantation of heparin-coated intraocular 
lenses. A lower incidence in diabetics was also reported in other studies of PCO in 
glaucoma (Shin et al, 1998;Shin et al, 2002) and pseudoexfoliation syndrome 
patients (Kuchle et al, 1997). In a recent prospective randomised clinical trial, 
Hayashi et al, 2002 (Hayashi et al, 2002), found that both PCO density and the 
incidence of Nd:YAG capsulotomy were significantly higher in diabetic patients up
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to 3 years after surgery. The differences in these studies design, patient populations 
and method of PCO assessment could explain the differences in their conclusions.
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2 POSTERIOR CAPSULAR OPACIFICATION IN 
DIABETIC PATIENTS
2.1 STUDY OF THE INCIDENCE AND RISK FACTORS OF 
ND:YAG CAPSULOTOMY IN NON-DIABETIC AND 
DIABETIC PATIENTS
2.1.1 Introduction
Posterior capsular opacification, in addition to impairing vision, can obscure fundus 
visualisation and potentially compromise the surveillance and timely treatment of 
posterior segment pathology such as diabetic retinopathy and macular oedema. 
Nd:YAG laser capsulotomy, the treatment of choice, is not without complications, 
some of which can be sight-threatening such as retinal oedema and detachment 
(Keates et al, 1984), which are particularly important in diabetic patients.
The long-term incidence of PCO in diabetic patients after phacoemulsification has 
not been separately examined before. Also, although factors such as young age, 
female gender, extra-capsular cataract extraction (ECCE), retinitis pigmentosa, better 
preoperative acuity and polymethylmethacrylate (PMMA) IOLs have been identified 
as risk factors for increased rate of PCO development and/or Nd:YAG capsulotomy 
(Baratz et al, 2001;Ando et al, 2003), the effect of diabetes mellitus remains 
uncertain. Some studies have shown an increased (Ionides et al, 1994;Hayashi et al,
2002), and others a decreased risk of PCO development and Nd:YAG capsulotomy 
in diabetic patients (Zaczek & Zetterstrom, 1999;Knorz et al, 1991). Moreover, none 
of the studies have investigated the influence of factors such as ethnic origin, 
postoperative inflammation and diabetes type and duration.
Many recent studies of PCO relied on the quantitative measurement of the density or 
extent of capsular opacification. While invaluable as an indicator of early lens 
epithelial cell (LEC) proliferative activity, the reported PCO rates in these studies do 
not necessarily reflect what might be a clinically significant opacification i.e. one 
that reduces visual functions or visibility of the posterior segment and thus requires 
treatment. Moreover, LEC proliferation and migration onto the posterior capsule can
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be variable and even show regression at the short- and long-terms (Hollick et al, 
1998;Meacock et al, 2001 ;Findl et al, 2004).
2.1.2 Aims
We undertook this retrospective study to examine the incidence and factors that 
affect Nd:YAG capsulotomy rate, which was used as a surrogate measure of PCO 
rate, in a cohort of non-diabetic and diabetic patients in a single medical retina unit at 
a tertiary referral hospital.
2.1.3 Patients and methods
2.1.3.1 lnclusion& exclusion criteria
After obtaining ethical approval for the study, we reviewed 1223 medical records of 
a continuous series of patients who underwent phacoemulsification cataract 
extraction in the medical retina service at Moorfields Eye Hospital between 1994 and 
2000. Only one eye was randomly included for patients who had bilateral surgery 
(n=216). Patients who underwent other anterior segment surgery (e.g. 
trabeculectomy or keratoplasty) (n=156) and those with unavailable records at the 
time of the study (n=45) were excluded. Four patients (0.5%) were included who had 
diagnoses of uveitis (Behcet’s, multifocal choroiditis, sympathetic ophthalmia and 
Eales disease). The number of included patients was 806, 327 (40.6%) of whom were 
diabetic.
2.1.3.2 Surgery
The number of included patients was 806, 327 (40.6%) of whom were diabetic. All 
patients underwent a standard phacoemulsification and implantation of an IOL. 
Surgery was performed by a consultant or a fellow (306; 38%); or a senior resident 
(420, 52.1%) attached to the medical retina service. In 80 patients (9.9%), it was not 
possible to identify the surgeon’s grade at the time of surgery. A corneal incision of
2.8 to 3.2mm was performed on all patients except those who were given PMMA 
implants where a 5.5mm to 6mm incision and corneal sutures were needed. A 
circular continuous capsulorhexis was fashioned, the size of which was aimed to just 
overlap the optic edge. This was typically 5 to 5.5mm, although details of the exact 
size and position of the lens in relation to the capsule was not routinely recorded.
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Hydrodissection was then performed followed by phacoemulsification of the nucleus 
and manual irrigation-aspiration of cortical lens matter. Intraocular lenses used were 
either polymethylmethacrylate (PMMA)(n=l 14, 14.2%) (MC550, Iolab, n=82 or 
6840U, Chiron Vision-Iolab, n=32), plate-haptic silicone (n=647, 80.3%) (Chiron 
C10UB, n=100; or Chiron Vision Cl 1UB, n=547) or 3-piece-silicone (LI41U, Iolab) 
(n=45, 5.6%). All IOLs were implanted inside the capsular bag except in 9 patients 
(1%), in whom posterior capsular tear necessitated sulcus-fixation.
At the conclusion of the procedure, subconjunctival Betamethasone (4mg) and 
Cefuroxime (125mg) or Gentamicin were given. After surgery, patients were 
prescribed Guttae Dexamethasone 0.1% and Guttae Chloramphenicol 0.5% QDS for 
2 weeks followed by Guttae Dexamethasone 0.1% BID for 2 weeks. Postoperative 
evaluation was performed immediately after surgery, within two weeks and at 
regular intervals thereafter depending on the clinical need.
2.1.3.3 Outcome measure and data collection
The principal outcome variable was the performance of Nd:YAG capsulotomy, taken 
as a surrogate measure for clinically significant PCO. Indications for this procedure 
were the presence of significant PCO that is: (1) causing visual symptoms such as 
reduced acuity or glare; or (2) interfering with the visualisation of the posterior 
segment.
A database file was used for entering all the relevant data including age at surgery, 
ethnic origin, the medical and surgical history, operative and postoperative details, 
the surgeon’s grade (resident or fellow/ consultant), the duration between surgery 
and the performance of Nd:YAG capsulotomy and the follow-up time. Information 
about diabetes mellitus included diabetes type: non-insulin dependent or insulin- 
dependent, duration (in years) and grade of retinopathy: none, non-proliferative or 
proliferative. Also, the presence of uveitis and the occurrence of clinically significant 
postoperative inflammation, i.e. documented inflammatory signs that required 
additional topical or systemic steroid treatment within 3 months of surgery, was 
recorded.
2.1.3.4 Statistical analysis
The Statistical Package for Social Science (SPSS, v.9; Chicago, 111.) for Windows 
software was used for statistical analysis. The median and inter-quartile range were
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used for description of continuous data. Survival tables and Kaplan-Meier curves, 
which accounts for censored data i.e. patients that did not have Nd:YAG laser 
treatment by the end of their follow-up, were used to derive the cumulative incidence 
and compare rates of Nd:YAG capsulotomy between patient subgroups. The 
cumulative incidence was calculated as the number of events (i.e. Nd:YAG 
capsulotomy) divided by the number of patients at risk at each of the time intervals 
(No. of patients entering the period less 50% of those lost to follow-up). Confidence 
intervals for the incidences were calculated using the Wilson score method.
A log rank test was used for bivariate analysis and a backward step-wise Cox- 
proportional hazard regression for multivariate analysis. A variable qualified for 
inclusion in the Cox-proportional hazard model if they had a p  value of 0.2 or less or 
if believed from previous studies to affect the rate of PCO. Post hoc assessment 
showed that the study sample size had a power of 90% to detect a hazard ratio of 
10% to 30% between the two subgroups for variables such as diabetes mellitus, 
postoperative inflammation, IOL type and vitrectomy over an accrual period of 48 
months. The sample size allowed for up to 95% censored data (loss of follow-up or 
no capsulotomy by the time patients were discharged) in either of the two subgroups 
and 10% conversion rate (from non-diabetic to diabetic) during the follow-up period. 
A p  value of <0.05 was considered statistically significant.
2.1.4 Results
2.1.4.1 Patient characteristics
The demographic and clinical features of the patients are listed in Table 2-1. The 
median age of the patients was 69.7 years (range=20.2 to 99.3) and the median length 
of follow-up was 16.6 months (range=1.8 to 74).
2.1.4.2 Incidences of PCO
Survival table analysis (Table 2-2) revealed that the incidences of Nd:YAG 
capsulotomy were 9.9%, 12.3%, 18% and 15.4% after 1,2,3 and 4 years respectively. 
In non-diabetic patients the incidences were 10.6%, 14.8%, 21.2% and 28.6% and in 
diabetic patients they were 9%, 9.4%, 15.3% and 5.4% after the same follow-up 
periods.
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Table 2-1. Patient characteristics
Total Non-diabetic Diabetic P
No. 806 479(59.4%) 327(40.6%)
Gender
Male 337(41.8%) 189(39.5%) 148(45.3%) 0.12
Female 469(58.2%) 290(61.8%) 179(54.7%)
Ethnic origin
Caucasian 311(38.6%) 229(47.8%) 82(25.1%) <0.001
Asian 99(12.3%) 38(7.9%) 61(18.7%)
Afro-Caribbean 59(7.3%) 19(4%) 40(12.2%)
Other 72(8.9%) 41(8.6%) 31(9.5%)
Unknown 265(32.9%) 152(31.7%) 113(34.6%)
Age
Median 70 72 67 <0.001
IQR 63-77 64-79 61-74
<= 65 years 283(35.1%) 144(30.1%) 139(42.5%) <0.001
> 65 years 523(64.9%) 335(69.9%) 188(57.5%)
Follow-up (months)
Median 13.8 12.9 14.97 0.001
IQR 7.3-22.8 6.77-20.07 7.83-26.43
Diabetes type
IDDM . . 37(11.3%)
NIDDM - - 290(88.7%)
Diabetic retinopathy
None . . 104(31.8%)
NPDR - - 137(41.9%)
PDR - - 86(26.3%)
Retinitis pigmentosa 12(1.5%) 11(2.3%) 1(0.3%) 0.02
Surgeon’s grade
Resident 420(52.1%) 262(54.7%) 158(48.3%) 0.04
Fellow/Consultant 306(38%) 179(37.4%) 127(38.8%)
Unknown grade 80(9.9%) 38(7.9%) 42(12.8%)
IOL
PMMA 114(14.1%) 62(12.9%) 52(15.9%) 0.04
PH silicone 647(80.3%) 397(82.9%) 250(76.5%)
3-piece silicone 45(5.6%) 20(4.2%) 25(7.6%)
Postop inflammation 62(7.7%) 43(9%) 19(5.8%) 0.10
Vitrectomy 114(14.1%) 82(17.1%) 32(9.8%) 0.003
IDDM=insulin-dependent diabetes mellitus; NIDDM=non-insulin dependent 
diabetes mellitus, NPDR=non-proliferative diabetic retinopathy; PDR=proliferative 
diabetic retinopathy, PMMA=polymethylmethacrylate; PH=plate-haptic
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Table 2-2. Incidences of NdrYAG capsulotomy in diabetic and non-diabetic patients
Non-Diabetic (n=479) Diabetic (n=327)
No. of patients : 
No. lost to follow-up
No of 
capsulotomy
% incidence
95% Confidence 
interval
No. of patients: 
No. lost to follow-up
No. of 
capsulotomy
% incidence
95% Confidence 
interval
Up to 1 year 479:200 40 10.6 7.9, 14.1 327:118 24 9 6.1,13
>1 year-2 years 239:140 25 14.8 10.2,20.9 185:92 13 9.4 5.6, 15.3
>2 years-3 years 74:44 11 21.2 12.2,34 80:42 9 15.3 8.2, 26.5
>3 years-4 years 19:10 4 28.6 11.7, 54.7 29:21 1 5.4 1,25.2
>4 years-5 years 5:4 0 0 0, 56.2 7:4 0 0 0, 43.5
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2.1.4.3 Risk factors for Nd:YAG capsulotomy
We constructed a Cox proportional hazard regression model (Table 2-3) that 
included gender, age (<65 or > 65), ethnic origin, diabetes mellitus, pars plana 
vitrectomy, surgeon’s grade, IOL type, postoperative inflammation and retinitis 
pigmentosa as potential risk factors. The model revealed that a decreased risk of 
Nd:YAG capsulotomy was associated with diabetes mellitus, [HR= 0.69; 95% Cl 
(0.47, 0.99)] and with the use of 3-piece silicone IOLs [HR= 0.25; 95% Cl (0.10, 
0.63)] while an increased risk was associated with patient age of 65 years or younger 
[HR=T.58; 95% Cl (1.09, 2.27)], postoperative inflammation [HR=2.63; 95% Cl 
(1.56, 4.42)] and vitrectomy surgery [HR=1.85; 95% Cl (1.20, 2.83)] (Figures 2-1 a 
to e).
In the non-diabetic subgroup (Table 2-4), a Cox proportional hazard model that 
included the same variables (except diabetes mellitus) showed that male gender 
[HR=1.63; 95% Cl (1.04, 2.57); p=0.03], vitrectomy [HR=1.90; 95% Cl (1.09, 3.33); 
/?=0.02], postoperative inflammation [HR=2.78; 95% Cl (1.51, 5.12); /?=0.001] were 
associated with an increased risk while 3-piece silicone IOL with a reduced risk for 
Nd:YAG capsulotomy [HR=0.18; 95% Cl (0.04, 0.82); /?=0.03]. In the diabetic 
subgroup (Table 2-4), a model that included, instead of diabetes mellitus, diabetes 
type (IDDM vs. NIDDM), duration, and diabetic retinopathy grade (None, NPDR 
and PDR), only vitrectomy was significantly associated with an increased risk of 
Nd:YAG capsulotomy [HR=2.47; 95% Cl (1.26, 4.83); /?=0.008].
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Table 2-3. Multivariate Cox regression analysis of the factors associated with Nd:YAG Capsulotomy
Hazard ratio 95% Confidence interval P
Diabetes mellitus
No Reference
Yes 0.69 0.47, 0.99 0.047
Age
>65 Reference
<=65 1.58 1.09,2.27 0.01
Postop inflammation (within 3 months)
No Reference
Yes 2.63 1.56,4.42 0.0003
IOL type
PMMA Reference
PH silicone 0.94 0.59,1.49 0.79
3-piece silicone 0.25 0.10, 0.63 0.003
Vitrectomy
No Reference
Yes 1.85 1.20,2.83 0.005
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Table 2-4. Multivariate Cox regression analysis of the factors associated with Nd:YAG capsulotomy in the two subgroups
Non-diabetic subgroup Diabetic subgroup
Hazard ratio 95% Confidence interval P Hazard ratio 95% Confidence interval P
Surgeon grade
Resident Reference
Consultant 0.86 0.45,2.10 0.74
Unknown 1.98 0.85,4.57 0.11
Gender
Female Reference
Male 1.63 1.04,2.57 0.03
Age
>65 Reference - - -
<=65 1.49 0.94,2.36 0.09
IOL type
3-piece silicone Reference
PH silicone 6.98 1.65,29.46 0.008
PMMA 5.48 1.22, 24.68 0.03
Postop inflammation
No Reference - - -
Yes 2.78 1.51,5.12 0.001
Vitrectomy
No Reference Reference
Yes 1.90 1.09,3.33 0.03 2.47 1.26,4.83 0.008
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Figure 2-1. Kaplan-Meier curves of the factors affecting the rate of Nd:YAG 
capsulotomy. An increased Nd:YAG capsulotomy rates is demonstrated in 
patients of 65 year or younger (a), in non-diabetic patients (b), in patients with 
plate-haptic silicone and PMMA implants compared to 3-piece silicone IOLs (c), 
in patients who developed postoperative inflammation (d) and in patients who
underwent vitrectomy (e).
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2.1.5 Discussion
2.1.5.1 Incidences of Nd:YAG capsulotomy
In this study, we estimated that the incidences of Nd:YAG capsulotomy were 9.9%, 
12.3%, 18% and 15.4% after 1, 2, 3 and 4 years of follow-up, respectively. While the 
incidences progressively increased within the first 3 postoperative years in the two 
subgroups (from 10.6% to 22.2% and from 9% to 15.3%), they were consistently 
lower in the diabetic subgroup. During the fourth year, the incidence increased to 
28.6% in the non-diabetic and dropped to 5.3% in the diabetic group (Table 2-3). The 
numbers of patients afterwards were too small to draw any useful conclusions about 
the incidences in either group.
These incidences are generally similar to those reported by Baratz et al (Baratz et al, 
2001) and Ando et al (Ando et al, 2003). They estimated cumulative probabilities of 
15 to 18.5% and 32.7 to 33% after 3 and 5 years of follow-up, respectively. Both 
studies, however, reported lower probabilities within one year of follow-up (6% & 
1.95%). This could be related to the inclusion in their studies of patients who had 
hydrophobic acrylic implants (1.2% and 12.6%). These implants were proved to have 
a lower PCO rate than PMMA and silicone implants (Ingram et al, 1980;Ursell et al, 
1998;Hollick et al, 1999c) and the patients must have been entered late in their 
studies and hence perhaps comprised a significant proportion of those followed up 
within the first year.
2.1.5.2 Effect of DM on the rate of PCO
We noticed, as suggested by Baratz study (Baratz et al, 2001), that the steady 
increase of capsulotomy rate did not appear to continue. While this can be attributed 
to the improvement in the surgical technique, especially with the use of small 
incisions and foldable IOLs, or even to a possible natural decline in LEC survival 
suggested in experimental studies (Kato et al, 1997b;Saika et al, 2002), our findings 
(the lower incidence of Nd:YAG capsulotomy, the sharp drop after the third year and 
the lower risk of Nd:YAG capsulotomy in diabetic patients) suggest a role for the 
presence of diabetes mellitus in lowering the long-term incidence of Nd:YAG 
capsulotomy and possibly PCO.
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While neither of the above studies found a difference between diabetic and non­
diabetic patients, conflicting reports exist regarding the rate of PCO in the two 
groups. Lower PCO rates in diabetic patients were reported by Knorz and coauthor 
(Knorz et al, 1991) in a retrospective study of 939 eyes following ECCE and an 
average follow-up of 26.3 months and by Zaczek and Zetterstrom (Zaczek & 
Zetterstrom, 1999) in a prospective study following phacoemulsification and 
implantation of heparin-coated IOLs. In a prospective randomised trial, Hayashi et 
al(Hayashi et al, 2002) found that both PCO density and Nd:YAG capsulotomy rate 
were significantly higher in diabetic patients after 3 years of follow-up.
The conflict of reported PCO rates between studies could be related to variation in 
the clinical features of their patients, the threshold for performing Nd:YAG 
capsulotomy or the duration of follow-up. The progression of retinopathy reported to 
occur after cataract extraction (Liao & Ku, 2003;Hauser et al, 2004) could increase 
the clinician’s threshold to perform Nd:YAG capsulotomy for fear of inducing 
macular oedema or because the decline in visual acuity could be attributed to the 
retinopathy when in fact PCO could, at least partly, be contributory to causing the 
poor vision. However, a plausible biological explanation for the lower PCO rate in 
diabetics can be related to the detrimental effect of accumulating intracellular 
sorbitol (Kinoshita, 1974;Lin et al, 1991;Takamura et al, 2003;Ramana et al, 2003) 
and that of free radicals and oxidative stress (Hothersall et al, 1988;Kubo et al, 2004) 
on proliferation and survival of LECs and their decreased density in the diabetic 
capsular bag (Saitoh et al, 1990;Struck et al, 2000). These effects, presumably 
reinforced by the longer postoperative duration, perhaps explain the drop in PCO rate 
in diabetics that manifested after the third year in our series (Table 2-2).
2.1.5.3 Other risk factors of PCO in non-diabetic and diabetic 
patients
We also found that Nd:YAG capsulotomy was more likely in patients who were 65 
years or younger, those who underwent pars plana vitrectomy or developed 
postoperative inflammation within 3 months and with implantation of PMMA or 
plate-haptic silicone IOLs (Figures 2-1 a to e). While, in addition, male sex increased 
the risk o f Nd:YAG capsulotomy and age had a non-significant effect in non-diabetic 
patients, only vitrectomy increased the risk in diabetic patients. The disturbance of 
LEC metabolism induced by the presence of diabetes or, perhaps, the relatively
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smaller sample sizes might have effaced the effect o f some o f the risk factors in the 
subgroups.
2.1.5.3.1 Age
The increased Nd:YAG capsulotomy rate in younger individuals has been attributed 
to the increased proliferative capacity of the LECs in younger patients demonstrated 
in experimental studies (Liu et al, 1996;Wormstone et al, 1997). This can also 
conceivably be due to the increased visual demands in younger patients.
2.1.5.3.2 Pars plana vitrectomy
The increased Nd:YAG capsulotomy rate in patients who underwent pars plana 
vitrectomy concurs with the findings by Helbig at al (Helbig et al, 1996), and Pinter 
and Sugar (Pinter & Sugar, 1999). This could be related to increased LEC 
proliferation or collagen formation as a result of surgical trauma. The development of 
posterior capsular plaques commonly described during cataract extraction after pars 
plana vitrectomy indirectly supports this hypothesis (Grusha et al, 1998;Pinter & 
Sugar, 1999;Chang et al, 2002). Another explanation is the possible increased 
exposure to retina-derived growth factors that could stimulate LEC proliferation 
(Jacob et al, 1988). This was suggested by Jones et al (Jones et al, 1995), who 
described massive LEC proliferation at the edge of the capsulotomy in 6 of 8 eyes, 
all of which had posterior segment pathology.
2.1.5.3.3 Diabetic retin opathy
In our study, as in the study by Hayashi et al, 2002 (Hayashi et al, 2002), although 
retinopathy had no significant effect on Nd:YAG capsulotomy rate, a possible effect 
could not be completely ruled out. The forward diffusion of retina-derived growth 
factors into the anterior segment (Aiello et al, 1994), which can be enhanced by 
vitrectomy (Noma et al, 2002), could provide a stimulatory drive for LEC 
proliferation. This was also suggested in Jones’ study (Jones et al, 1995) as 4 of their 
patients had proliferative diabetic retinopathy.
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2.1.5.3.4 IOLs: Polymethylmethacrylate (PMMA) and plate-haptic silicone versus 
3-piece silicone
PMMA and plate-haptic silicone IOLs were associated with a higher risk for 
Nd:YAG capsulotomy in comparison with 3-piece-silicone IOLs. This is in 
agreement with other studies that have shown a higher PCO rate with PMMA when 
compared to 3-piece silicone IOLs (Hayashi et al, 1998c;01son & Crandall, 1998). In 
earlier studies by Mamalis et al (Mamalis et al, 1996b) and Cumming et al 
(Cumming, 1993) a lower rate of PCO with plate-haptic silicone IOLs than with 3- 
piece silicone IOLs was reported. In a postmortem analysis of the Nd:YAG rates 
with different IOLs, Apple et al (Apple et al, 2001) found that foldable IOLs had a 
lower rate than rigid PMMA IOLs (14.1% vs. 31.1%). Schmidbauer et al 
(Schmidbauer et al, 2001b) later reported that 3-piece silicone IOLs had Nd:YAG 
capsulotomy rates between 14.5% to 23.3% and plate-haptic silicone 15.3% to 25%. 
The rates vary between small-hole and large-hole implants (possibly due to of the 
advances in surgical technique rather than to the hole size).
2.1.5.3.5 Postoperative inflammation
Our study also suggests an independent risk associated with the occurrence of 
postoperative inflammation for the development of PCO. This relationship, which is 
consistent with the clinical impression of many surgeons, has not been suggested in a 
clinical study before. The interaction between the presence of residual LECs, their 
proliferation and the development of postoperative inflammation seem to pose a 
clinical conundrum, similar to the evolutionary ones, of ‘which came first?’ Clinical 
and experimental studies have demonstrated that cytokine release from residual 
LECs after cataract extraction can excite postoperative inflammation (Nishi & Nishi, 
1992;Nishi et al, 1992;Nishi et al, 1999). On the other hand, the rate of LEC 
proliferation has been shown to increase in a protein rich environment (Quinlan et al, 
1997;Davidson et al, 2000;Wallentin et al, 1998;Wormstone et al, 1997), which 
would be similar to that resulting from inflammation due to the influx of growth 
factors through the damaged blood-aqueous barrier and the consequent decreased 
concentration of aqueous transforming growth factor-beta (TGF-p) that would 
normally inhibit LEC proliferation (Wormstone et al, 2002;de Boer et al, 1994). It is 
most likely that these two mechanisms, as intimately consequential as they may look,
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are independent of each other as several other factors are associated with 
postoperative inflammation, such as incision size (Oshika et al, 1994;Oshika et al, 
1998a) and surgical technique (Pande et al, 1996b). In addition LECs can grow 
independently of external growth factors (Wormstone et al, 1997).
This finding raises the question of whether prophylactic or more aggressive treatment 
of postoperative inflammation would be a worthwhile strategy in patients at risk of 
developing postoperative inflammation and in the presence of other risk factors e.g. 
young age. The inhibitory effect of steroids and other antiinflammtory medications 
on the LECs proliferation and extracellular matrix formation has been suggested in 
experimental studies (Mansfield et al, 2004;Cortina et al, 1997) but remains to be 
established clinically.
2.1.5.3.6 Gender
The relationship between gender and Nd:YAG capsulotomy is not clear and is 
difficult to explain. In this study we found that, in contrast to that by Ando et al 
(Ando et al, 2003), in the non-diabetic group, men were more likely to have 
Nd:YAG capsulotomy than women. Ando et al explained the excess of PCO in the 
female patients by the gender difference in attitude towards health problems, with 
more women seeking medical advice and reporting symptoms more readily than 
men. This, however, varies across different cultures and the presence of more 
ethnically diverse population in our study might have reversed that effect. Moreover, 
in women, the protective effect of oestrogen against TGF-P (Hales et al, 1997;Chen 
et al, 2004), implicated in cellular trans-differentiation and extracellular matrix 
formation for PCO (Davidson et al, 2000;Wormstone et al, 2002), provides a 
possible hormonal explanation in favour of our finding.
2.1.6 Limitations
The retrospective nature is an apparent limitation of this study because of the 
inability to account for all potential confounders. Attempts to avoid bias because of 
the retrospective design of this study included: the large sample size, the continuous 
nature o f the series, drawing the sample from a single service in the hospital to 
ensure as much as possible homogeneity of the indications for Nd:YAG capsulotomy 
and the random inclusion of one eye in patients with bilateral surgeries. Also, we
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used multivariate analysis to identify the independent risk factors after accounting for 
all possible clinical and surgery-related confounders.
2.1.7 Conclusion
Despite its limitations, this study is an addition to other large-scale studies that aimed 
to identify the potential risk factors of developing clinically significant PCO, which 
is the preliminary step towards developing strategies of preventing its development 
and planning for the review and treatment of predisposed patients. It suggests that 
diabetic patients have a lower long-term incidence and risk of PCO and an increased 
risk of PCO in association with younger age, postoperative inflammation, vitrectomy 
surgery and PMMA or plate-haptic silicone implants in comparison to 3-piece 
silicone implants. Future studies should perhaps aim at further exploring the long­
term effect of diabetes and of prophylactic control of postoperative inflammation in 
predisposed patients on the incidence and risk of developing PCO.
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2.2 POSTERIOR CAPSULAR OPACIFICATION AFTER 
IMPLANTATION OF PLATE HAPTIC SILICONE AND 
HYDROPHOBIC ACRYLIC INTRAOCULAR LENSES IN 
DIABETIC PATIENTS: A PILOT RANDOM ISED CLINICAL 
TRIAL
2.2.1 Introduction
The IOL physical properties, including the optic material and design were shown to 
be important determinants of the rate of PCO development (Ursell et al, 
1998;Hollick et al, 1999c). Also, postoperative breakdown of the blood-aqueous 
barrier was related to the type of IOL (Abela-Formanek et al, 2002c;Miyake et al, 
1996;Schauersberger et al, 1999) and could potentially affect the rate of PCO 
devlopment.
Chiron Cl 1UB (Bausch & Lomb) and AcrySof MA 60 BM (Alcon Inc.) are two of 
the commonly used implants that are made of different materials and have different 
designs. The former is a single-piece second-generation silicone implant that has a 6- 
mm biconvex optic, plate-haptics and an overall diameter of 10.5mm (Figure 1-4). 
The latter is a 3-piece hydrophobic acrylic implant that has a 6-mm biconvex optic 
and a polymethylmethacrylate haptics that make 10° angles with the optic and an 
overall diameter of 12.5 mm. Chiron CHUB IOL is normally implanted using an 
injector, which allows introduction of the IOL through a relatively small corneal 
incision (3.2 to 3.5 mm). Acrysof hydrophobic acrylic IOL, on the other hand, is 
inserted using lens forceps and needs comeal incision enlargement. This, in addition 
to increasing the incidence of wound-related complications (Kumar et al, 2001), was 
found to increase blood-aqueous barrier breakdown and postoperative inflammatory 
reaction (Oshika et al, 1992;Pande et al, 1996b;Chee et al, 1999). Moreover, some 
studies have established a greater inflammatory response and blood-aqueous barrier 
breakdown after hydrophobic acrylic IOL implantation (Abela-Formanek et al, 
2002c;Miyake et al, 1996). In the meantime, previous studies of plate-haptic silicone 
IOLs have established favourable results (Maar et al, 2002;Kent et al, 1997) and
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suggested a lower PCO rate than with 3-piece silicone IOLs (Cumming, 
1993;Mamalis et al, 1996b).
In diabetic patients, posterior capsular opacification obstructs the posterior segment 
view and can interfere with timely diagnosis and treatment of sight-threatening 
retinopathy and postoperative inflammation was shown to occur more frequently in 
diabetic patients, especially those with diabetic retinopathy (Zaczek & Zetterstrom, 
1998). Comparison of the above two implants in diabetic patients has not been 
previously published.
2.2.2 Aims
In this pilot randomised clinical trial, we aimed to compare the magnitude of 
inflammation and extent of PCO up to one year after surgery in a group of diabetic 
patients who were randomised to be given one the above two IOLs.
2.2.3 Patients and methods
After approval of the study protocol by Moorfields ethical committee, patients were 
recruited consecutively from those who had diabetes mellitus and were listed for 
phacoemulsification cataract extraction. The study was performed in accordance with 
the tenets of Helsinki treaty.
2.2.3.1 Inclusion and exclusion criteria
Recruitment was carried out between March 2001 and February 2002. Patients were 
considered eligible for inclusion if  they were diagnosed with diabetes mellitus 
(according to the World Health Organization and American Diabetic Association 
criteria), had cataract sufficient to either cause visual disturbance or impair the 
fundus view and gave consent to be included in the study. Both type I and type II 
diabetic patients were eligible.
Exclusion criteria included patients on oral steroids or medications for glaucoma, 
coexistent ocular disease unrelated to diabetes that were likely to reduce visual 
acuity, e.g. age-related macular degeneration, amblyopia or retinal venous occlusion. 
Also, patients with iris neovascularisation or those who had had prior intraocular
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surgery, e.g. trabeculectomy or vitrectomy, were excluded. Also, capsular 
complication lead to the patient being excluded and replaced.
2.2.3.2 Randomisation
Patients were randomised when in the operating theatre using a computer-generated 
random number to have either an injectable plate-haptic silicone (Chiron, C11UB, 
Bausch and Lomb) or a hydrophobic acrylic (AcrySof, MA60BM, Alcon) IOL. The 
Cl 1UB plate-haptic silicone IOL has a 6-mm biconvex surface optic and an overall 
diameter of 10.5mm (Figure 1-4). The hydrophobic acrylic IOL, also, has a 6-mm 
biconvex optic but polymethylmethacrylate haptics that make an angle of 10° and an 
overall diameter o f 12.5 mm.
2.2.3.3 Preoperative management
Before surgery, mydriasis was achieved using G. Phenylepherine 5 % and G. 
Cyclopentolate 1 % six times within an hour and a half prior to surgery. Topical 
anaesthesia was used on all patients using G. Amethocaine and that was coupled with 
a single quadrant subtenon injection of 3 ml of Lignocaine in 2 patients. Preoperative 
assessment included measuring the best-corrected visual acuity (BCVA) using the 
logarithm of the minimum angle of resolution (logMAR) chart at 4 meters in addition 
to routine anterior and posterior segment examination.
2.2.3A  Surgery
A standard phacoemulsification was carried out by a single surgeon (JGD) through a 
3.2mm self-sealing clear comeal section. Hyroxypropylmethylcellulose (HPMC) 
viscoelastic was used to fill the anterior chamber and a continuous curvilinear 
capsulorhexis was performed followed by hydrodissection of the nucleus and divide- 
and-conquer removal of the nucleus. Manual aspiration of cortical lens matter was 
conducted using a Simcoe irrigation-aspiration cannula and a balanced salt solution 
containing 1 ml of 1:1000 adrenaline per 500 ml. No attempt was made to remove 
the subcapsular LECs. The viscoelastic was then used to fill in the capsular bag 
before placement of the IOL. The occurrence of a posterior capsular tear or radial 
extension o f the capsulorhexis edge led to the patient being excluded.
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2.2.3.5 Postoperative management
Patients were routinely examined immediately after surgery and prescribed G. 
Dexamethasone 0.1% four times a day for two weeks then twice a day for two 
weeks, and G. Chloramphenicol four times a day for two weeks. Acetazolamide 
(Diamox) 250mg QDS for 2 days was prescribed for any elevation of intraocular 
pressure above 21 mmHg. For the purpose of the study, patients were reviewed at 2- 
3 weeks, 6 months and 12 months and additional visits were arranged, if  needed, for 
assessment and treatment of postoperative inflammation and/or diabetic retinopathy 
(Dowler et al, 1999;Dowler & Hykin, 2001).
At each of the postoperative visit, assessment was made of anterior capsular opening 
and posterior capsular opacification as well as of the anterior chamber flare and cells 
using Kowa FC 1000 laser flare-cell meter. Seven consecutive readings were taken 
and after discarding the highest and lowest values, the average of the remaining 
readings was taken. The flare was expressed as photons/millisecond and the cells as 
number/0.075 mm3. Also, logMAR BCVA at 4 meters and Pelli-Robson contrast 
sensitivity at 1 meter were measured at each visit.
2.2.3.6 Posterior capsule imaging system
Standardized retro-illumination photographs were taken at each of the 3 visits using 
St Thomas’ digital retro-illumination camera system, described in more details 
elsewhere (1.1.5.2.2.3.2.3.2. Digital photography). The system is based on a Zeiss 
120 slit lamp frame with specially adapted optics to provide axial illumination to the 
camera light path from a flash pack through a fibre-optic cable and the images are 
acquired through a 420 digital camera (Eastman-Kodak, Rochester, NY). The system 
produces high definition, evenly illuminated images of the posterior capsule that are 
accessed directly by computer. The reproducibility of the system was assessed before 
and its short-term variability was estimated to be less than 10% (Hollick et al, 
1999c).
Only one observer carried out the analysis for the PCO pictures. Because of the 
distinctive shapes of the IOLs, the observer could not be masked to the IOL type. 
The area of the posterior capsule assessed was that not obscured by the anterior 
capsular rim (the mask). That area, which corresponds to that of the anterior capsular 
opening, was measured in pixels after being defined manually on a 21-inch monitor
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screen using a mouse. Dedicated software was used to calculate the area of opacity 
using a technique known as image segmentation. The software allows separation of 
the pixels into binary classes of opaque and clear areas. The areas of opacified 
posterior capsule are characterized by having an increased texture of the 
corresponding area of the image, whereas clear areas have little or no texture. From 
the binary values the area of PCO is calculated and expressed as percentage of the 
mask area.
2.2.3.7 Statistical analysis
The primary outcome of interest was the percentage of the area of opacified posterior 
capsule. Other outcome measures were anterior chamber flare value and cell count, 
anterior capsular opening size, logMAR BCVA and Pelli-Robson contrast sensitivity.
For the purpose of description, the mean and standard deviation (SD) were used. 
Categorical data were compared using the Chi-squared test. Between-group 
comparison of the percentage of the area of PCO, flare value, cell count and the size 
of the anterior capsular opening (in pixels) at the different visits between the two 
groups was carried out using either independent Student-t or Mann-Whitney test after 
checking the data for normality of distribution. Within-group analysis of the changes 
in the above measurements over the follow-up period in each group was carried out 
using Friedman within-group analysis. A p  value of <0.05 was considered 
statistically significant. A post hoc analysis showed that the study had between 
97.9% and 99% power for 2-sided and 1-sided tests, respectively, to detect the 
difference in the area of PCO.
2.2.4 Results
2.2.4.1 Patient characteristics
We recruited 43 patients between March 2001 and February 2002, three of whom 
opted out. Four patients were excluded because two of those randomised to acrylic 
and one randomised to plate-haptic silicone IOL had posterior capsular tears. 
Another patient, who was randomised to a plate-haptic silicone IOL, had a radial 
extension o f the capsulorhexis and was excluded, which left 35 patinets. During the 
study 2 patients died and the overall follow-up rate was 60% after 1 year. The
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recruitment was terminated in February 2002 after the results suggested increased 
PCO in patients with plate-haptic silicone IOLs.
Demographic data of the two groups of patients are detailed in Table 2-5. There was 
no significant difference in the mean age, preoperative logMAR BCVA, the gender 
distribution or grade of diabetic retinopathy between the two groups.
Table 2-5. Clinical features of patients in the non-diabetic and diabetic groups
PH Silicone 
(N=15)
Hydrophobic Acrylic 
(No=20)
Age (years)
Mean (SD) 72.5(9.6) 68.6(12.1)
Median 71 69.3
IQR 65.2-80.3 62.2-75.8
M:F 8:7 9:11
IDDM: NIDDM 2:13 2:18
Diabetic retinopathy
No 8 10
NPDR 2 6
PDR 5 4
Preop logMAR BCVA
Mean 0.66(0.8) 0.62(0.7)
Median .38 0.51
IQR 0.38 to 0.80 0.51 to 0.96
SD=standard deviation; IQR=interquartile range, PH=plate-haptic; SD=standard 
deviation; M=male; F=female; IDDM= insulin- dependent diabetes mellitus; 
NIDDM=non-insulin-dependent diabetes mellitus
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2.2A.2  Between-group analysis: inflammatory indices, ACO and 
PCO difference between the two groups
Between-group analysis (Table 2-6 & Figures 2-2, 2-3 & 2-4) showed that at 2-3 
weeks, there was a higher flare value in the hydrophobic acrylic than in the PH 
silicone group but the difference was only of borderline significance (p=0.08). No 
significant difference was found in cell count, size of the anterior capsular opening 
(the mask size) or the percentage of PCO between the two groups. Within the first 
month, 5 patients developed clinically significant inflammation that required 
additional topical steroid treatment, 3 in the PH silicone IOL group (20%) and 2 in 
the hydrophobic acrylic group (10%). This difference was not statistically 
significant.
At 6 and 12 months, there was no significant difference in flare value or cell count 
between the two groups. At 6 months, the anterior capsular opening size was 
significantly smaller in the PH silicone group (p=0.04) but the difference was not 
statistically significant at 12 months (p=0.08). The average percentage area of PCO 
was significantly greater in patients with PH silicone than in those with hydrophobic 
acrylic IOLs (p=0.002 & p=0.002; at 6 and 12 months, respectively). LogMAR 
visual acuity and Pelli-Robson contrast sensitivity scores were not significantly 
different between the two groups at any postoperative visit.
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Table 2-6. Anterior chamber reaction and percentage of PCO at the different postoperative periods
PH silicone
Mean (SD)
Hydrophobic acrylic
Mean (SD) P*
2-3 weeks
AC Flare 15.3 (7.3) 26.9(18.1) 0.08
AC cells 2.9 (2.5) 6.3 (7.9) 0.2
Mask size in pixelst 431941.3 (82675.9) 411965.5 (77615.9) 0.5
% of PCO 10(13.2) 10.3 (8.3) 0.9
6 months
AC Flare 11.1 (4.3) 11.2 (5.4) 0.9
AC cells 0.03 (0.08) 0.10(0.2) 0.5X
Mask size in pixels 371652.1 (93355.7) 440504.2 (56537.8) 0.04
% of PCO 27.2(13.9) 10.9 (8.7) 0.002
12 months
AC Flare 9.5 (3.2) 11.5 (7.5) 0.5
AC cells 0(0) 0(0) 0.9
Mask size in pixels 383974.1 (104230.7) 443102.3 (61838.5) 0.08
% of PCO 57.7 (41.1) 13.9(11.1) 0.002J
PH=plate-haptic, SD=standard deviation; AC= anterior chamber 
* Between-group analysis.
t  Corresponds to the size of the anterior capsular opening. 
JMann-Whitney test used for comparison
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2.2.4.3 Within-group analysis: the inflammatory indices, ACO and 
PCO in each group over the follow-up period
Within group analysis (Figures 2-2, 2-3 & 2-4) showed a significant reduction in 
anterior chamber flare value in the hydrophobic acrylic group (p=0.01) but not in the 
PH silicone group {p=0Al). Cell count did not change significantly in the two groups 
over the period of follow-up. The mask size decreased over the follow-up period in 
both groups but the difference was of borderline significance only in the PH silicone 
group (p=0.09 & 0.9). There was a statistically significant increase in the area of 
opacified posterior capsule in the PH group (p=0.003) but the difference was not 
significant in the hydrophobic acrylic group (/?=0.4) (Figure 2-5).
One of the patients in the PH silicone IOL group required Nd:YAG capsulotomy 
after one year and 4 patients in the hydrophobic acrylic group had less area of PCO 
at 1 year than at 6 months (Figure 2-6). There was no significant difference in 
logMAR BCVA or Pelli-Robson CS scores between the three visits in either of the 
two groups.
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Figure 2-2. Anterior chamber flare (a) and cells (b) in the two groups of 
patients. Both flare and cells decreased significantly as the time went by, but 
there was only a borderline significant increase of flare in the Acrylic group in
the early postoperative period.
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Figure 2-3. The mask size (a) and the percentage of the area of opacified 
posterior capsule (b) in the two groups of patients. There was a decrease of the 
mask size in the plate-haptic silicone group and an increase in the area of PCO 
in the plate-haptic silicone IOL group. Only the latter was statistically
significant.
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Figure 2-4. Visual acuity (a) and contrast sensitivity (b) in the two groups of 
patients. Although both function showed some deterioration over time, the 
differences were not statistically significant.
109
Chapter 2: Posterior Capsular Opacification in Diabetic Patients
2.2.5 Discussion
2.2.5.1 Postoperative inflammation
The hydrophobic acrylic IOL was associated with increased flare and cells within the 
first 2-3 weeks after surgery. Although the differences were not statistically 
significant, they are in agreement with other studies, which showed increased flare in 
the early postoperative period with this type of implant in comparison with 
hydrophilic acrylic and silicone IOLs (Schauersberger et al, 1999).
The mechanical trauma induced by the use of forceps to introduce the hydrophobic 
acrylic implant, the need for a larger incision (Oshika et al, 1994;Oshika et al, 
1998a) or the hydrophobic nature (Miyake et al, 1996) could all have contributed to 
increasing the flare intensity and cell count in these patients. Notably, however, these
changes were not clinically significant as there was no difference between the two
groups in the incidence of clinically significant postoperative inflammation (i.e. 
requiring additional steroid treatment) at any time in the postoperative period.
In a study by Zaczek and Zetterstrom, 1998 (Zaczek & Zetterstrom, 1998), flare 
intensity was associated with the severity of retinopathy in diabetic patients. 
Although our patients were matched as regards their postoperative retinopathy grade, 
a mild influence due to the retinopathy could not be completely ruled out because of 
the relatively small sample size.
2.2.5.2 Anterior capsular contraction
We found that at 6 months the anterior capsular opening as indicated by the mask 
size was significantly smaller in the plate-haptic silicone group but there was no 
significant difference at 1 year. Also the mask size got significantly smaller over the 
follow-up period in the plate-haptic silicone group. Hayashi et al (Hayashi et al, 
1997) and Zamabrakji et al (Zambarakji et al, 1997) found that anterior capsular 
opacification occurs mostly within the first 3 months after surgery.
This finding is consistent with that by Werner et al, 2001 (Werner et al, 2001), who, 
in an autopsy series, found that plate-haptic silicone IOLs were associated with 
higher anterior capsular opacification scoring in addition to increased incidence of 
anterior capsular phimosis in comparison with hydrophobic acrylic IOL.
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The relatively smaller overall diameter of the IOL as well as its ability to easily yield 
under pressure form the contracting capsule make this complication more likely with 
these implants.
2.2.5.3 Posterior capsular opacification
Recent research seems to underscore the role of IOLs as the most important factor in 
preventing its development of PCO. This role is further emphasised in diabetic 
patients, where prevention of PCO development is essential for maintenance of clear 
fundus view. Our findings established a significantly increased rate of PCO 
development with plate-haptic silicone IOLs after 6 months and 1 year when 
compared to hydrophobic acrylic IOLs in diabetic patients, which is in agreement 
with the findings of a recent study that compared the two lenses in non-diabetic 
patients (Abhilakh Missier et al, 2003).
Figures 2-5 and 2-6 (A & B) show examples of the changes in PCO over the follow- 
up time with the two implants. Four cases in the hydrophobic acrylic group showed 
reduction of the PCO area at 1 year in comparison with 6 months. Although the 
number was too small to be statistically tested, the finding is consistent with that of 
Hollick et al (Hollick et al, 1998;Meacock et al, 2001;Findl et al, 2004), who found 
regression of LEC in 83% of patients with that implant after 2 years of follow-up.
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MGO at 4 days
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Figure 2-5. An example of a patien t with plate-haptic silicone IOL. The left 
panel show the contrast-enhanced  images with the outlines of the masks and 
their sizes (in pixels). The r igh t panel shows the software-processed images and 
the percentages of the a rea  of PCO. M GO =the photo’s ID
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Figure 2-6 (A & B). Exam ples of patien ts w ith hydrophobic acrylic IO Ls. The 
left panels show the con trast-enhanced  images w ith the outline of the m asks and 
the ir sizes (in pixels). The rig h t panels show the softw are-processed images and 
the percentages of the area  of PC O . T hey show relatively sm aller increase in the 
area of PCO  over the follow-up period  (A) and even regression and reduction of 
the area  of PCO th a t occu rred  in some cases (B). NCI & JH A =the Ids of the
photos.
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Although the two im plants have biconvex surfaces and similar optic size, the 
difference in the rate o f  PCO development betw een the two implants can be 
attributed m ainly to other differences in design and to their material. The most 
important o f these features seem to be the square-edge o f  the acrylic IOLs.This has 
been shown in experimental research and clinical studies o f  non-diabetic patients to 
inhibit m igration o f  the LECs onto the posterior capsule and hence the development 
o f  PCO (Nishi & Nishi, 1999;Nishi et al, 2000;Nishi & Nishi, 2002;W ejde et al, 
2003;Nishi et al, 2002). This was suggested to be due to either a contact inhibition 
mechanism (Nishi et al, 1998c) or a mechanical barrier effect (Boyce et al, 2002).
The haptic angulation (10° in the acrylic and 0 in the plate-haptic silicone IOL) 
together with the larger overall diameter o f  the acrylic implant are other features that 
could play an important role in preventing migration o f  the LECs by creating and 
increasing posterior vaulting o f  the optic upon capsular contraction. This further 
reinforces the barrier effect o f the square edge by increasing the force o f  mechanical 
apposition between the IOL optic and the posterior capsule.
Also, Oshika et al, 1998 (Oshika et al, 1998b), found that acrylic IOLs adhered more 
strongly to the posterior capsule than polym ethylmethacrylate and silicone IOLs and 
proposed that this strong adhesion prevents lens epithelial cell migration and PCO 
formation. Linnola et al, 2000 (Linnola et al, 2000b), suggested that to be due to 
fibronectin and vitronectin adhering better to hydrophobic acrylic IOLs than to 
silicone IOLs.
2.2.6 Conclusion
In diabetic patients, PCO and anterior capsular contraction occurs at a higher rate 
with plate-haptic silicone than with hydrophobic acrylic IOLs. Although the latter 
may cause more early postoperative flare, this was not associated with increased 
clinically significant postoperative inflammation. This suggests that hydrophobic 
acrylic implants are more favourable than plate-haptic silicone implants in these 
patients.
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IN VIVO ASSESSMENT OF THE RELATIONSHIP 
BETWEEN THE INTRAOCULAR LENS AND THE 
POSTERIOR CAPSULE
Chapter 3. OCT o f the Relationship between the IOL Optic and the Posterior Capsule
3 USING THE OPTICAL COHERENCE 
TOMOGRAPHY TO COMPARE THE 
RELATIONSHIP OF A PLATE HAPTIC 
SILICONE AND A HYDROPHOBIC ACRYLIC 
INTRAOCULAR LENS TO THE POSTERIOR 
CAPSULE: A PILOT RANDOMISED CLINICAL 
TRIAL
3.1 INTRODUCTION
3.1.1 Optical coherence tomography
Optical coherence tom ography (OCT)(Huang et al, 1991;Fujimoto et al, 
2004;Schmitt J.M., 1999) (Figure 3-1) is an imaging technology that is based on 
modification o f  the M ichelson’s interferometer. The latter has been used to measure 
distances accurately by using a split light beam; a reference and a sample beam, each 
traverses a different path and then are recombined at a photo-detector that captures 
all the light to form an interference fringe. Depending on the length o f  the two paths, 
constructive or destructive fringes are formed and hence the centre o f  the fringe can 
be bright or less so by an am ount proportional to the path difference.
3.1.2 Light source in OCT
In optical coherence tom ography (Huang et al, 1991;Fujimoto et al, 2004), the light 
source is a super-luminant diode laser, which has a wave-length o f  800 to 1300 nm 
and an emission pow er o f  1-10 mW . This has low coherence (15-30 pm), which 
helps produce interference patterns o f  short temporal and spatial extent.
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Figure 3-1. O ptical coherence tom ography: principle and com ponents (R eproduced from  Schm itt J . 1999 & H uang D. et al 1991)
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3.1.3 The beam splitter
The beam o f light is split into two separate, m utually coherent beams by means o f 
two isosceles prisms with their bases apposed w ith an intervening layer o f  partial 
silvering.
3.1.4 Scanning and scan images
The OCT relies on mechanical scanning mechanism s based on translation o f  a 
reference mirror mounted on a stage driven by a motor. A constant excursion o f 
about 2.72 mm /s and a repetition rate o f 55 Hz are maintained in the middle o f the 
scan range by means o f  a feedback control.
The X-Y length o f  the scan can be varied from 2.5 to 19mm in air at a working 
distance o f  43 mm. This represents a scan angle o f  between 3° and 25°. The angular 
orientation o f  the scan can also be changed within X-Y plane within 360°.
The lateral resolution o f the OCT image is limited by diffraction to a maximum o f 25 
pm (Chauhan & M arshall, 1999). However, lateral resolution depends also on the 
scan length as each image is composed o f 100 scans regardless o f scan length. The 
longer scan, therefore, has a lower lateral resolution. Also, because the image 
acquisition tim e is approxim ately 1 sec with no compensation for drifts in patient 
fixation, the lateral resolution can also be compromised.
The device has an internal fixation light visible to the patient but not on the operators 
viewing screen. A second light, generated by HeNe laser, is seen on the viewing 
screen and could be m oved under the control o f  the operator to fall on any given 
tissues. The acquisition time for each composite OCT image is about 0.9s, 
independent o f  scan length and orientation.
The light reflected from the tissues is processed and a transducer is used to convert 
the light signal into pseudochrom atic real-tim e image based on the reflectance o f the 
light from the different tissues. The arbitrary pseudo-colour scale is logarithmic and 
had the effect o f  grouping a range o f  signal intensity into one colour. The image is 
displayed on a com puter screen and the setting for each scan is stored on the 
computer for repeated m easurem ent.
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3.1.5 Use of the Optical conherence tomography for anterior 
segment examination
The OCT has been used before to examine the anterior segment structures. Because 
o f  the transparency o f  these structures, the only parts that are likely to result in 
significant OCT signals are the interfaces between different media. H oerauf H 
(H oerauf et al, 2000) used a slit-lamp adapted OCT and Radhakrishnan S et al 
(Radhakrishnan et al, 2001) used a high speed OCT (at 1310 nm wavelength) for in 
vivo im aging o f  the anterior segment structures, including the cornea, the chamber 
angle, the iris and the crystalline lens. Also, Hirano et al (Hirano et al, 2001) used the 
OCT 2000 (Zeiss-Humphrey) to study the different pathologies o f  the cornea. They 
demonstrated that the OCT was able to obtain reflection signals at the interface o f the 
different comeal layers. Also, in a non-published in vitro and in vivo studies by 
Chauhan et al (Chauhan DS et al, 2000), the intraocular lens surfaces and posterior 
capsule opacification were clearly identified and characterised using the OCT.
It is known that IOL material and design influence the rate o f  PCO development. 
Acrylic implants have been found to be associated with lower rates than silicone 
implants (Hollick et al, 1999c), plano-convex (Nagamoto & Eguchi, 1997), and 
square edged implants (Nishi et al, 2000) with lower rates than other IOL profiles. In 
1992, Apple and coauthors (Apple et al, 1992) proposed that the absence o f  space 
between the IOL and posterior capsule prevents LECs from migrating centripetally 
onto the posterior capsule and producing PCO: the ‘no space, no cells ‘ theory, which 
has not, hitherto, been dem onstrated in vivo.
3.2 AIMS
In the previous study, it was shown that the plate-haptic silicone IOL (Chiron C l l  
UB; Bausch & Lomb) had a higher PCO rate than the hydrophobic acrylic IOL 
(Acrysof; Alcon Inc.). The aims o f  this study were to demonstrate the ability o f the 
OCT scan to obtain in vivo im ages o f  the two IOLs; and to describe the characteristic 
relationships o f their optics to the posterior capsule that can be related to the known 
difference in their PCO rates.
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3.3 PATIENTS AND METHODS
3.3.1 Inclusion & exclusion criteria
Twenty-six patients were recruited consecutively between September 2001 and 
March 2002 from those who had uneventful phacoem ulsification and IOL 
implantation o f  either plate-haptic silicone (Chiron C11UB) or hydrophobic acrylic 
(AcrySof) IOLs and gave consent to be included in the study. Twelve o f  the patients 
(46%) were recruited prospectively after they had been randomised to be given either 
o f  the above two implants. The rest o f  the patients (n=14, 54%) were recruited 
retrospectively.
Exclusion criteria were history o f  uveitis or other intraocular surgery, systemic 
steroids or other im munosuppressive therapy, the presence o f corneal opacity, the 
development o f  postoperative uveitis that required additional steroid treatment, poor 
mydriasis, or refusal to be included in the study.
3.3.2 Surgical technique
One surgeon performed 81% o f operations, including all those in the randomised 
group. All patients underwent a standard phacoemulsification through a supero- 
temporal corneal incision. Subconjunctival antibiotic (Cefuroxime) and steroids 
(Betamethasone) were injected at the conclusion o f the procedure. Patients were 
reviewed within 24 hours after surgery and prescribed G Chloramphenicol 0.1% to 
be used QDS for 2 weeks and Dexamethasone 0.1% QDS for 2 weeks than BID for 2 
weeks.
3.3.3 OCT image acquisition
OCT scan was performed within 48 hours and 4 to 6 weeks later in the randomised 
group but only once in the retrospective group, except in one o f  the patients who 
needed Nd:YAG capsulotom y that had a follow-up scan after the laser. The scans 
were performed following pupillary dilatation with G. tropicamide 1% and G. 
phenylephrine 2.5% using a H um phery OCT scanner (Humphrey Inst., San 
Leonardo, CA). Patients were asked to fixate straight ahead with the other eye on the
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instrum ent’s external target because the internal fixation light was not visible when 
scanning the anterior segment. Linear scans, w hich take approximately 0.9s to 
acquire regardless o f  their length and angular orientation, were obtained. A vertical 
and a horizontal scans o f 4-6mm across the pupillary area were taken for all the 
patients. Because short scans provided better resolution, 4 scans o f  1.5-3mm were 
added, when necessary, astride the pupillary margin at 12, 3, 6 & 9 o ’clock positions 
for detailed study o f  the peripheral part o f the optic. (Figures 3-2, 3-3 & 3-4).
F igure 3-2. D iagram  show ing the positions of the long scans across the pup illary  
area  (in te rru p te d  lines) and  sh o rt scans astride  the pup illa ry  m argin
(con tinuous lines)
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F igure 3-3. An exam ple o f the  video pho tog raphs and O C T  scan im ages o f a 
p a tien t w ith a hydrophob ic  acry lic  IO L . Top 2 panels: horizon tal and  vertical 
long scans, bo ttom  2 panels: sh o rt scans a t 12 and 3 o ’clock positions. Top panel 
O C T scan shows: pu p illa ry  m arg in  (th in  horizontal arrow ), an te rio r capsule 
(thick horizontal arrow s), a n te r io r  lens surface (thin vertical arrow ), posterior 
lens su rface (th ick  v ertica l a rro w ) and  posterior capsule (curved arrow ).
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F igure  3-4. Video p h o to g rap h  an d  O C T  scan of a p a tien t w ith p la te-haptic  
silicone IO L. Top 2 panels: v e rtica l and  horizon tal long scans; bottom  2 panels: 
sho rt scans a t 6 and  9 o ’clock positions. Top panel O C T scan shows: pup illary  
m arg in  (thin ho rizon ta l a rro w ), a n te r io r  capsule (thick horizontal arrow s), 
posterio r lens surface (th in  vertica l a rro w ) and  posterio r capsule (thick vertical
a rrow s).
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3.3.4 Outcome measures and statistical analysis
The outcome o f  interest was the ability o f the OCT to capture the outline o f the IOL 
optic and the appositional relationship o f the lens optic to the posterior capsule. An 
implant outline was classified ‘well-defined’ if  clearly distinguishable signals were 
obtained from the anterior and posterior surfaces. Conversely, if  either o f the 
surfaces was partially or not at all distinguishable on all the scans, the outline was 
classified ‘partially defined’ or ‘ill-defined’.
W hen at least the posterior surface o f the optic o f  the IOL and the posterior capsule 
were distinguishable, the pattern o f  apposition between them was examined. A ‘close 
apposition’ pattern described the absence o f  any discernible optical space i.e. a single 
signal is obtainable from both o f them (Figure 3-3 & 3-4). The posterior capsule was 
distinguished from the anterior hyaloid, if  visible, by its relative proximity to and 
conformity with the posterior surface o f the IOL optic, the higher intensity o f  its 
signal, and by the absence o f  undulating movements with the saccadic eye 
movements that are characteristic o f the anterior hyaloid face (Chauhan et al, 2000).
Binary variables were created for the presence o f  a ‘w ell-defined’ outline and for the 
presence o f  ‘close apposition’ between the IOL optic and the posterior capsule. 
Fisher’s exact test was used to compare the proportions o f  these binary variables in 
the two IOL groups. M ultivariate logistic regression analysis was used to test the 
likelihood o f  having ‘w ell-defined’ outline as well as the association between the 
IOL type and the presence o f ‘close apposition’ o f  its posterior surface to the capsule 
after controlling for possible confounders. A p value o f < 0.05 was considered 
statistically significant.
3.4 RESULTS
3.4.1 Patient characteristics
Twenty-six patients were exam ined, 16 (63%) had plate-haptic silicone and 10 (37%) 
acrylic IOLs. The dem ographic data o f  the two groups o f patients are shown in Table 
3-1. The patients’ age ranged betw een 44 and 84 (median=67). Fifteen (57.7%) o f 
the patients were male and 15 (57.7% ) were diabetics, 10 o f  them were in the plate-
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haptic silicone group. There was no significant difference in age, sex distribution or 
the proportion o f  diabetic patients between the two groups.
Table 3-1. Patient characteristics
PH silicone 
(N=16)
Hydrophobic acrylic 
(N=10)
Age (Years)
M edian 66 67
IQR 59.8-76.3 58.3-73.5
Gender
M:F 9:7 7:3
Ethnic origin
Caucasian: Asian 8:8 4:6
Follow-up
M edian 10.5 0.5
IQR 3.8 days to 22.2 months 1 day to 5.5 months
PH=plate-haptic; IQR=interquartile range
3.4.2 Delineation of lOLs on the OCT scans
In the randomised group, all the acrylic implants (n=6) had a ‘well-defined’ outline 
whereas all the plate-haptic silicone implants (n=6) had either o f their surfaces ‘ill- 
defined’ or ‘partially defined’.
In the whole group, significantly m ore patients in the acrylic group had a ‘well- 
defined’ outline than in the plate-haptic silicone group (9/10 vs. 1/15) (p<0.001). 
There was no significant difference between diabetic and non-diabetic patients in the 
proportions with ‘w ell-defined’ IOL outline. After controlling for the length o f  
follow-up and the presence o f  diabetes mellitus, the hydrophobic acrylic IOL was 
found to be more likely to have a ‘w ell-defined’ outline on the OCT scan [Odds 
Ratio= 134.9; 95% Confidence Interval (7.5; 2433.2);/?=0.0009].
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3.4.3 Appositional relationship between the intraocular 
lenses and the posterior capsule
In the randomised group, 9 patients had distinguishable signals from the peripheral 
part o f  the optic i.e. the part subjacent to the pupillary margin and the posterior 
capsule. All the acrylic IOLs (n=5) showed ‘close apposition’ between the optic and 
the mid-peripheral part o f  the posterior capsule and an optically empty space 
centrally (Figure 3-5), whereas all the plate-haptic silicone implants (n=4) showed a 
distinct optically empty space between the peripheral parts o f their optics and the 
capsule (Figure 3-6) but their central parts o f  the optics were difficult to discern from 
the capsule.
In the whole group, 20 IOLs (76.9%) had ‘well-defined’ posterior surfaces. The 
appositional pattern between the IOL and the posterior capsule varied. A ‘close 
apposition’ pattern existed in 7/8 (88%) o f the patients with acrylic IOLs and in 1/12 
(8%) o f  those with plate-haptic silicone IOLs (p<0.001). No significant difference 
was found between non-diabetic and diabetic patients in the presence o f IOL- 
capsular apposition (4/9 vs. 4/11). After controlling for the length o f follow-up and 
the presence o f  diabetes mellitus, the optics o f acrylic IOLs were more likely to have 
‘close apposition’ with the posterior capsule on OCT [Odds Ratio=480.3; 95% 
Confidence Interval (1.62, 142460.8); p=0.03].
3.4.4 Follow-up scans
In 8 patients in the randomised group (4 in each group), where the first and follow-up 
scan showed distinguishable signals from both the optic and the capsule, the central 
part o f  the optic was distinguishable only on all the patients with acrylic implants. In 
these patients, a central optically em pty space was identified on their first scans 
(Figures 3-a & 4-a top panels). This was either shallow or completely obliterated on 
the follow-up scans at 4 to 6 weeks (Figure 3-7).
3.4.5 Posterior capsular opacification and IOL outline
Four patients had PCO and 3, all w ith plate-haptic silicone IOLs (16%), underwent 
Nd:YAG laser capsulotomy. The reflective substances on the posterior capsule on
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the scan corresponded to the lens epithelial pearls seen in the colour photograph, 
which enhanced the outline o f  the posterior surface o f  the optic (Figure 3-8 & 3-9). 
Notably, however, the posterior optic surface outline was no longer discernible after 
Nd:YAG laser capsulotomy.
3.5 DISCUSSION
In this pilot study, OCT enabled us to examine in vivo features o f  two IOLs that are 
different in material and design and were shown to be different in their PCO rate in 
our previouus study as well as in a recent study by Abhilakh M issier et al (Abhilakh 
M issier et al, 2003).
3.5.1 Delineation of the IOLs
The first feature studied here was the difference in the ability o f  the OCT to delineate 
the outline o f  the two IOLs. The outlines o f  the hydrophobic acrylic IOLs were better 
defined than those o f  the plate-haptic silicone IOLs (Figures 3-3 & 3-4). In latter 
group o f  patients, the outline o f the peripheral part o f the posterior surface o f the 
optic was the only discernible part rather than their central part. This could be related 
to accumulation o f  extracellular substance and LECs on that part because o f its 
proxim ity to the highly proliferative equatorial LECs. In patients with PCO, the 
posterior surface outline was enhanced by the presence o f  LECs and extracellular 
substance on the posterior capsule (Figure 3-7 & 3-8). This feature was lost 
following Nd:YAG posterior capsulotomy.
The ability o f  the OCT to delineate the outline o f the hydrophobic acrylic IOLs better 
than than that o f  the plate-haptic silicone IOLs can be related to the principle o f the 
OCT and the reflective characteristics o f  the IOLs. The definition o f tissues on the 
OCT relies on the formation o f  constructive interference fringes from the interaction 
between the reference light and that reflected from the target tissue, with more 
reflections leading to enhancem ent o f  the interference fringe signal. In an 
experimental study by Erie et al, 2003 (Erie et al, 2001) more external reflections 
were found with hydrophobic acrylic IOLs (A crySof MA60) than with silicone IOLs 
(LI61U). They attributed that to the higher refractive index o f the acylic IOLs (1.55 
vs. 1.43) and their optic design (an unequal biconvex vs. equiconvex). The latter 
features are similar to those o f  the plate-haptic silicone IO L’s, which has a refractive
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index o f 1.413 and an equiconvex optic. The deposition o f  a biofilm o f extracellular 
substances such as fibronectin and vitronectin that was shown to occur more on the 
acrylic than on the silicone IOL surfaces (Kochounian et al, 1994) might perhaps 
have a role in rendering the surfaces o f these implants more reflective or light- 
scattering.
Figure 3-5. Video photographs and OCT scan of two patients with hydrophobic 
acrylic IOLs within 2 days (top panel) and 9 months after surgery (bottom 
panel). Note the clear delineation of the IOL outline. The OCT scans show the 
anterior capsular leaflet (thin vertical arrows), the haptic (thin horizontal 
arrows) and the posterior capsule (thick vertical arrow). The mid-peripheral 
part of the latter (thick horizontal arrows) is in close apposition to the optic
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Figure 3-6. Video photographs and OCT scans of two patients with plate-haptic 
silicone IOLs within 2days (top panel) and 14 months after surgery (bottom 
panel). The OCT scan shows that the implant surfaces are poorly delineated in 
both panels. The peripheral part of the optics are visible though (horizontal 
arrows) and there is absence of the close apposition pattern demonstrated in 3- 
a. Instead there is an optically empty space between the optic (horizontal 
arrows) and the posterior capsule (vertical arrows)
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3.5.2 Appositional relationship of the posterior capsule to the 
IOLs
In the 20 patients where the posterior surface of the optic and the posterior capsule 
were identifiable, the most distinctive feature was the presence of ‘close apposition’ 
between the peripheral part of the optic of the acrylic IOL and the posterior capsule 
(Figures 3-7 & 3-8). On the other hand, an optically empty space was identifiable 
between the optic of the plate-haptic silicone IOLs (Figures 3-3, 3-6 and 3-8 upper 
panel) and the mid-peripheral part of the capsule that was filled with material of high 
reflectance, presumably LECs and extracellular substance, (Figures 3-6, 3-8 & 3-9).
Figure 3-10 depicts the relationship and the proposed appositional patterns between 
the posterior capsule and the two implants once in the capsular bag. The close 
apposition of the optic of the hydrophobic acrylic implant to the posterior capsule is 
evidently the result of its design and the interaction between its material and the 
capsule and concurs with the findings of other studies. The angulation between the 
haptic and the optic (10°) of the hydrophobic acrylic implants, which is lacking in 
the plate-haptic silicone IOL design, as well as their larger overall diameter (13 vs.
10.5 mm) presumably lead to posterior vaulting of the optic once they are in the 
capsular bag. It is conceivable that this increases as the capsular bag 
circumferentially contracts, increasing the appositional force between the optic and 
the posterior capsule. This could explain the disappearance of the central space in 
patients examined later after surgery (Figures 3-4 & 3-7). The sharp square edge of 
the lens optic is another attribute of the acrylic lens and perhaps the most important 
in producing this characteristic appositional relationship. Nishi and coauthors (Nishi 
et al, 2002) showed that capsular bend formation around the IOL implant occurs 
earlier with hydrophobic acrylic IOL than with silicone and PMMA IOL. Boyce et 
al, using a mathematical model, found that square-edged optic profiles exert a higher 
pressure on the posterior capsule than IOLs with round-edged optic profiles (Boyce 
et al, 2002). Also, in the study by Nagata et al, 1998 (Nagata et al, 1998), and 
another by Oshika et al, 1998 (Oshika et al, 1998b), the adherence force between the 
IOL and the capsule, attributable to integrins and cadherin adhesion molecules 
expressed by the LECs (Birk et al, 1994), was found to be greater with acrylic than
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with silicone IOLs. This adherence was found to occur even faster with the acrylic 
than with silicone and PMMA IOLs (Nishi et al, 2002).
In a study by Hollick et al (Hollick et al, 1998), LECs that migrated behind 
hydrophobic acrylic IOL optic were found to disappear. Our finding that the central 
optically empty space between the hydrophobic acrylic implant and the posterior 
capsule disappeared within few weeks after surgery corroborates the authors’ 
hypothesis that related the disappearance of cells to their demise as a result of 
posterior vaulting and mechanical compression of the cells by the optic.
The demonstrable appositional differences between the two implants are in keeping 
with experimental (Nishi et al, 1998c;Nishi et al, 2000) and clinical studies 
(Beltrame et al, 2002;Hayashi et al, 1998c;Hollick et al, 1999c) that have shown that 
square-edged acrylic implants prevent lens epithelial cell migration onto the posterior 
capsule and hence had lower PCO rate. All, also, is consistent with the time- 
honoured concept of ’no space, no cells, no PCO’ (Apple et al, 1992).
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Figure 3-7. Video photographs and OCT scans of a patient with a hydrophobic 
acrylic IOL. It shows a close mid-peripheral apposition between the posterior 
capsule and the optic 2 days (top panel: thin arrows) and total apposition 4 
weeks after surgery (Bottom panel: thick arrow)
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Figure 3-8. Video photographs and OCT scan of 2 patients with plate-haptic 
IOLs 2 years after surgery. There is lack of apposition between the implant and 
the m id-peripheral part of the capsule (thin arrows). A high-reflectance 
material is present between the capsule and the posterior lens surface (vertical 
arrows)(presumably of LECs and extracellular substance) and an optically 
similar substance underneath the anterior capsular leaflet (thick arrows), 
corresponding to the anterior capsular fibrosis showing in the video photograph
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Figure 3-9. A colour photograph and OCT scan of a patient with plate-haptic 
silicone IOL and PCO. The colour photograph shows abundant LECs forming 
Elshnig’s pearls on the posterior capsule. The OCT scans shows better 
definition of the posterior surface of the optic (top panel: thin arrow), the 
central part of which became indiscernible after Nd:YAG capsulotomy (bottom 
panel: thick arrow), indicating that the reflections were predominantly from the 
posterior capsule ra ther than the optic of the implant
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Figure 3-10. A diagram of the proposed appositional patterns that develop 
between hydrophobic acrylic and plate-haptic silicone implants, and the 
posterior capsule. Once in the capsule bag, early close apposition of the edge of 
the hydrophobic acrylic IOL optic to the posterior capsule occurs due to the 
posterior vaulting that result from their larger overall diameter (13mm vs. 10 
mm) and the angulation between the optic and the haptic (10°) that supposedly 
increases as the capsular bag contracts. The square edge and the acrylic 
material create a tighter adherence force between the capsule and the IOL 
optic. This close apposition with the posterior capsule helps prevent LEC 
migration (straight arrows), whereas the lack of similar apposition with the 
plate-haptic silicone IOLs allows early migration and proliferation of the LECs 
on the posterior capsule (curved arrows)
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3.6 LIMITATIONS
The apparent limitation of the OCT is the dependency on pupillary dilation and 
medial clarity. This, however, is a uniform requirement for all currently used 
posterior capsule-imaging systems. Furthermore, the ability of the machine to 
delineate the outline of an IOL varies with the IOL material because of the 
differences in refractive indices that in turn affect light reflectance. It is not known, 
however, if this is true for all IOLs with a refractive index similar to that of the plate- 
haptic silicone IOL and if the IOL design had contributed to producing the difference 
in IOL surface reflectivity.
3.7 CONCLUSION
This is the first study to demonstrate in vivo the relationship between the optic of the 
IOL and the posterior capsule using OCT. We have shown that OCT can be used to 
demonstrate the appositional relationship between the IOL and the lens capsule. We 
have also shown that the optic of hydrophobic acrylic IOLs, in addition to being 
more reflective and thus better delineated on the OCT scan than plate-haptic silicone 
IOL, maintains a close appositional relationship with the posterior capsule that 
appears lacking with the plate-haptic silicone. These features are consistent with the 
‘no-space; no-cell; no PCO’ concept.
The recent generations of OCT and their higher resolution may be able to overcome 
the above limitations and provide a potentially useful tool for in vivo examination of 
the IOL-capsule relationship. This should help to identify important design features 
in preventing PCO development.
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4 INCIDENCE AND RISK FACTORS OF
POSTERIOR CAPSULAR OPACIFICATION IN 
UVEITIS PATIENTS FOLLOWING 
PHACOEMULSIFICATION AND 
EXTRACAPSULAR CATARACT EXTRACTION
4.1 INTRODUCTION
Similar to diabetic patients, posterior capsule opacification in uveitis patients carries 
the risk of obscuring the fundus view and hence the timely diagnosis and treatment 
of posterior segment complications such as macular oedema. Moreover, performing 
Nd:YAG capsulotomy can potentially excite the dormant uveal inflammation and 
can itself cause macular oedema or other posterior segment complications such as 
retinal detachment. According to Dana et al, 1997 (Dana et al, 1997), the incidence 
of PCO in uveitis patients can be higher than in patients without uveitis and has been 
estimated to be 38.5% at 1 year and 56% at 3 years. In that study, the relatively 
young age of the patients was considered the most important risk factor that led to 
increased PCO in uveitis patients.
Dana’s study, however, included patients who underwent phacoemulsification as 
well as ECCE. Also, no study to date has investigated other factors that can 
potentially affect the rate of PCO in uveitis patients, including the surgical technique, 
prophylactic steroids, the development of postoperative inflammation, gender, type 
of IOL and ethnic origin.
4.2 AIMS
In the following two studies, we aimed at:
1. Estimating the incidence and identifying the factors that could potentially affect 
the rate of PCO in patients with uveitis.
2. Estimating and comparing the incidence of PCO in uveitis patients after 
phacoemulsification and ECCE
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4.3 STUDY OF THE INCIDENCE AND RISK FACTORS OF 
ND:YAG CAPSULOTOMY AFTER 
PHACOEMULSIFICATION IN PATIENTS WITH UVEITIS
For the purpose of this study two groups of patients were examined. The ‘Uveitis 
group’ refers to a consecutive series of patients that were recruited from 3 tertiary 
referral centres. The ‘Non-uveitic and uveitic group’ refers to a comparative series 
that was derived from the same centre.
4.3.1 Material and Methods
4.3.1.1 Uveitis group
4. S. 1.1.1 Design and study population
This is a retrospective case-note review of a consecutive series of 156 uveitis patients 
who underwent phacoemulsification and intraocular lens implantation between 1996 
and 2001 under the care of 3 consultants at Moorfields Eye Hospital and Whipps’ 
Cross University Hospital, London, UK; and at the Royal Prince Alfred Hospital and 
St Vincent’s Hospital, Sydney, Australia.
There were 57 patients with anterior uveitis (56%), comprising three subgroups: 
recurrent acute anterior uveitis (RAAU)(n=25,43.9%), chronic anterior uveitis 
(CAU)(n=22, 38.6%), and Fuchs’ heterochromic cyclitis (FHC)(n=10,17.5%). The 
posterior uveitis group comprised 44 patients (44%) consisting of intermediate 
uveitis (IU)(n=17,39%) and posterior uveitis, retinal vasculitis and panuveitis 
(PU)(n=27,61%).
A systemic disease associated with the uveitis was found in 25 (25%) of the patients. 
These included sarcoidosis (n=6, 24%), toxoplasmosis (n=5, 20%), Vogt-Koyanagi- 
Harada disease (n=3, 12%), ankylosing spondylitis (n=3, 12%), Crohn’s disease 
(n=2, 8%), ulcerative colitis (n=l, 4%), Reiter’s disease (n=2, 8%), B e lie fs  disease 
(n=2, 8%) and tuberculosis (n=l, 4%). Eight patients had diabetes mellitus but none 
of them had clinically significant retinopathy requiring treatment. One of the patients 
had undergone a trabeculectomy operation for chronic glaucoma 5 years 
preoperatively and another pars plana vitrectomy for rhegmatogenous retinal
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detachment 18 months preoperatively.
4.3.1.1.2 Inclusion & exclusion criteria
We included patients with a minimum postoperative follow-up of 3 months (n=151 
eyes) and only the first eye of patients who had bilateral surgeries (n=36). Patients 
with juvenile idiopathic arthritis (n=2), herpetic kerato-uveitis (n=4) and lymphoma- 
associated uveitis (n=2) and patients who underwent phaco-trabeculectomy (n=6) 
were excluded. This left 101 patients whose details are shown in Table 1.
4.3.1.1.3 Data collection
The collected data, included age at surgery, gender, type of uveitis, the presence of 
systemic disease, the occurrence of uveitis episodes within the preoperative year and 
preoperative ocular findings, preoperative best-corrected visual acuity (BCVA), 
operative details, postoperative and final BCVA and postoperative complication, 
including early rise of intraocular pressure, uveitis or macular oedema requiring 
additional treatment.
4.3.1.1.4 Preoperative management
According to the uveitis service protocol in the 3 hospitals, all the patients had to 
have good control of ocular inflammation for a minimum of 3 months preoperatively, 
except in patients with chronic anterior uveitis or pan-uveitis, in whom the surgery 
had to be undertaken when the AC activity had been reduced to the lowest possible 
level.
Patients with disease activity within 3 months prior to surgery and those with 
previously documented posterior uveitis or macular oedema were given prophylactic 
systemic steroids (58, 57%). These were given either orally (50, 86%) as 40mg of 
prednisolone for 2 weeks prior to surgery or intravenously (4, 7%) as 
methylprednisolone 500mg on the day of surgery.
4.3.1.1.5 Surgery
Phacoemulsification was performed via a comeal or scleral tunnel incision using a 
standard technique. Pupillary dilation using iris hooks was carried out in 6 patients 
and iris sphincterotomy in another patient for poor dilation due to posterior 
synechiae.
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One of 5 types o f IOL was implanted in the capsular bag: silicone either plate-haptic 
(C10/11UB; Chiron, Bausch& Lomb) (32, 31.7%) or 3-piece (SI30 or SA40; 
Allergan Medical Optics or LI41U; Iolab) (15, 14.8%), hydrophobic acrylic 
(AcrySof MA60U, Alcon Lab Inc.) (24, 23.8%), polymethylmethacylate (MC550, 
Bausch & Lomb Surgical) (21, 20.8%) or hydrogel (Hydroview, H60M) (Bausch & 
Lomb Surgical) (9, 9%)*.
Twenty-three patients (23%) required corneal sutures, 2 of them for poorly sealing 
wounds and the rest for larger incision size in those who had PMMA implants.
There were no major operative complications. Three patients with FHC and one who 
required sphincterotomy developed intraoperative hyphema. In one patient with 
chronic anterior uveitis, posterior capsular rupture occurred requiring anterior 
vitrectomy but an acrylic IOL was successfully placed in the bag. Corneal suturing 
was needed for the patients who had PMMA IOLs (21, 20.8%) in addition to 2 other 
patients who had leaky wounds at the end of the operation. Subconjunctival injection 
of antibiotics and steroids was performed in all patients at the conclusion of the 
procedure.
Two of the patients with sarcoidosis-related posterior uveitis required vitrectomy for 
persistent floaters and retinal detachment almost 1 and 4 years after surgery.
4.3.1.1.6 Postoperative management
Patients were discharged on the day of surgery and all but two, were reviewed within 
48 hours. The frequency of subsequent clinic visits were determined by the treating 
clinician according to clinical findings and patients were advised to present to 
casualty should they have symptoms of uveal inflammation.
* The percentages do not add up to 100% because o f  the rounding.
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4.3.1.2 Non-uveitic and uveitic group
4.3.1.2.1 Design an d study population
W e reviewed the case-notes o f 251 patients, 53 had established diagnoses o f  uveitis 
(10 (18.9%) recurrent acure anterior uveitis, 6 (11.3% ) chronic anterior uveitis, 14 
(26.4%) interm ediate uveitis, 6 (11.3%) posterior uveitis and 17 (32.1%) pan-uveitis) 
and 198 contem porary random controls. Both groups underwent uneventful 
phacoemulsification cataract surgery and in-the-bag IOL implantation at Moorfields 
Eye Hospital between 1995 and 2001.
4.3.1.2.2 Inclusion and exclusion criteria
Only the first eye o f  those who underwent bilateral surgery was randomly included. 
Also, only non-diabetic patients and patients who had not undergone other 
intraocular surgery (e.g. penetrating kertoplasty, vitrectom y and trabeculectomy) 
were included. Also, in the uveitic group, patients with juvenile idiopathic arthritis, 
herpetic kerato-uveitis, lymphoma-associated uveitis and patients who underwent 
phaco-trabeculectom y were excluded.
The relevant preoperative, operative and postoperative data were collected, including 
gender, age at surgery, type o f  IOL, surgeon’s grade, the development o f 
postoperative inflam m ation (within 3 months), the performance o f  Nd:YAG 
capsulotomy and best-corrected visual acuity at the final visit.
4.3.1.2.3 Preoperative management
Preoperatively, in the uveitis group the inflammation had to be controlled for a 
minimum o f 3 months, except in patients with chronic anterior uveitis and 3 o f those 
with posterior uveitis. In these patients, the surgery was undertaken when AC 
activity had been reduced to the lowest possible level. Patients with previously 
documented m acular edema, disease activity within 3 months preoperatively or those 
with a poor outcome in the first eye due to macular edema or postoperative uveitis 
had been given prophylactic system ic corticosteroid treatment.
4.3.1.2.4 Postoperative management
After surgery, patients were review ed within 48 hours and subsequent visits were 
determined according to clinical findings. Oral corticosteroids were withdrawn
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gradually over 8 weeks. Routine phacoemulsification was performed and 
subconjunctival injection o f antibiotics and corticosteroids was given to all the 
patients at the conclusion o f  the procedure.
4.3.1.2.5 Outcome measures and statistical analysis
In the two study groups, the primary outcome o f  interest was the performance o f 
N d:YAG capsulotomy, which was used as a surrogate measure o f  clinically 
significant PCO. The indications for NdiYAG capsulotom y in the two groups were 
the presence o f  an opacified capsule that caused reduction in visual acuity in 
comparison to that achieved in the immediate postoperative period especially in the 
presence o f  visual symptoms or that com prom ised posterior segment visualisation 
even in the absence o f  visual symptoms.
Statistical analysis was undertaken using version 9 o f  Statistical Package for Social 
Science (SPSS) for W indows software. The distribution o f continuous variables was 
expressed as the mean, standard deviation and inter-quartile range (IQR). Survival 
table analysis was used to derive the cumulative incidences as previously described 
(in 2.1.3.4) and W ilson’s method to calculate their 95% confidence intervals (Cl). 
Univariate and Cox multivariate survival analysis were used to identify risk factors 
associated with NdiYAG capsulotomy. All variables that could possibly affect the 
development o f  PCO were included in the regression model especially if  it had been 
shown to be associated with PCO in previous studies or if  it had a p  value o f less 
than 0.2 in the univariate analysis. The backward stepwise method was used and the 
strength o f  association as a hazard ratio (HR) and the 95% confidence interval (Cl) 
was calculated for both ratios. A p  value o f  < 0.05 was considered significant. Post- 
hoc assessm ent showed that the study had more than 90% power to detect the 
difference in median survival time and to identify a 10% difference in the hazard 
ratio between the different study groups.
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4.3.2 Results
4.3.2.1 Uveitis group
4.3.2.1.1 Patient characteristics
Table 4-1 shows the demographic and different clinical features o f  the patients. One 
hundred and one eyes o f  101 patients were included, 43 (43%) o f  them were male. 
The mean age was 52.8 years (range= 14.1 to 88.2 years) and the mean follow-up 
tim e was 23.3 years (range= 3 to 79.5 months).
Postoperatively, 76 patients (75%) had one or more Snellen’s lines o f  visual 
improvement (median=3 lines), with 65 (64%) having 2 or more lines. Fifty-eight 
(57%) o f  the patients had 6/12 or better and 32 (32%) 6/9 or better. At the final visit, 
82 (81%) had 1 to 9 lines o f visual improvement (median=4), with 72 (71%) having 
2 or more lines. Seventy-eight (77%) had 6/12 or better and 57 (56%) 6/9 or better.
4.3.2.1.2 Postoperative complications
Raised intraocular pressure (IOP) requiring treatment occurred within the first 2 days 
in 6 patients (6%). During the postoperative follow-up, recurrence o f  uveitis occurred 
in 22 patients (22%) and m acular oedem a in 21 patients (21%).
Clinically significant deposits on the anterior lens surface were formed in 3 patients 
with plate-haptic silicone IOLs. They were dispersed using low-energy Nd:YAG 
laser applications. The procedures were uneventful and resulted in visual 
improvement in 2 o f  them.
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Table 4-1. Patient characteristics in the uveitis group
No 101
Age at surgery (in years)
Mean (SD) 52.8(15.6)
Median 51.5
IQR 42.7-65.2
Sex
Male: Female 43: 58
Ethnic Origin
Caucasian 67(66%)
Asian 13(13%)
Afro-Caribbean 10(10%)
Others 11(11%)
Uveitis type
Anterior 57(56%)
Posterior uveitis 44(44%)
Systemic diseases associated with uveitis 25(25%)
IOL types
PH silicone 32(32%)
3-piece silicone 15(15%)
Acrylic 24(24%)
Hydrogel 9(9%)
PMMA 21(21%)
Surgeon’s grade
Resident 20 (20%)
Fellow or consultant 81(80%)
Follow-up (in months)
Mean (SD) 23.3(18)
Median 18.1
IQR 8.5-31.4
SD=standard deviation, IQR=interquartile range, BCVA=best- 
corrected visual acuity (Snellen’s), CF=count fingers, 
PL=perception o f  light, PH=plate-haptic, PMMA=poly- 
methylm ethacrylate
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4.3.2.1.3 PCO and Nd: YA G Capsulotomy
4.3.2.1.3.1 Incidence
The crude incidences o f  PCO and Nd:YAG capsulotom y were 39 (39%) and 33 
(33%), respectively, over the follow-up period. As such, PCO was the most common 
postoperative complication. The median time to Nd:Y AG  capsulotomy was 10.8 
m onths (range=1.5 to 42.3 months).
Survival table analysis showed that the incidences o f  NdiYAG capsulotomy were 
19.2% [95% Cl (12.4, 28.6)], 19% [95% Cl (10.3, 32.2)], 27.9% [95% Cl (13.5, 49)] 
and 15.4% [95% Cl (2.8, 53.7)] after 1, 2, 3 and 4 years, respectively (Table 4-2).
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Table 4-2. Incidences of Nd:YAG capsulotomy in the uveitic group
No. of Patients Entering the Period: 
No. lost to follow-up
No. of Nd:YAG 
Capsulotomy
% Incidence 95% Confidence 
Interval
Up to 1 year 101:25 17 19.2 12.4, 28.6
>1 year-2 years 59:23 9 19 10.3,32.2
>2 years-3 years 27:11 6 27.9 13.5, 49
>3 years-4 years 10:7 1 15.4 2.8, 53.7
>4 years-5 years 2:0 0 0 0, 65.8
PCO=posterior capsular opacification
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4.3.2.1.3.2 Risk factors
In order to identify the independent risk factors for Nd:Y AG  capsulotomy, a Cox 
regression model was constructed and included the patient’s age (>55 years vs. <=55 
years), gender, ethnic origin, the uveitis type (anterior vs. posterior), the use o f 
prophylactic steroids, the presence o f a uveitis-associated systemic disease, the 
surgeon’s grade, the presence o f  significant posterior synechiae and the type o f  the 
IOL as covariates. The model revealed that Nd:YAG  capsulotomy was more likely in 
patients o f  55 years or younger and with the use o f  hydrogel IOLs [HR=3.74; 95% 
Cl (1.05, 13.33)] and was lower with the use o f  plate-haptic silicone [HR=0.23; 95% 
Cl (0.08, 0.62)] and 3-piece silicone [HR=0.18; 95% Cl (0.05, 0.71)] in comparison 
with PM MA IOL and in patients who had prophylactic steroids [HR=0.24; 95% Cl 
(0.11, 0.60)] (Table 4-3 & Figure 4-1).
Table 4-3. Cox regression analysis of the factors affecting the rate of Nd:YAG
capsulotomy
HR 95% Cl P
Age
>55 years Reference
<=55 years 2.28 1.06, 4.93 0.04
Prophylactic steroids
No Reference
Yes 0.25 0.11,0.59 0.002
IOL
PMMA Reference
PH silicone 0.23 0.08, 0.64 0.005
3-piece silicone 0.19 0.05, 0.74 0.02
Hydrophobic acrylic 0.74 0.25, 2.23 0.60
Hydrogel 3.71 1.04, 13.20 0.04
HR=Hazard ratio ; CI=confidence interval, IOP=intraocular pressure, PH=plate- 
haptic
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Figure 4-1. Kaplan Meier curves of Nd:YAG capsulotomy. It shows that 
increased rate was associated with age of 55 or younger (a) and decreased rate 
with the use of prophylactic steroids (b). In comparison with PMMA IOL, plate- 
haptic and 3-piece silicone had lower capsulotomy rates whereas Hydrogel had 
higher capsulotomy rate (c). Censored data are that of patients whose follow-up 
ended before they need Nd:YAG capsulotomy
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4.3.2.1.4 Post-Nd: YA G uveitis or macular oedema
After the procedure, 3 (7.7%) o f the patients needed treatm ent for macular oedema or 
uveitis. One o f  the patients with sarcoidosis-related posterior uveitis was diagnosed 
with m acular oedem a immediately after the procedure and was given peri-ocular 
steroids. A nother patient (3%) with posterior uveitis developed m acular oedema at 8 
weeks and was treated with peri-ocular steroid injection. The same patient developed 
uveitis within 3 m onths and was treated with topical steroids.
4.3.2.1.5 Post-Nd: YA G visual improvem en t
Visual im provement o f 1 or more Snellen’s lines occurred in 22 patients (67%).
4.3.2.2 Non-uveitic and uveitic group
4.3.2.2.1 Incidence
Table 4-4 lists the demographic and different clinical features o f the patients. There 
was a significant difference between the two groups in their Table 4-5 shows the 
incidence o f  PCO that required Nd:YAG capsulotomy in the two patient groups over 
the follow-up period.
4.3.2.2.2 Risk factors
Survival analysis showed that there was no statistically significant difference 
between the rate o f  Nd:YAG capsulotomy between the two groups (Figure . On Cox 
multivariate regression analysis, no significant association was found between the 
presence o f  uveitis, type o f  IOL, surgeon’s grade, young age, the devotement o f 
postoperative inflam m ation and the need for Nd:YAG capsulotomy.
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Table 4-4. Patient characteristic in the Non-uveitic and Uveitic group
Non-uveitis Uveitis
(n=198) (n=53) P
Male:Female 76:122 27:26
Age (years)
Median 73.5 55.5 <0.001
IQR 65-80 45.3-69
<=55 22(11.1% ) 26 (49.1%) <0.001
>55 176 (88.9%) 27 (50.9%)
Ethnic origin
Caucasian 90 (45.5%) 27 (50.9%) <0.001
Asian 20(10.1% ) 12 (22.6%)
Afro-Caribean 8 (4%) 6(11.3%
Other 17(8.6% ) 8 (15.1%)
Unknown 63 (31.8%) 0 (0%)
Surgeon’s grade
Resident 118 (59.6%) 4 (7.5%) <0.001
Fellow/consultant 64 (32.3%) 10(18.9% )
Unknown 16(8.1% ) 39 (73.9%)
IOL
PMM A 28 (14.1%) 0 (0%) <0.001
Plate-haptic silicone 158 (79.8%) 31 (58.5%)
3-piece silicone 12 (6.1%) 7(13.2%)
Hydrophobic acrylic 0 (0%) 15 (28.3%)
Postop. Inflammation 20(10.1% ) 15 (28.3%) 0.001
Nd:YAG 30(15.2% ) 12 (22.6%)
Follow-up (months)
Median 13 18.9 <0.001
IQR 6.4-18.6 11.7-29.5
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Table 4-5. The incidence of Nd:YAG capsulotomy in the non-uveitic and uveitic group
Non-uveitic (n=198) Uveitic (n=53)
No. of Patients : 
No. lost to follow-up
No of YAG 
capsulotomy
% Incidence
95% Confidence 
Interval
No. of Patients : 
No. lost to follow-up
No. of YAG
% Incidence
Capsulotomy
* 95% Confidence 
Interval
Up to 6 moths 198:40 12 7.6 4.4:12.8 53:2 0 0 0
>6 months-12 months 146:38 5 4.6 2:10.4 51:10 5 12.2 5.3:25.5
>12 months-18 months 103:49 3 5.6 1.9:15.1 36:13 2 8.7 2.4:26.8
>18 months-24 months 51:20 3 9.7 3.4:24.9 21:5 2 12.5 3.5:36
>24 months-30 months 28:11 0 0 0 14:4 3 30 10.8:60.3
>30 months-36 months 17:5 5 41.7 19.3:68.1 7:1 0 0 0
>36 months-42 months 7:2 1 20 3.6:62.5 6:5 0 0 0
>42months-48months 4:0 0 0 0 1:1 0 0 0
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Figure 4-2. Kaplan Meier curves of Nd:YAG capsulotomy. It shows no 
significant difference in the rate of Nd:YAG capsulotomy between non-uveitic 
and uveitic patients. Censored data are that of patients whose follow-up ended 
before they need Nd:YAG capsulotomy
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4.3.3 Discussion
4.3.3.1 Incidences of Nd:YAG capsulotomy
In the uveitis group, PCO occurred in 39%, and Nd:YAG capsulotomy was 
performed on 33%. In the non-uveitic and uveitic group, the incidences were 15.2% 
and 22.6%, respectively. Table 4-6 shows the reported crude incidence of PCO in 
other studies of phacoemulsification in uveitis patients with a similar length of 
follow-up. Notably, the study by Dana et al reported a higher incidence, which was 
probably because some of their patients did not have IOL implantation. The variation 
in the reported percentages can also be attributed to differences in patient clinical and 
demographic features in addition to the variations in deciding on the indications and 
timing of Nd:YAG capsulotomy that in relation to the variability of disease activity.
In the uveitis group, the incidences of Nd:YAG capsulotomy were 19.2%, 19%, 
27.9% and 15.4% after 1,2,3 and 4 years, respectively. The fourth year drop in 
Nd:YAG capsulotomy rate has not been shown before in uveitis patients. This is 
consistent with our previous observation in non-diabetic and diabetic patients study 
and can be related to the limited survival and proliferative capacity of the LECs 
shown in experimental studies (Kato et al, 1997b;Saika et al, 2002). The incidences, 
however, especially within the first 2 years, were higher than those reported before in 
patient without uveitis (Table 4-5). This was also the case in the non-uveitic and 
uveitic group, where the incidences were consistently higher in patients with uveitis 
over the first 2 years.
Although, we could not establish an independent risk associated with the presence of 
uveitis for an overall increase in the rate of Nd:YAG capsulotomy, the increased 
incidence within the first 2 years after surgery is in agreement with other studies. 
Abela Formanek et al (Abela-Formanek et al, 2002d) found that uveitis patients had 
a denser PCO at 6 months after surgery. Also, Dana et al suggested an increased 
incidence of PCO in patients with uveitis that is related to their younger age at the 
time of surgery (Dana et al, 1997).
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Table 4-6. Demographic features and prevalence of PCO after phacoemulsification in uveitis patients in recent studies of similar follow-
up
Dana et al, 1997 
N=78 (108 eyes)*
Rauz et al, 2000 
N=49 (60 eyes)
Estefanous et al, 2001 
N=32 (39 eyes)
Suresh et al, 2001 
N=75 (86 eyes)
This study 
N=101 (101 eyes)
Study type Retrospective Prospective Retrospective Retrospective Retrospective
M:F 26:23 10:22 35:40 43:58
Age (years)
Range 6-81 9-83 21-73 19-89 14.1-88.2
Mean 68.51* 48.2 50 43.8 52.8
Follow-up (months)
Range - 1-33 3-63 4-63 3-79.5
Mean 51.6 17.03 20 24.1 23.3
PCO - 49(81.7%) 24(62%) 36(42%) 39(38.6%)
Nd:YAG capsulotomy 58(54%) 5(8.3%) 12(31%) 18(21%) 33(32.7%)
IOL deposits - 19(31.7%) - 17(19.7%) 3(3%)
Treatment of deposits
(NdrYAG or steroids) No Yes Yes
tMedian, *80% had a posterior chamber IOL.
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Table 4-7. Comparison of the incidences of NdrYAG capsulotomy in previous studies of non-uveitic and uveitic patients
Non-uveitic Uveitic
Dana et al, 1997* Baratz et al, 2001 Ando et al, 2003 Dana et al, 1997** This study
Type of study Retrospective Retrospective Retrospective Retrospective Retrospective
No. 106(122 eyes) 2718 3997 78(108 eyes) 101
M:F (%) - 33:67 34.8:65.2 - 43:57
Average age in years (Range) 68.51(27-96) 741(1-103) - 44.5t(6-81) 52.8(14.1-88.2)
Average follow-up in months (Range or SD) 
%  Incidence (95% confidence interval)
46.8 44.4^(0-116.4) 17.8J(17.1 SD) 51.6 23.4(3-79.5)
Up to 1 year 11.5 (6.2, 16.8) 6 (5, 7) 1.95(1.43,2.47) 38.5 (28.9, 48.2) 19.2 (12.4, 28.6)
>1 year-2 years - 15(14, 17) - - 19(10.3,32.2)
>2 years-3 years 38.4 (29,47.8) 23 (20, 25) 18.5(16.1,20.9) 56 (45.8, 66.3) 27.9(13.5,49)
>3 years-4 years - - - - 15.4 (2.8, 53.7)
>4 years-5 years - 33 (31,35) 32.7 (28.7, 36.7) - -
>5 years-6 years - 38 (35, 40) - - -
SD=Standard deviation, f  Median, J Mean, * 98% had a posterior chamber IOL, **80% had a posterior chamber IOL.
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4.3.3.2 Risk factors for Nd:YAG capsulotomy
In the uveitis group, an increased Nd:YAG capsulotomy rate was associated with 
hydrogel IOLs, while a decreased rate was associated with plate-haptic and 3-piece 
silicone IOLs, in comparison to PMMA IOLs, and with the use of prophylactic 
steroids. There was no significant difference in the rate of Nd:YAG capsulotomy 
between patients with anterior and posterior uveitis nor between those who 
developed postoperative inflammation and those who did not. Also, neither ethnic 
origin nor gender affected the rate of Nd:YAG capsulotomy. In the non-uveitic and 
uveitic group, there was no association between increased risk of Nd:YAG 
capsulotomy over the follow-up period and the presence of uveitis, gender, ethnic 
origin, younger age, surgeon’s grade or the type of IOL. In the study by Dana et al, 
1997 (Dana et al, 1997), increased PCO rate in uveitis patients and was attributed 
mainly to the patients’ younger age at surgery rather than to the presenc of uveitis. 
Increased PCO rate with hydrogel implants has been shown before in uveitis (Abela- 
Formanek et al, 2002a) and non-uveitis patients (Abela-Formanek et al, 
2002a;Hollick et al, 2000) and was ascribed to its increased water content in 
comparison with other implants, which encourages the proliferation of LECs.
To our knowledge, the effect of prophylactic steroids on lowering PCO rate in these 
patients has not been shown previously and may be related to inhibition of the lens 
epithelial cell proliferation as has been demonstrated in vitro studies with 
dexamethasone (McDonnell et al, 1988) and cyclosporin (Cortina et al, 1997). A 
possible indirect effect through inhibition of uveal inflammatory response cannot be 
excluded, however.
In the majority of patients, Nd:YAG capsulotomy was a relatively safe procedure and 
resulted in improvement of visual acuity in the majority of patients. The development 
of postoperative inflammation and CMO in 3 patients of those who needed the 
procedure (7.7%) seemed to be related to the natural course of the uveitis rather than 
to the procedure and its treatment was satisfactory.
There is lack of consensus regarding the most suitable type of IOLs to use in patients 
with uveitis (Rauz et al, 2000). In the current study, 3 patients with plate-haptic 
silicone IOLs developed clinically significant deposits on the anterior lens surface 
that required Nd:YAG laser treatment. Also, an increased rate of Nd:YAG laser
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capsulotomy was found with the hydrogel implants. Both findings suggest that these 
two lenses should be better avoided in patients with uveitis.
4.3.4 Limitations
One caveat of this study seems to be its retrospective nature. We have tried to avoid 
bias in patient selection by including a continuous series. We also collected data 
about the possible surgery and uveitis-related potential confounders and used Cox 
multivariate analysis to account for differences in patient follow-up and to isolate 
independent factors associated with Nd:YAG capsulotomy. The lack of information 
on factors such as uveitis duration and the biochemical profile for all the patients, 
however, precluded their use in the multivariate analysis and their possible influence 
could not be rule out.
4.3.5 Conclusion
Posterior capsular opacification is the most frequent complication after 
phacoemulsification in uveitis patients. The incidence appears to be higher within the 
first two postoperative years than those reported in non-uveitic patients, although the 
presence of uveitis does not seem to be independely associated with an overall 
increased risk of PCO. Hydrophilic acrylic IOLs (in comparison to PMMA IOLs) 
and an age of 55 years or younger can be associated with an increased risk, while the 
use of prophylactic steroids and silicone IOLs (in comparison to PMMA IOLs) with 
a decreased risk of PCO. Nd:YAG capsulotomy is a relatively safe procedure and 
results in improvement of visual acuity in the majority of uveitis patients.
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4.4 STUDY OF THE INCIDENCE AND RISK FACTORS OF 
ND:YAG CAPSULOTOMY IN UVEITIS PATIENTS: 
PHACOEMULSIFICATION VERSUS EXTRACAPSULAR 
CATARACT EXTRACTION
4.4.1 Patients and methods
4.4.1.1 Design
This is a retrospective study. The dataset of a previous study of ECCE in uveitis that 
was conducted at one of the study centres(Okhravi et al, 1999) was retrieved and 
added to dataset of the previous study. The variables common to both datasets were 
collated and a new dataset was created.
4.4.1.2 Inclusion and exclusion criteria
In order to match the two groups of patients, only patients who were followed up for 
at least 3 months and who had preoperative visual acuity of <6/18 were included. 
Both subgroups were managed using the same preoperative and postoperative 
protocols. The exclusion criteria were similar to those in the previous study.
4.4.2 Results
4.4.2.1 Patient Characteristics
Table 4-8 details the demographic and clinical features of the two groups of patients. 
There were 71 patients in the phacoemulsification group, 41 with anterior uveitis 
(57.7%) and 30 with posterior uveitis (42.3%) and 63 in the ECCE group, 38 
(60.3%) with anterior uveitis and 25 (39.7%) with posterior uveitis. Prophylactic 
systemic steroids were used in 29(41%) of phacoemulsification group and in 27 
(43%) in the ECCE group.
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Table 4-8. Demographic and clinical features of patients in the 
phacoemulsification and ECCE groups
Phacoemulsification
(N=71)
ECCE
(N=63) P
Age (years) *
Mean (SD) 52.4(15.4) 52(16.3) 0.92
Median 51.9 52.9
IQR 41.9-64.5 37.8-66
Male: Female 30:41 30:33 0.53
Ethnic origin (%)
Caucasian 46(65%) 40(64%) 0.88
Asian 7(10%) 7(11%) 0.03
Afro-Caribbean 8(11%) 16(25%) 0.81
Uveitis diagnosis
Anterior: posterior 30:41 38:25 0.76
Systemic disease associated with the uveitis (%) 16(23%) 13(21%) 0.84
Preoperative Steroids 42(59%) 36(57%) 0.81
IOLt
PMMA 19(26.8) 63(100) <0.001
PH silicone 18(25.4) 0
3-piece silicone 12(16.9) 0
Hydrophobic acrylic 14(19.7) 0
Hydrophilic acrylic 8(11.3) 0
Time to Nd:YAG
Mean 13 12.6 0.9
Median 10.8 11.9
IQR 4.2-19.1 6.7-19.1
Follow-up J
Mean (SD) 23.1(19.4) 11.5(5.2) <0.001
Median 15.9 11.3
IQR 8.4-29.5 7.3-14.1
ECCE=extracapsular cataract extraction, IQR=interquartile range; PH=plate-haptic 
*Independent t-test 
t  Chi-squared 
$ Mann-Whitney test
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The two groups had similar age, gender distribution, uveitis diagnoses and 
preoperative acuity. No significant difference was found in the proportion who had 
systemic diseases in association with uveitis or those who had preoperative 
prophylactic corticosteroids. The number of Asians in the ECCE group was 
significantly larger (16/63 vs. 8/71; p=0.03) and the phacoemulsification group had 
a significantly longer follow-up (median=16.9 vs. 1 1.3,/k0.001).
4.4.2.2 Postoperative findings
Postoperative visual improvement occurred in 66 (93%) and 64 (90%) of the 
phacoemulsification group and in 61 (96.8%) and 59 (93.7%) of the ECCE subgroup. 
Immediate postoperative BCVA was significantly better in the phacoemulsification 
group than in the ECCE group (p=0.015).
Postoperative uveitis occurred in 14 patients (19.7%) in the phacoemulsification 
group and 19 patients (30.2%) in the ECCE subgroup. Macular oedema occurred in 
14 (19.7%) and 13 (20.6%) in the phacoemulsification and ECCE subgroups, 
respectively.
4.4.2.3 Incidence of Nd:YAG capsulotomy
Nd:YAG capsulotomy was carried out on 22 patients in the phacoemulsification 
group and on 21 in the ECCE subgroup. The median time to Nd:YAG capsulotomy 
was 10.8 months in the phacoemulsification group (range=1.5-30.5 months) and 11.9 
(range=3.3-26.9 months) in the ECCE subgroup. No postoperative complications 
were noted after Nd:YAG capsulotomy in either of the two subgroups.
Table 4-9 shows the incidences of Nd:YAG capsulotomy in the phacoemulsification 
and ECCE subgroups at each of the 6 monthly intervals following surgery. The 
incidences increased in the phacoemulsification group from 9% within the first 6 
months to 20.2% within first half of the third year. In the ECCE subgroup, the 
incidences were 8.3% and 100% within the same periods. Notably, the incidences 
were consistently higher in the ECCE group after the first 6 months.
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Table 4-9. Incidences of Nd:YAG capsulotomy in phacoemulsification and ECCE groups
PE (n=71) ECCE (n=63)
No. of Patients 
Entering the Period: 
No. lost to follow-up
No of 
Nd:YAG 
capsulotomy
% incidence
95%
Confidence
Interval
No. of Patients 
Entering the Period: 
No. lost to follow-up
No. of
Nd:YAG % incidence 
Capsulotomy
95%
Confidence
Interval
Up to 6 months 71:8 6 9 4.2, 18.2 63:6 5 8.3 3.6, 18.1
>6 months-12 months 57:11 6 11.7 5.5, 23.2 52:18 6 14 6.6, 27.3
>12 months-18 months 40:12 4 11.8 4.7, 26.6 28:16 4 20 8.1,41.6
>18 months-24 months 24:5 2 9.3 2.6, 28.4 8:2 5 71.4 35.9,91.8
>24 months-30 months 17:7 3 22.2 7.9,48.9 1:0 1 100 20.7, 100
>30 months-36 months 7:0 1 14.3 2.6,51.3 0 0 0 0
PCO=posterior capsular opacification
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4.4.2.4 Factors affecting the rate of Nd:YAG capsulotomy
A Cox regression hazard model including the type of surgery in addition to the 
patients’ age (<=55 years or > 55 years), gender, ethnic origin, uveitis type (anterior 
vs. posterior) the use of prophylactic steroids, the presence of a uveitis-associated 
systemic disease and the development of postoperative uveitis showed that ECCE 
was an independent risk factors for increased Nd:YAG capsulotomy rate (HR=2.02; 
95% Confidence Interval (CI)=1.05, 3.89; /?=0.03) in comparison with PE, and so 
was age of 55 years or younger (HR=2.69; 95% CI=1.36, 5.30; /?=0.004) in 
comparison with those of older age. The use of prophylactic steroids reduced the risk 
for Nd:YAG capsulotomy (HR=0.52; 95% CI=0.27, 0.98; /?=0.04), Figures 4-2. The 
development of postoperative uveitis mildly increased the risk (HR=1.88; 95% 
0=0.98 , 3.58;p=0.06).
Including the type of IOL in the regression model (Table 4-8) showed that surgery 
had no significant effect while age of 55 years or younger, the use of prophylactic 
steroid and the development of postoperative uveitis were associated with increased 
risk of Nd:YAG capsulotomy. On the other hand, in comparison with PMMA IOL, 
plate-haptic silicone and 3-piece silicone IOLs were associated with a decreased 
while hydrophilic acrylic IOL with an increased risk.
Nd:YAG capsulotomy was generally a safe procedure and none of the patients 
developed a clinically significant complication that required treatment.
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Table 4-10. Cox regression analysis of the factors affecting the rate of Nd:YAG
capsulotomy
HR 95% Cl P
Age
>55 years Reference
<=55 years 2.62 1.30,5.30 0.007
Prophylactic steroids
No Reference
Yes 0.27 0.13,0.56 0.0005
IOL
PMMA Reference
PH silicone 0.09 0.02, 0.40 0.001
3-piece silicone 0.18 0.05, 0.68 0.01
Hydrophobic acrylic 0.93 0.28,3.10 0.91
Hydrogel 5.81 1.57,21.49 0.008
Postop uveitis 2.65 1.36,5.18 0.004
HR=Hazard ratio; CI=confidence interval, IOP=intraocular pressure, PH=plate- 
haptic
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Figure 4-3. Kaplan-Meier curve of Nd:YAG capsulotomy rate of 
phacoemulsification and ECCE groups
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4.4.3 Discussion
Posterior capsular opacification occurred in 22% and 21 % in the phacoemulsification 
and ECCE groups after a median follow-up of 16.1 and 11.3 months respectively. 
PCO rate, albeit similar in the two groups within the first 6 months, was consistently 
higher following ECCE within the rest of the first year and second year (Table 4-7).
Extracapsular cataract extraction and age of 55 years or younger age were 
independent risk factors for the development of clinically significant PCO. A lower 
PCO rate following phacoemulsification was found in non-uveitis patients 
(Minassian et al, 2001 ;Ram et al, 2001). This is believed to be mainly due to the 
improved cortical clean up and modem lens material and design used in patients 
undergoing PE (Apple et al, 2001). This was further supported by the absence of an 
independent effect of the surgical procedure after including IOL type as a separate 
variable to the multivariate model.
Also, the relationship between younger age and increased PCO rate has been 
established before (Wormstone et al, 1997) and was explained in view of the better 
survival and proliferative capacity of the LECs (Oharazawa et al, 2001;Balaram et 
al, 2000). Less traumatic removal of the lens nucleus by and hence the lower 
magnitude of blood-aqueous barrier damage (Pande et al, 1996b;Chee et al, 1999) 
and inflammatory response (Oshika et al, 1992) could be contributory to lowering 
the PCO rate after PE.
The development of postoperative inflammation, the use of prophylactic steroids and 
IOL type independently affected the rate of PCO development. Increased PCO in 
uveitis patients and in patients who develop postoperative inflammation can be 
related to the stimulatory effect of the plasma-derived growth factors in the aqueous 
of these patients, as a result of blood-aqueous barrier breakdown, on LEC 
proliferation (The paracrine mechanism in 1.1.6.1.2.1.3). In a study by Wormstone et 
al, 1997 (Wormstone et al, 1997), the addition of serum to the growing LECs 
increased the rate of lens epithelial cell proliferation via increasing the amount of 
stimulating growth factors in the aqueous humour. The effect of prophylactic steroids 
and intraocular lenses has been discussed in the previous study.
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4.4.4 Limitations
The comparablitiy of the two subgroups in the known major sources of bias, such as 
age, preoperative acuity, use of prophylactic steroids and type of uveitis in addition 
to the standard protocol of management used in both groups must have limited that 
and yielded fairly reliable comparisons. It was not possible to include factors such as 
the preoperative course or severity of the disease because of the different length of 
time after the onset of the disease when the patients were referred to us and because 
of the lack of standardised system for clinically grading the severity of uveitis.
4.4.5 Conclusion
This study has shown that in patients with uveitis, the surgical technique affect the 
rate of Nd:YAG capsulotomy over the follow-up period. This appears to be related 
mainly to the type of the IOL rather than to the surgical technique per se. Other risk 
fators include younger age, the development of postoperative uveitis and hydrophilic 
acrylic IOL, in comparison to PMMA IOLs while the use of prophylactic steroid 
seems to have a protective effect against the development of PCO.
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5 POSTERIOR CAPSULAR OPACIFICATION 
AFTER MULTIFOCAL INTRAOCULAR LENS 
IMPLANTATION
5.1 STUDY OF THE INCIDENCE OF POSTERIOR CAPSULAR 
OPACIFICATION AND ND:YAG CAPSULOTOMY AFTER 
IMPLANTATION OF MULTIFOCAL INTRAOCULAR LENS 
IMPLANTATION
5.1.1 Introduction
SA40N A rray intraocular lens (Advanced Medical Optics, Inc. (AMO)) (Fine & 
Hoffman, 2000;Steinert, 2000;Avitabile & Marano, 2001) is a second-generation 
silicone refractive m ultifocal IOL that enables focusing for near as well as for 
interm ediate and distant objects. The lens design was discussed in detail in 1.1.4.2.4. 
It has five aspheric concentric zones that incorporate an additional refractive power 
o f  3.5 diopters (Figures 1-7 & 1-8). The design allows 50% o f the light entering the 
eye to be dedicated to distance focusing, 13 % to intermediate focusing and 37% to 
near focusing. Because o f  these features, the Array IOL is known to cause 
dysphotopic sym ptom s such as glare (Haring et al, 2001;Javitt & Steinert, 
2000;Leyland et al, 2002;Leyland & Zinicola, 2003;Steinert et al, 1999) and to 
reduce contrast sensitivity (Gimbel et al, 1991;Leyland & Zinicola, 2003;Steinert et 
al, 1999).
Dysphotopic sym ptom s and reduced contrast sensitivity can be exacerbated by 
opacification o f  the posterior capsule, which often gives rise to similar symptoms 
(Magno et al, 1997;Tan et al, 1998;M eacock et al, 2003;Hayashi et al, 2003), and, 
therefore, could potentially increase N d:Y A G  capsulotomy rate among patients with 
this implant. Also, it is not know n i f  factors such increasing age (Schmitz et al, 2000) 
and the degree o f  corneal astigm atism , which were found to affect the degree of 
contrast sensitivity loss as well as patien ts’ satisfaction with these lenses (Ravalico et 
al, 1999) (Hayashi et al, 2000), can similarly affect the rate o f Nd:YAG 
capsulotomy.
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Several reports have been published o f the incidence o f  PCO with monofocal 
silicone IOLs, w hich ranged between 24% to 39% up to 3 years after surgery 
(Mamalis et al, 1996b;M ilazzo et al, 1996). One previous study reported an 
incidence o f  32.5%  PCO  within one year in patients with diffractive multifocal IOLs 
(Voigt & Strobel, 1999). No study to date, however, has reported the long-term 
incidence and potential risk factors o f PCO development and Nd:YAG capsulotomy 
following im plantation o f  refractie multifocal IOLs.
5.1.2 Aims
The purpose o f  this study was to report the incidence o f  PCO and Nd:YAG 
capsulotom y after im plantation o f  multifocal AMO Array IOL. We also aimed to 
examine the potential risk factors associated with the development o f PCO and the 
symptoms m ost frequently prom pting Nd:YAG capsulotomy.
5.1.3 Patients and methods
5.1.3.1 Inclusion and exclusion criteria
All available clinical notes o f  consecutive patients who underwent 
phacoem ulsification and im plantation o f  AM O Array IOLs between January 1996 
and Septem ber 2002 (n=181) w ere retrieved and reviewed. All those who had 
uneventful surgery were eligible for inclusion. Exclusion criteria included amblyopia 
(n= l), concurrent ocular pathology such as significant macular scars o f age-related 
maculopathy (n=3), uveitis (n=2) and glaucoma (n=3), a systemic disease that could 
affect PCO developm ent such as diabetes mellitus (n=3) and long-term use of 
systemic steroids or cytotoxic agents (n=8). One eye only was randomly chosen for 
those who had bilateral surgery (n= l 1), which left 150 eyes o f 150 patients.
5.1.3.2 Surgical technique
All the patients were operated on by a single surgeon using a standard 
phacoemulsification technique involving a temporal corneal section, capsulorhexis, 
hydrodissection, washout o f  the cortical matter, and insertion o f the IOL using an 
unfolder (Advanced M edical O ptics, Inc.). This was followed by subconjuntival 
injection o f Cefuroxime lOOmg and methylprednisolone acetate 40mg (Depo- 
Medrone, Pharmacia& Upjohn) at the conclusion o f the procedure. Postoperative
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treatment included G. M axitrol (Alcon) QDS for 2 weeks then BID for 2 weeks or G 
Chloram phenicol and Dexamethosone. 1 % in patient allergic to the preparation. 
Patients w ere review ed at 1 day, 6 weeks and 3 months then discharged or further 
follow-up arranged should there be a clinical indication.
5.1.3.3 Data collection
A spreadsheet was used for entering all the relevant data including age at surgery 
(<75 years & >= 75 years), the medical and ocular history, Snellen’s best-corrected 
visual acuity (BCVA) preoperatively, postoperatively as well as pre and post 
Nd:Y AG  capsulotom y, the time to Nd:YAG capsulotom y and follow-up time. The 
occurrence o f  uveal inflamm ation that required steroid treatment within 3 months 
after surgery, the dioptric power o f  the IOL, postoperative refraction and visual 
symptom s that prom pted capsulotomy were recorded. The spherical equivalent was 
categorised into: emmetropic, myopic or hyperopic, and the presence o f astigmatism 
into <1 dioptre or >= 1 dioptre.
5.1.3.4 Outcome measure and statistical analysis
Two outcom e m easures were examined: the presence o f  PCO and the need for 
Nd:YAG capsulotomy. Patients were either self-referred or referred by a primary 
care unit i f  they had developed visual symptoms attributable to PCO i.e. blurred or 
double vision or increased glare or halos. Patients were offered Nd:YAG 
capsulotom y i f  they were found to have PCO in the presence o f  the above symptoms 
or im paired fundus visualization. Slitlamp grading o f PCO was carried out by a 
single observer into: mild (faint opacity, clear fundus view, with or without minimal 
symptoms o f  reduced acuity or glare symptoms), moderate (moderate opacity, 
slightly hazy fundus view, and symptom s o f  glare or reduced acuity) or severe 
(severe opacity, blurred fundus view and symptoms o f  reduced acuity).
The Statistical Package for Social Science software for W indows (Release 9, SPSS 
Inc., Chicago, Illinois, USA) was used for statistical analysis. Survival tables were 
used to derive the incidences o f  PCO and Nd:YAG capsulotomy. The incidence was 
calculated as the num ber o f  events (i.e. PCO or Nd:YAG) divided by the number o f 
patients at risk at each o f  the tim e intervals (No. o f patients entering the period-50% 
o f those lost to follow-up). C onfidence intervals for incidences were calculated using 
the W ilson score method. Log rank and the Median tests were used for comparisons
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and a p  value o f  <0.05 was considered significant. The study had more than 90% 
power to detect a 10% difference in hazard ratio for the examined risk factors o f 
PCO (age, refractive outcome, degree o f  astigmatism and postoperative 
inflamm ation).
5.1.4 Results
5.1.4.1 Patient characteristics
W e included 150 patients, o f  whom 87 (58%) were female. The median age was 78 
years (range=47-100) and the median follow-up 23.4 m onths (range= l.4-73.2).
Tw enty-three patients (15.3%) were referred with PCO, 14 o f whom (60.1%) were o f 
grade 1 and 9 (39.1% ) o f  grade 2. Nd:YAG capsulotomy was performed in 14 (9.3%) 
and the m edian tim e to Nd:YAG capsulotomy was 25.2 months (range=8.6 to 47.7 
months).
5.1.4.2 Incidence of PCO and Nd:YAG capsulotomy
Survival tables (Table 5-1) and the survival curves (Figure 5-1) show the incidences 
o f  PCO and N d:Y AG  capsulotomy within 6 years o f  follow-up. Both show that the 
majority o f  PCO and Nd:YAG capsulotomy occurred between two and four years 
after surgery and that no new cases o f  PCO or Nd:YAG capsulotomy were noted 
after the fourth year.
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Table 5-1. Incidence of PCO and Nd:YAG capsulotomy
PCO (n=23) Nd:YAG capsulotomy (n=14)
No. of Patients 
Entering the Period: 
No. lost to follow-up No of PCO % Incidence
95% Confidence 
Interval
No. of Patients 
Entering the Period: 
No. lost to follow-up
No. of 
Nd:YAG 
Capsulotomy % Incidence
95% Confidence 
Interval
Up to 1 year 150:27 2 1.5 0.4, 5.2 150:27 2 1.5 0.4, 5.2
>1 year-2 years 121:47 5 5.1 2.2, 11.5 121:49 3 3.1 1.1, 8.8
>2 years-3 years 69: 26 9 16.1 8.7,27.8 69:30 5 9.2 4, 19.9
>3 years-4 years 34: 16 7 26.9 13.7,46 34:19 4 16.7 6.7, 35.9
>4 years-5 years 11: 8 0 0 0-35.4 11:8 0 0 0-35.4
>5years-6years 3:3 0 0 0-56.2 3:3 0 0 0-56.2
PCO=posterior capsular opacification
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Figure 5-1. Kaplan-Meier survival curve of PCO (a) and Nd:YAG capsulotomy 
(b) over the follow-up period. It shows that the majority of cases occurred 
between 2 to 4 years after surgery
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Table 5-2 shows that patients who developed PCO were younger (median=74.4 
years) than those who did not (median=78.4) {Median test; p=  0.01). The difference 
was only o f  borderline significance between those who required Nd:YAG 
capsulotomy and those who did not (median= 75.5 vs. 78.1); {Median test; p=  0.09).
Postoperative refraction was available on 122 and IOL pow er on 148 o f the patients. 
No significant difference was found in postoperative spherical equivalence or in the 
power o f  the IOL given between patients who underwent Nd:YAG capsulotomy and 
those who did not. Kaplan-M eier survival analysis and Log-rank test showed that 
gender, postoperative inflammation, the refractive outcome (myopic, emmetropic & 
hyperopic) and the degree o f  astigmatism (<1 dioptre & >=1 dioptre) did not have a 
statistically significant effect on the rate o f  PCO or Nd:YAG capsulotomy.
PCO-related symptom s that prompted Nd:YAG capsulotomy included predominantly 
reduction o f  BCVA, which ranged between 1 to 5 Snellen’s lines (median=2.5 lines) 
(n=12; 85.7%) and, less frequently, glare or halos (n=2, 14.3%), which was not 
associated with reduced acuity in either o f  them.
Table 5-2. Clinical features of patients who developed PCO and those who 
underwent Nd:YAG capsulotomy
PCO Nd:YAG capsulotomy
Yes (n=23) No (n=127) Yes (n=14) No (n=136)
Age (years)
Median 74.4 78.4 75.5 78.1
IQR 66-79.6 72.9-83.1 68.2-80.7 72.3-82.9
Sex
M:F 12:11 51:76 9:5 54:82
IOL power (dioptres)
Median 21.5 21 21.3 21.
IQR 19.5-22.5 20-22.5 19.4-22.6 19.9-22.5
Postop sph. equivalent
Median -0.25 0.13 -0.25 0.13
IQR -0.50 to 0.50 -0.50 to 0.50 -0.88 to 0.43 -0.5to 0.50
Postop inflammation
Yes/No 4/19 8/119 2/12 10/126
PCO=posterior capsular opacification, M =m ale, F=female, IQR=interquartile range
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5.1.5 Discussion
5.1.5.1 Incidences of PCO and Nd:YAG capsulotomy
This study is the first to report the long-term incidence o f  PCO with AMO ARRAY 
multifocal im plants. The estimated annual incidences w ere based on the number o f 
patients who w ere self-referred or were referred by prim ary care units for PCO- 
related sym ptom s. The assumption o f the study was that the rest o f the patients either 
had clinically insignificant PCO or did not require Nd:YAG capsulotomy for their 
vision was reduced because o f  other concom itant ocular pathology. As such, our 
estim ated incidences should reflect those in the majority o f  secondary ophthalmic 
units. Sundelin and Sjostrand (Sundelin & Sjostrand, 1999) estimated that a ‘hidden’ 
group o f  patients that would have clinically significant PCO and benefit form 
NdiYAG capsulotom y represents only 9% o f patients within 5 years following 
cataract extraction.
In this study, the incidences o f  PCO were 1.5% (0.4, 5.2), 5.1% (2.2, 11.5), 16.1% 
(8.7, 27.8) and 26.9%  (13.7, 46) and that o f  Nd:YAG capsulotomy were 1.5% (0.4, 
5.2), 3.1% (1.1, 8.8), 9.2% (4, 19.9) and 16.7% (6.7, 35.9) after 1, 2, 3 and 4 years o f 
follow-up. These progressively increasing incidences concur with the study by Ando 
et al, (Ando et al, 2003) who reported a cumulative probability o f  capsulotomy o f 
1.95%, 18.5% and 32.7%  after 1, 3, and 5 years, respectively. The relatively higher 
percentage in their study could possibly be related to the variety o f  IOLs used, which 
included PM M A (43.6% ), silicone (41.5%) and acrylic (12.6%) types, in addition to 
the inclusion in their series o f  patients with other systemic and ocular comorbidity 
such as diabetes m ellitus (14%), diabetic retinopathy (5.2%) and retinitis pigmentosa 
(0 .8%).
In our study, no cases were noted after the fourth year possibly because o f the 
relatively small num ber o f  patients that were followed up m ore than 4 years. Baratz 
et al (Baratz et al, 2001) in a large retrospective series, reported a cumulative 
incidence o f  23 % at 3 years that increased to 33% at 5 years and only to 38% at 9 
years. They suggested that the increase in PCO rate that occurs within the first 5 
years might not continue after the sixth year. This could be related to a plausible 
temporal decline in the survival o f  LECs and their proliferative capacity.
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The PCO incidence in this study is less than that reported after other multifocal IOLs. 
Negishi and associates (Negishi et al, 1996) reported 4.2% incidence o f  PCO after 6 
months o f  follow -up o f  patients who had a five-zone refractive multifocal IOL made 
o f  PM MA. The incidences in our study are, however, comparable to those reported 
after other m odem  silicone and acrylic IOLs. Beltrame et al (Beltrame et al, 2002) 
found that two years after surgery 27.6% o f patients with the SI-40 monofocal 
silicone lens had PCO  and 9.7% had Nd:YAG laser capsulotomy. Oner et al (Oner et 
al, 2000) and A bhilakh et al (Abhilakh M issier et al, 2003) reported incidences o f 
14.3% and 8.5%  o f  PCO after 18 months and 3 years o f  implantation o f acrylic IOLs, 
respectively.
5.1.5.2 Risk factors for PCO and Nd:YAG capsulotomy
W e found that patients who developed PCO were younger, but there was no 
significant age difference between those who had Nd:YAG capsulotomy and those 
who did not. The explanation could be that the need for Nd:YAG capsulotomy is 
perhaps m ore related to the magnitude o f influence o f  PCO on visual function and 
visual dem ands dictated by patients’ life style than their age. On the other hand, our 
sample size could have limited the ability to detect a difference in the age between 
patients who needed Nd:Y AG capsulotom y and those who did not.
5.1.5.3 Symptoms associated with Nd:YAG capsulotomy
Patients required N d:Y A G  capsulotom y predominantly for reduced vision (85.7%) 
rather than for glare sym ptom s (14.3%). This concurs with the findings by Hayashi et 
al (Hayashi et al, 2003) that PCO value in patients with monofocal IOLs correlates 
more strongly with visual acuity than with contrast sensitivity and glare sensitivity. 
Notably, however, none o f  our patients had PCO o f more than grade 2 and it is not 
known if  that is due to a tendency o f  these patients to present earlier due to the effect 
o f PCO on other visual functions such as near acuity or contrast sensitivity.
5.1.6 Limitations
The limitation o f this study is related to the retrospective design. Future prospective 
studies that will include a contem porary group o f patients with monofocal implants 
will be able to avoid some o f  the inherent potential bias o f  the retrospective design 
and will help to directly com pare the incidences as well as the differential effect o f
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PCO on the different aspects o f  visual function betw een the two groups. It will also 
help to establish i f  that effect will rather vary the length o f  time to presentation and 
to requiring N d:Y A G  capsulotom y than its incidence.
5.1.7 Conclusion
After phacoem ulsification and AMO ARRAY IOL im plantation, PCO and Nd:YAG 
capsulotom y incidences are similar to those reported after other m odem  foldable 
monofocal im plants. The incidences steadily increase till the fourth year, with the 
m ajority o f  cases occurring after the first year. PCO tends to develop in younger 
patients and N d.Y A G  capsulotomy, similar to the case with monofocal implants, 
appears to be largely prom pted by reduced vision rather than glare symptoms.
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5.2 STUDY OF THE EFFECT OF POSTERIOR CAPSULAR 
OPACIFICATION ON VISUAL FUNCTION IN PATIENTS 
WITH MONOFOCAL AND MULTIFOCAL INTRAOCULAR 
LENSES
5.2.1 Introduction
Posterior capsular opacification (PCO), by causing forward and backward light 
scattering, reduces visual acuity and contrast sensitivity (Cheng et al, 2001;Meacock 
et al, 2003;H ayashi et al, 2003;M agno et al, 1997;Tan et al, 1999). The magnitude o f 
the effect o f  PCO on visual function was found to be related mainly to its location, 
density and type, with epithelial pearls having a m ore pronounced effect on visual 
acuity and contrast sensitivity (Cheng et al, 2001;Aslam  et al, 2003a;Aslam & 
Patton, 2004).
All published studies o f  the effect o f PCO on visual function have been conducted on 
patients w ith m onofocal IOLs. Because multifocal intraocular lens design reduces 
contrast sensitivity (Haring et al, 2001;Leyland & Zinicola, 2003), it is not known if  
this can be exacerbated by the development o f  PCO, which could lead to an 
increased rate o f  Nd:YAG  capsulotomy. W e hypothesised that the magnitude o f 
PCO-induced im pairm ent o f visual function when presenting for NdrYAG 
capsulotom y m ight be different between patients with monofocal and multifocal 
IOLs.
5.2.2 Aim
The aim o f  this study was to com pare the functional impairment in patients with 
monofocal and m ultifocal IOLs who presented for Nd:YAG capsulotomy. The 
results will help in understanding the relative effect o f this complication on visual 
function in the two groups o f  patients and to assess whether functional loss can 
potentially be a risk factor for increased Nd:Y AG capsulotomy rate.
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5.2.3 Patients and method
This is a prospective non-randomised case-control study. The appropriate ethical 
approval was obtained for the study and all eligible patients were informed o f the 
study design and and its aims before they gave consent to be included.
5.2.3.1 Eligibillity and inclusion criteria
Fifty-four patients w ere recruited consecutively from the outpatient clinic at Essex 
County H ospital, Colchester between April and November 2004. Only the first eye to 
develop the sym ptom s for patients who needed bilateral Nd:YAG capsulotomy was 
included. Patients were considered eligible for inclusion if  they had undergone 
cataract extraction and im plantation o f  either monofocal or multifocal IOLs and were 
referred because o f  visual symptoms attributable to PCO and had lost at least one 
line o f  Snellen’s visual acuity.
5.2.3.2 Exclusion criteria
Patients w ith a history suggestive o f  amblyopia (n= l) or colour blindness (n= l) and 
those who had glaucom a (n=6), diabetic retinopathy (n=4), neo-vascular or atrophic 
age-related m aculopathy (n=6) or pupillary abnormality (n=3) were excluded, which 
left 33 patients.
5.2.3.3 Examination
5.2.3.3.1 Visual acuity
High-contrast (90% ) distance and near best-corrected visual acuities (BCVA) were 
measured using logM A R charts at 3 meters and 40cm, respectively. The charts were 
externally illum inated and illum ination levels at the charts were 400 lux. The patients 
were encouraged to read as far down the charts as they can. The acuity was recorded 
as a logM AR score o f  the total num ber o f  letters that were identified correctly.
5.2.3.3.2 Contrast sensitivity
Pelli-Robson and low-contrast (10% ) logM AR acuity charts were used to examine 
contrast sensitivity. Pelli-Robson chart has 8 lines o f Sloan letters that subtend a 
visual angle o f  3 degrees at a test distance o f  1 meter. The letters are arranged in 
triplets, each progressively decrease in contrast from 96% to 1%. The 10% logMAR
184
Chapter 5. PCO after Multifocal IOL Implantation
acuity chart was tested at 3 meters. Both charts w ere externally illuminated and the 
illum ination levels at their surfaces were approxim ately 400 and 300 lux, 
respectively.
5.2.3.3.3 Colour vision
All the patients underw ent Ishihara test to identify those with congenital colour 
blindness. C olour vision was then tested using Lanthony desaturated D15 test that 
was conducted under an additional external illumination o f  1000 lux produced by a 
fluorescent lam p placed at 35 cm from the colour chips. The Colour Vision Recorder 
software (v. 2.3; Optical Diagnostics, The Netherlands) was used to record the results 
and to calculate the colour confusion index (CCI). (Bowman, 1982) The latter 
indicates how m uch the patient's arrangement o f  the colour chips deviates from the 
perfect arrangem ent: an index o f  1 indicates a perfect arrangement and a value larger 
than 1 indicates some colour confusion or error.
5.2.3.3.4 Slit lamp examination
This included anterior segment and fundus examination in addition to intraocular 
pressure m easurem ent.
5.2.3.3.5 Determ inng type and grading o f  PCO
A single exam iner determ ined the PCO type and grade. PCO was classified clinically 
into ‘fibrotic’ or ‘cellular’ according to the predominant feature (> 50%) within the 
retro-optic part o f  the posterior capsule. PCO grading was carried out after pupillary 
dilatation and was determ ined based on the visibility o f the posterior segment 
structures on the slit lamp. A m odification o f  the grading system used by several 
other authors (Aslam & Dhillon, 2002;Kucuksumer et al, 2000;Kruger et al, 
2000;Sellman & Lindstrom, 1988) was adopted (Table 5-3).
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Table 5-3. PCO grades
Grade I  (Mild) The outlines o f  the optic nerve head and main retinal 
vessels (± retinal striations) are clearly 
distinguishable.
Grade II  (Moderate PCO) The outlines o f  the optic nerve head or o f  the main 
retinal blood vessels are blurred
Grade III (Severe or Dense) The optic nerve head and blood vessels are barely 
visible.
5.2.3.4 Questionnaire
A questionnaire (Table 5-4) was administered by the examiner during the 
consultation before and 2 to 6 weeks after capsulotomy. It included questions about 
different PCO-related visual symptoms, including blurred distance and near vision, 
colour vision, dysphotopic symptoms or diplopia. Patients were asked to rate the 
symptom s as m ild, m oderate or severe, depending on how much it affected their day- 
to-day activities. A fter capsulotomy, the questions were wether the symptoms have 
disappeared, im proved or got worse and if  new symptoms had developed.
5.2.3.5 Nd:YAG capsulotomy
Before capsulotom y, G. Tropicam ide 1% was instilled in the eye to achieve 4 to 
6mm o f  pupillary dilation. Also, G. Apraclonidine 0.1% (Iopidine) was used before 
and after the procedure to prevent rise o f intraocular pressure. The procedure was 
preformed using Cooper V ision 2500 (Alcon) machine and 2 to 4mJ o f energy per 
pulse that w ere increased as needed. The laser beam was posteriorly defocused in 
order to avoid pitting the lens.
5.2.3.6 After care
After capsulotomy, G. D exam ethasone 0.1% (M axidex; Alcon Inc.) was prescribed 
QDS for 1 week and BID for one week. All the patients were reviewed 2 to 6 weeks 
when the same visual tests were carried out and a questionnaire regarding the change 
in visual symptoms was adm inistered. V isual acuity, contrast sensitivity and colour 
vision were assessed as before and under the same conditions. The anterior and 
posterior segments were assessed for adequacy o f the capsular opening, IOL 
position, clarity o f  the visual axis, signs o f  inflammation and m acular oedema.
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Table 5-4. The questionnaires administered before and after Nd:YAG
capsulotomy
Before capsulotomy
What is the main problem with the eye that needs laser treatment?
Mild (can manage)/ Moderate (manage with difficulty)/ Severe (unable to 
manage)*
■ Blurred distance vision (e.g. TV/reading signs or bus numbers)
■ Blurred near vision (e.g. reading/needle work)
■ Disturbed colour vision
■ Glare
■ Halos
■ Streaks/stars/flare
■ D ouble vision
■ Other (please m ention)
After capsulotomy
How has the laser affected the symptoms you had?
Disappeared, No change, Worse*
■ Blurred distance vision (e.g. TV/reading signs or bus numbers)
■ Blurred near vision (e.g. reading/needle work)
■ Disturbed colour vision
■ Glare
■ Halo
■ Streak/stars/flare
■ Double vision
■ Other (please m ention)
* These w ere the choices for each o f  the questions.
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5.2.3.7 Statistical Analysis
The primary outcome o f the study was the difference in the presenting visual 
functions (distance and near visual acuity, contrast sensitivity and colour confusion 
index) at presentation between the two groups o f  patients. The secondary outcome 
was the difference in the proportion o f patients with different PCO-related symptoms 
in the two groups.
We used the independent t-test or M ann-W hitney test (when the data were not 
normally distributed) for comparison o f  continuous data. Fisher’s exact test was used 
for comparing proportions o f patients with different PCO-related symptoms. The 
study had 90% power to detect a 0.2 log units (2 lines on the high and low contrast 
log MAR chart) in the mean preoperative acuity (SD 0.1), o f 0.3 o f  log units o f Pelli- 
Robson contrast sensitivity (1 line) and 0.25 in the mean colour confusion index 
(with a standard deviation o f 0.15) at an alpha level o f 0.05.
5.2.4 Results
5.2.4.1 Clinical features
Thirty-three patients were included in the study, 13 o f them were males and the 
median age was 76.2 years (range 18 to 91). Thirty-two o f the patients had 
undergone phacoemulsification and one extracapsular cataract extraction. Twenty- 
four patients (72.7%) had monofocal IOL, including PMMA: 95UV, Storz 
(Refractive index (RI)=1.49) (n=3, 12.6%); Silicone: SI30NB, SI40NB or Clariflex; 
Advanced Medical Optics, Inc. (RI=1.46) (n=15, 62.6%), Lenstec LH3000, Lenstec 
Inc. (RI=1.4585) (n=5, 25%) or Hydrogel: Li61U Soflex, Bausch & Lomb 
(RI=1.427) (n= l, 4.2%). Nine patients (27.3%) had silicone refractive multifocal 
IOL, Array SA40N, Advanced Medical Optics, Inc. (RI=1.46, n=9, 100%).
There was no significant difference in age, gender distribution, PCO type or grade, 
the time to presentation for capsulotomy or the spherical equivalent between the two 
groups (Table 5-5).
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Table 5-5. Clinical features of patients in the two groups
Monofocal Multifocal P
M:F 12:12 1:8 0.06
Age
Mean (SD) 75.1 (9.5) 67.01 (22.6) 0.48
Median 76.2 75.9
IQR 71.4 to 82.6 54.4 to 83.1
PCO type
Cellular 10(41.7%) 3 (33.3%) 0.25
Fibrotic 14(58.3%) 6(66.7%)
PCO grade
Mild 5(20.8%) 5(55.6%) 0.15
Moderate 13(54.2%) 3(33.3%)
Severe 6(25%) 1(11.1%)
Time to NdrYAG
Mean (SD) 36.5 (34.6) 24.8(18.3) 0.54
Median 28.9 16.5
IQR 11.1 to 49.1 8.1 to 40.7
Spherical equivalent
Mean (SD) -0.31 (1.31) -0.33 (0.56) 0.54
Median 0 -0.38
IQR -1.19 to 0.75 -0.69 to 0.06
M -m ale; F -fem ale; SD=standard deviation; IQR=interquartile range
5.2.4.2 Visual function
At presentation, high- and low-contrast logMAR acuity were significantly better 
(smaller values) in the multifocal group (0.40 vs. 0.20; p=  0.04 & 0.34 vs. 0.98; 
p=0.006) (Table 5-6). On the other hand, near acuity, Pelli-Robson contrast 
sensitivity and CCI were not significantly different between the two groups. After 
capsulotomy, high- and low contrast distance and near visual acuity, Pelli-Robson 
contrast sensitivity and CCI were not significantly different between the two groups 
(Table 5-6).
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Table 5-6. Visual function in the two groups of patients
Monofocal (n=24; 72.7%) Multifocal (n=9; 27.3%)
Pre-Nd:YAG Post-Nd:YAG Difference Pre-Nd:YAG Post-Nd:YAG Difference
Distance BCVA (logMAR)
Mean (SD) 0.40 (0.58)* -0.13(0.17) 0.54(0.64) 0.20 (0.69)* -0.13(0.15) 0.33(0.77)
Near BCVA (logMAR)
Mean (SD) 0.68 (0.36) 0.19(0.17) 0.47(0.39) 0.42 (0.41) 0.10(0.11) 0.3(0.37)
CS (Pelli-Robson)
Mean (SD) 1.15 (0.39) 1.66(0.08) 0.48(0.39) 1.34 (0.44) 1.64(0.13) 0.24(0.42)
CS (10% log MAR)
Mean (SD) 0.98 (0.76)* 0.07(0.19) 0.88(0.79)t 0.34 (0.32)* 0.16(0.22) 0.12(0.33)t
CCI
Mean (SD) 1.31 (0.34) 1.23(0.41) 0.07(0.36) * 1.36 (0.48) 1.31(0.33) 0.09(0.36) *
BCVA=best-corrected visual acuity; logMAR=logarithm of minimum angle o f resolution; SD-standard deviation;
IQR=interquartile range; CS=contrast sensitivity; CCI=colour confusion index 
*Mann-Whitney test
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5.2.4.3 Questionnaire results
The presenting sym ptom s (Table 5-7 & Figure 5-2) in the majority o f  patients in the 
two groups w ere blurred distance or near vision (95.8%  & 100% in the monofocal 
group and 88.9% and 66.7% in the multifocal group). Glare and halos affected 45.8% 
and 25% o f  patients in the monofocal group and each affected 44.4% o f patients in 
the multifocal group. Other dysphotopic symptoms such as seeing stars/ streaks/ 
flare; and other symptoms such as double vision and floaters affected a smaller 
proportion o f  patients in the two groups. A significantly greater proportion o f 
patients in the monofocal group had blurred near vision (24/24 vs. 6/9; Fisher’s 
exact; /?=0.01). There was no statistically significant difference between the 
proportions o f  patients affected by the other symptoms in the two groups. W hile the 
symptoms in the majority o f patients in the monofocal group were moderate to 
severe, in the majority o f  patients in the multifocal group they were mild to moderate 
(Table 5-7).
After capsulotomy, Table 5-8 shows that all patients in the monofocal group 
experienced im provement or complete disappearance o f their symptoms. One o f  the 
patients in the multifocal group (1/8, 12.5%) had persistent symptoms o f blurred 
distance and near vision and another (1/8, 12.5%) had persistent glare and halos. 
Also, 19% and 25% o f  the monofocal and multifocal group, respectively, reported 
seeing floaters that was graded as mild by all the patients.
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Table 5-7. Questionnaire result before Nd:YAG capsulotomy
Monofocal (n=24); 
n (%)
Multifocal (n=9); 
n(%)
No Mild Moderate Severe No Mild Moderate Severe
Blurred distance vision 1(4.2) 5(20.8) 9(37.5) 9(37.5) 1(11.1) 5(55.6) 2(22.2) 1(11.1)
Blurred near vision* 0 4(16.7) 10(41.7) 10(41.7) 3(33.3) 3(33.3) 2(22.2) 1(11.1)
Disturbed colour vision 24(100) 0 0 0 8(88.9) 1(11.1) 0 0
Glare 13(54.2) 2(8.3) 6(25) 3(12.5) 5(55.6) 2(22.2) 2(22.2) 0
Halos 18(75) 2(8.3) 3(12.5) 1(4.2) 5(55.6) 0 3(33.3) 1(11.1)
Streaks/stars/flare 20(83.3) 2(8.3) 1(4.2) 1(4.2) 9(100) 0 0 0
Double vision 22(91.7) 2(8.3) 0 0 8(88.9) 1(11.1) 0 0
Floaters 21(87.5) 3(12.5) 0 0 9(100) 0 0 0
*p=0.01
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100%
El Monofocal 
■  Multifocal
Figure 5-2. B ar ch a rt of the d ifferent presenting symptom s of PCO in the monofocal and  m ultifocal IO L patients
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Table 5-8. Questionnaire result after Nd:YAG capsulotomy
Monofocal (n=21; 72.4%) 
n (%)
Multifocal (n=8; 27.6%) 
n (%)
Yes (new cases) The same Less Disappeared Yes (new cases) The same Less Disappeared
Blurring of distance vision 0 0 5(23.8) 15(71.4) 0 1(12.5) 3(37.5) 3(37.5)
Blurring of near vision 0 0 5(23.8) 16(76.2) 0 1(12.5) 1(12.5) 3(37.5)
Disturbance of colour vision 0 0 0 0 0 0 0 1(12.5)
Glare 0 0 3(14.3) 7(33.3) 0 1(12.5) 0 2(25)
Halos 0 0 2(9.5) 4(19) 0 1(12.5) 1(12.5) 1(12.5)
Streaks/stars/sunburst/flare 0 0 2(9.5) 2(9.5) 0 0 0 0
Double vision 0 0 0 5(23.8) 0 0 0 1(12.5)
Floaters 4(19) 3(14.3) 0 0 2(25) 0 0 0
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5.2.5 Discussion
Several studies have shown that patients with m onofocal and multifocal IOL have 
comparable visual functions and that the effect o f  the multifocal lens design on visual 
function is limited and clinically insignificant (Steinert et al, 1999;Vaquero et al, 
1996;Arens et al, 1999;Elgohary & Beckingsale, 2004). In this study, we compared 
the presenting visual functions between two groups o f  patients who had either 
monofocal or multifocal IOLs and presented with PCO and needed Nd:YAG 
capsulotomy with view to relating that to a possible effect on Nd:YAG capsulotomy 
rate. W e showed that while near BCVA, Pelli-Robson contrast sensitivity and colour 
confusion index were not significantly different at presentation in the two groups, 
high- and low-contrast acuity values were significantly greater in the multifocal 
group. After Nd:YAG capsulotomy, all visual functions were comparable in the two 
groups.
Hayashi et al (Hayashi et al, 2003) showed that visual acuity reflects most relevantly 
the degree o f  PCO. Other studies o f  the effect o f PCO on contrast sensitivity 
(M eacock et al, 2003 ;Tan et al, 1999) have shown that patients suffer a 
predom inantly global loss over all spatial frequencies and Cheng et al (Cheng et al, 
2001) showed a preferential loss at low- to intermediate spatial frequency (6 cpd). 
Our finding suggest that logM AR acuity charts, perhaps by displaying a wide range 
o f spatial frequencies (Adams, 1993) (Figure 5.3), are probably more sensitive in 
detecting PCO-related differences between the two groups than other charts.
There are two explanations for the difference between two groups: either that 
patients with multifocal IOLs were referred earlier for Nd:YAG capsulotomy or that 
these patients were less tolerant to PCO-induced functional loss. Against the first 
proposition is the fact that the two groups had comparable pre-capsulotomy features, 
including their PCO type (cellular or fibrotic) and grade. In support o f the second 
proposition, is that in our m ultifocal group, the difference between pre-YAG and 
post-YAG mean functional loss was 0.33 log units for high contrast acuity, 0.24 log 
units for Pelli-Robson contrast sensitivity and 0.12 log units for low-contrast acuity. 
The respective values in the m onofocal group were 0.54, 0.48 and 0.88 (Table 5-6). 
Moreover, the presenting sym ptom s in the multifocal group were predominantly mild 
or moderate while in the m onofocal group moderate or severe. Also, although
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symptoms in the two groups were generally comparable, more patients in the 
monofocal group had difficulty with reading than those in multifocal group. This, in 
addition to further confirming the earlier presentation of patients with multifocal 
IOLs, can be related to the enhancement of near vision performance achieved by the 
power incorporated within the multifocal IOL design.
Colour confusion index showed the least change of all the visual functions, 
indicating that colour vision is perhaps more resistant to PCO-induced blur. This is 
consistent with the evidence suggesting that colour vision is resistant to different 
forms of blur, including optical blur (Mantyjarvi & Tuppurainen, 1995;Degen et al, 
1983) and that resulting from medial opacities such as cataract (Pinckers, 1980).
After capsulotomy, the majority of patients in the two groups experienced 
improvement or disappearance of their symptoms after capsulotomy. On the other 
hand, one patient (12.5%) with multifocal IOL experienced persistent glare or halos. 
In the other patient there was no explanation for the persistent bluring of vision. A 
small percentage in each group, (19% & 25%, respectively) developed floaters, but 
all patient reported that to be mild and not affecting their vision.
5.2.6 Limitations
It was not possible to compare the survival time between the two groups of patients 
nor between those in the subgroups with different PCO type and grade because of the 
small sample size and the absence of control groups who did not have PCO or 
require Nd:YAG capsulotomy. A similarly designed study with a larger sample size 
and a contemporary control group will enable further assessment of the incidences in 
patients with different types of PCO.
5.2.7 Conclusion
This study suggests that patients with multifocal IOLs present for Nd:YAG 
capsulotomy with a lesser magnitude of functional impairment, that mainly affects 
high- and low-contrast acuity. This perhaps reflects more vision-consciousness or 
sensitivity to early functional loss and could lead to a higher rate of Nd:YAG 
capsulotomy in these patients.
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Figure 5-3. The relationship between different letter-based test charts and 
contrast sensitivity. (Courtesy of T. Adams) (Adams, 1993).
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6 SUMMARY AND FUTURE DIRECTIONS
The ever-increasing drive to perfect the outcome of cataract extraction is a lasting 
motivation for researchers to explore the means by which the incidence of PCO can 
be reduced or even prevented. The latter, perhaps, would be the next revolutionary 
step in cataract surgery development.
From the previous studies, it is clear that clinically significant PCO-that requires 
Nd:YAG capsulotomy-still develops in a large proportion of all patient groups 
(Figure 6-1). The incidence, however, seems to have decreased in comparison to that 
reported in previous studies. This is mainly because of the improvement in surgical 
techniques, with the use of phacoemulsficiation and the development of new 
intraocular lenses with better designs and greater capsular biocompatibility.
We have shown that there is a tendency for diabetic patients to have a lower 
incidence of Nd:YAG capsulotomy than non-diabetic patients. Similarly, we have 
shown that in uveitic patients, there was a decrease in the incidence of Nd:YAG 
capsulotomy after the first three years, which showed consistently higher incidences 
than those reported in non-uveitic patients. In patients with multifocal IOLs, the 
capsulotomy incidence was not particularly higher than those reported with 
monofocal implants of similar designs and the incidence pattern was generally 
similar to the non-diabetic/non-uveitic group of patients (Figure 6-1), with gradual 
increase in incidence over the 4 postoperative years.
Several factors were found to affect the rate of Nd:YAG capsulotomy and PCO 
development (Table 6-1). The presence of diabetes mellitus was found to be 
associated with a lower risk of Nd:YAG capsulotomy over a 4-year postoperative 
period. Factors associated with increased risk of Nd:YAG capsulotomy included 
young age, postoperative inflammation, pars plana vitrectomy and 
polymethylmethacrylate and plate-haptic silicone IOL, as compared to 3-piece 
silicone IOLs. Also, in diabetic patients, plate-haptic silicone (Chiron C11UB) were 
associated with a higher PCO rate than hydrophobic acrylic IOLs (AcrySof) within 1 
year after surgery. Optical coherence tomography showed that decreased PCO and 
Nd:YAG capsulotomy rates in patients with hydrophobic acrylic IOLs could be 
related to the development of a peripheral appositional contact between the IOL optic 
and the posterior capsule. This is consistent with the previously demonstrated
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beneficial effect of the square-edge of these IOL optic, its stronger adherence to the 
capsule and the ‘no-space, no cell, no PCO theory’.
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□  1 st year 
■  2nd year
□  3rd year
□  4th year
Non-diabetic/non- Diabetic Uveitic Multifocal
uveitic
Figure 6-1. Summary of the incidences of Nd:YAG laser capsulotomy in non- 
diabetic/non-uveitic patients, diabetic and uveitic. The incidences increased 
gradually over the 4 years (including in those with multifocal IOL). A drop in 
the incidence occurs after the third year in both diabetic and uveitic patients.
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In uveitis patients, in addition to young age, postoperative uveitis and the use o f 
hydrophilic acrylic im plants were associated with a higher Nd:YAG capsulotomy 
rates over the follow-up period. The use o f silicone IOLs and prophylactic systemic 
steroids were associated with a lower risk.
Y oung age was a risk factor for developing PCO in patients with multifocal IOLs. 
These patients presented for Nd:YAG capsulotomy with earlier loss o f high and 
low-contrast acuity than those with monofocal IOLs. This suggests that functional 
loss can potentially increase the rate o f Nd:YAG capsulotomy in these patients.
201
Summary and future directions
Table 6-1. Risk factors for PCO/Nd:YAG capsulotomy identified in the different
studies
Non-diabetic/Diabetic Uveitis Multifocal IOL
Studies Study Study
Increased risk Young age Young age Young age
PH silicone IOL* Hydrophilic acrylic
IOLf
PMMA IOL**
Postoperative uveitis Postoperative uveitis
(within 3 months) (within 3 months)
Pars plana vitrectomy
Decreased risk Diabetes mellitus Prophylactic steroids
Hydrophobic acrylic IOL 3-piece silicone IOLf
(AcrySof)$
PH silicone IOLf
PH=plate-haptic, PM M A=polym ethylm ethacrylate
* Reference IOL was 3-piece silicone IOL & hydrophobic acrylic IOL
** Reference IOL was 3-piece silicone
'(■Reference IOL was polym ethylm ethacrylate (PMMA) IOL
:fThe rate o f PCO form ation after 6 m onths and 1 year was compared to that o f PH 
silicone IOL
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From the prev ious studies, there are clearly still unresolved issues that should be 
addressed in fu ture studies. Although we found a tendency for diabetic patients to 
have a low er incidence o f  N d:Y A G  capsulotomy, the bias o f  the retrospective design 
have lim ited our conclusion from that finding. A prospective long-term case-control 
study o f  a single-surgeon, using a single-implant will be a pre-requisite to validly 
establish the relative incidences o f this com plication in diabetic and non-diabetic 
patients. O bjective photographic assessment as well as functional and subjective 
assessm ent o f  PCO  w ill perhaps be more clinically relevant than using either o f them 
alone in such a study.
The developm ent o f  postoperative inflamm ation is one o f the modifiable risk factors 
that was identified in our studies to increase the risk for requiring Nd:YAG 
capsulotom y in diabetic and uveitic patient groups. Futhermore, in the latter group 
we found that the use o f  prophylactic systemic steroids preoperatively was associated 
with a low er risk for requiring Nd:Y AG  capsulotomy. Investigations are required o f 
the possible causa-effect relationship between postoperative inflammation and PCO 
developm ent. Also, the proposed beneficial effect o f  using peri-operative steroids in 
patients predisposed to postoperative inflam m ation or to increased rate o f PCO such 
as those o f  a relatively young age and those who underwent vitrectom y will need 
further studies.
The use o f  the high-resolution OCT should enable us to study the relationship 
between the posterior capsule and the different IOL optics in vivo. This should help 
to establish the required enhancem ent and modification o f the IOL designs to lower 
or prevent the PCO  developm ent. Correlating the different capsular features to the 
clinical and functional features m ay help to establish OCT as an additional beneficial 
PCO im aging technique.
Studies involving com parison o f  contem porary groups o f  patients with monofocal 
and m ultifocal IOLs will determ ine whether the latter group have a higher rate o f 
Nd:YAG capsulotom y that could be attributed to IOL multifocal design alone and its 
effect on visual function. The purpose-designed questionnaire that was used in 
assessing the subjective effect o f  PCO  on visual function o f patients with multifocal 
IOLs will need validation by  com paring it to other currently used and more 
established visual function questionnaires i.e. VF-14 in order to enable its use in 
future studies o f  PCO  assessm ent.
203
Publications and presentations
7 PUBLICATIONS AND PRESENTATIONS 
GENERATED FROM THIS THESIS
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Elgohary M A , C hauhan DS, D owler JFG. Optical Coherence tomography o f the 
relationship  betw een the posterior capsule and plate-haptic silicone and 
acrylic IO Ls after phacoem ulsification. Accepted by Ophthalmic Research
Elgohary M A, H ollick EJ, D ow ler JFG, Bender L, Heatly C, W ren S, Spalton D:
Posterior capsular opacification after plate-haptic silicone and acrylic IOLs 
in diabetic patients. A ccepted by Journal o f  Cataract and Refractive 
Surgery
Elgohary M A, D ow ler JF. Incidence and risk factors o f  posterior capsular
opacification in non-diabetic and diabetic patients. Accepted by Journal o f  
Clinical and Experimental Ophthalmology
Elgohary M A, B eckingsale AB. Effect o f  illum ination on visual function in patients 
w ith m onofocal and multifocal intraocular lenses. Accepted by Eye
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m ethacrylate intraocular lens. R ef Eye News, 3, 22.
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Imaging
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7.2 ORAL PRESENTATIONS
Outcom e o f  phacoem ulsification in patients w ith uveitis. European society o f Vision 
and Eye R esearch (EVER), Sept 2004
A nterior segm ent changes after cataract extraction in patients with diabetes mellitus.
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7.3 POSTER PRESENTATIONS
Effect o f  posterior capsular opacification on visual function o f patients with 
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Factors influencing posterior capsular opacification in diabetic and non-diabetic 
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A nnual Congress, M ay 2002
Evaluation o f  the lens capsule w ith the optical coherence tomography. Elgohary MA, 
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Effect o f  diabetes, diabetic retinopathy and surgical technique on the incidence of 
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